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SUMMARY 
The aim of this work was to purify type-specific glycoproteins from 
herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) for diagnos-
tic use. The most likely candidate for a type-specific glycopro-
tein of HSV-1 is glycoprotein C (gC), although it has recently been 
shown to contain some type-common antigenic determinants. 
HSV-1 and HSV-2 were produced in BHK-21 cells and labelled with 
either (3H)-glucosamine ((3H)-gln) or a mixture of (14c)-amino 
acids ((14c)-aa). Analysis of the radiolabelled products by analy-
tical sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SOS-PAGE) and autoradiography revealed that in the HSV-1 infected 
cells the radiolabelled components were incorporated into viral 
specific proteins only, whereas in the HSV-2 infected cells they 
were incorporated into host cell proteins as well as viral pro-
teins. 
Preparative polyacrylamide gel electrophoresis (Prep-PAGE) was used 
as an initial step in separating HSV-1 infected cell proteins la-
belled with (3H)-gln. Two cycles of Prep-PAGE were sufficient to 
produce solutions containing either glycoprotein B ( gB) or glyco-
(i) 
protein C (gC), which were free of other HSV-1 glycoproteins. 
However, these solutions still contained a number of non-glycosy-
lated proteins. 
Two different techniques were utilized to remove the non-glycosyla-
ted proteins from the glycoprotein solutions. Hydroxylapatite (HA-
Ultrogel) chromatography in the presence of sodium dodecyl sulphate 
(SDS-HTP) did not separate the different HSV-1 glycoproteins and 
was not satisfactory for removing the non-glycosylated proteins. 
Gel-bound lectin affinity chromatography using wheat germ lectin 
and Helix pomatia lectin was not successful in purifying the glyco-
proteins because the glycoproteins which bound to the lectins could 
not be eluted under normal conditions. 
Difficulties encountered in eluting the HSV-1 glycoproteins from 
the lectins may have been due to the sodium dodecyl sulphate (SOS) 
in which the proteins were solubilized. For this reason, the gel-
bound lectin affinity chromatography was repeated using HSV-1 mem-
brane proteins solubilized in a non-ionic detergent, Triton X-100. 
Using material prepared in this way, several HSV-1 glycoproteins 
were bound by wheat germ lectin and eluted under normal conditions 
to yield glycoproteins which were purified with respect to non-
glycosylated proteins. 
(ii) 
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1 
INTRODUCTION 
VIRUS STRUCTURE 
Herpes Simplex virus (RSV) is a member of the Herpesvirus family. 
The herpesviruses are large DNA viruses characterized by capsids of 
approximately 100 nm in diameter. Like other herpesviruses, the 
virions of RSV consist of four major architectural components (Fig-
ure 1) (Roizman & Furlong, 1974) : 
1. A centrally located DNA core. 
2. A capsid containing 162 capsomers arranged in the form of 
an icosadeltahedron. 
3. A tegument, which is the granular zone surrounding the 
capsid. 
4. An envelope consisting of a trilaminar membrane with 
spikes projecting from its outer surface. 
The spikes projecting from the outer surface of the envelope are, 
in fact, virus specific antigens (Figure 1). These antigens have 
been shown to be the major, if not exclusive, targets of neutrali-
zing antibodies (Courtney & Benyesh-Melnick, 1974; Honess et al, 
1974; Norrild et al, 1978(a)). The same antigens are found on 
infected cell surfaces (Glorioso & Smith, 1977; Norrild et al, 
1978(b)), and their presence early in the infectious cycle, before 
the production of active ·virus, makes them potentially important 
a 
Envelope 
b 
2 
Surface 
glycoproteins 
3 
target antigens for the control of virus spread by destruction of 
infected cells (Shore et al, 1979). These antigens have been shown 
to be glycoproteins (Spear, 1976; Glorioso & Smith, 1977; Pauli & 
Ludwig, 1977; Norrild et al, 1979, 1980; Sarmiento et al, 1979; 
Glorioso et al, 1984). 
RSV SPECIFIC PROTEINS 
Upon infection of a cell with RSV, the viral DNA finds its way to 
the cell nucleus and is transcribed. The viral RNA sequences are 
transported from the nucleus to the cytoplasm, where the proteins 
are synthesized (Roizman & Furlong, 1974). The viral specified 
polypeptides may be divided into three sequentially synthesized, 
co-ordinately regulated groups, designated a , f3 and Y The a -
group, which consists mainly of non-structural proteins, is produ-
ced independently of prior infected cell synthesis mainly between 
3-4 hours post-infection. The f3 -group, consisting of minor struc-
tural and non-structural proteins, is produced at the highest rate 
between 5-7 hours post-infection. The f3 -group is dependent on both 
prior a polypeptide synthesis and new RNA synthesis. The Y -group, 
consisting of major structural polypeptides, is synthesized at 
increasing rates until at least 12 · hours post-infection, and is 
dependent on prior synthesis of f3 -polypeptides (Roness & Roizman, 
1974). 
Using SDS-polyacrylamide gel eletrophoresis (SDS-PAGE) and auto-
radiography, herpes simplex virus has been shown to induce between 
4 
44 and 52 polypeptides in infected cells (Honess & Roizman, 1973; 
Powell & Courtney, 197 5; Marsden, Crombie & Subak-Sharpe, 1976; 
Morse et al, 1978). Approximately 12 of these polypeptides have 
been shown to be glycosylated (Heine et al, 19741 although some of 
these are precursors of the fully glycosylated proteins (Spear, 
1976; Baucke & Spear, 1979). The major glycoproteins have been 
designated gC, gB, gA, gE and gD (Spear, 1976; Baucke & Spear, 
1979; Pereira et al, 1980). However, it has been shown that gA and 
gB are, in fact, different forms of the same polypeptide (Eberle & 
Courtney, 1980(b); Person et al, 1982; Pereira et al, 1982) (See 
Chapter 3.1.1 for a discussion of the nomenclature of the HSV-1 
g lycoproteins). Most, if not all, the glycoproteins fall into the 
Y- g roup of polypeptides (Honess & Roizman, 1974). 
By the use of antisera and monoclonal antibodies that reacted spe-
cifically with the viral glycoproteins of HSV-1, and pulse-chase 
experiments, polypeptide precursors to the major glycoproteins of 
HSV-1 have been identified. This work has demonstrated that the 
major glycoproteins are glycosylated in discrete steps consisting 
of partially glycosylated intermediates and a fully glycosylated 
product (Spear, 1976; Cohen et al, 1978; Eisenberg et al, 1979; 
Baucke & Spear, 1979; Compton & Courtney, 1984(a); 1984(b)). 
FUNCTIONS ASSOCIATED WITH THE GLYCOPROTEINS OF RSV 
Since viral glycoproteins are the major constituents of the virion 
surface, and the insertion of viral glycoproteins into the plasma 
5 
membrane is the most noticeable change in the plasma membrane of 
infected cells (Glorioso & Smith, 1977; Pauli & Ludwig, 1977), 
certain functions have been attributed to the viral glycoproteins. 
These functions are the adsorption and penetration of the virion 
into uninfected cells during the initiation of infection, the in-
teraction of infected cells among themselves in cell culture, and 
the expression of Fe receptors and complement receptors. Mutants 
which are defective in glycoprotein synthesis and mutants with 
altered functions which are related to or mediated by viral mem-
brane proteins have been used in determining the functions of HSV 
glycoproteins. 
(a) Virion Infectivity 
Events which occur during the initiation of infection are 
adsorption of virus to the cell surface, fusion of the enve-
lope with the plasma membrane, and dissolution of the fused 
membrane. Glycoprotein gC is not required for any of these 
functions since HSV-1 mutants such as HSV-1 (MP), which lack 
this glycoprotein, are still infectious (Ejercito et al, 1968; 
Manservigi et al, 1977; Norrild et al, 1979). Glycoprotein 
gB appears to be required at least for the penetration of 
virions into the cell because the HSV-1 mutant, HSV-1 (HFEM) 
tsB5, which does not produce gB at the nonpermissive tempera-
ture, adsorbs but does not penetrate into the cell. This is 
supported by the fact that the addition of polyethylene glycol 
6 
(PEG) to the cells after adsorption, significantly increased 
the infectivity (Sarmiento et al, 1979). 
The importance of gB in the initiation of infection is also 
demonstrated by the fact that antisera raised to gC will only 
neutralize HSV-1 in the presence of complement (complement-
dependent), whereas antisera raised to gB does not require 
complement for neutralization (complement-independent). This 
suggests that antibodies to gB bind to sites which are inti-
mately associated with the HSV-1 surface sites which determine 
virus infectivity (Eberle & Courtney, 1980(a)). 
(b) Cell Fusion 
The change in the cell-to-cell interactions is demonstrated by 
the fact that some variants of HSV-1 and HSV-2 cause fusion 
rather than rounding and clumping (Ejercito et al, 1968; 
Ruyechan et al, 1979). Gene mapping of several viral mutants 
causing cell fusion has revealed that there are at least three 
genetic loci, designated syn 1, syn 2 and syn 3, which deter-
mine cell fusion (Ruyechan et al, 1979). Loci syn 1 and syn 2 
do not map in the position of the structural genes of any of 
the major glycoproteins, whereas the syn 3 locus maps within 
the position assigned to the structural protein of glycopro-
tein B (gB). Hence, gB appears to play a role in cell fusion 
as well as viral penetration. 
7 
(c) Expression of Receptors 
Cells infected with RSV have been shown to express new recep-
tors. One of these receptors has affinity for the Fe region 
of IgG and another has affinity for the activated C3b compo-
nent of complement. These receptors have been shown to be 
composed partially or completely by some of the RSV glycopro-
teins. 
1. Fe receptors. The presence of the Fe receptor on the 
surface of RSV infected cells was first shown by the 
adherence of sheep erythrocytes coated with antibody 
directed to sheep erythrocytes, to RSV infected cells 
(Watkins, 1964; 1965). This finding has since been con-
firmed using normal IgG, the purified Fe fragment and 
soluble immune complexes (Westmoreland & Watkins, 1974; 
Adler et al, 1978; Nakamura et al, 1978; Dowler & Veltri, 
1984). 
Glycoprotein E (gE) of HSV-1 and RSV-2 has been purified 
using affinity columns consisting of rabbit antibodies 
bound to Sepharose 4B. The affinity of gE for the rabbit 
antibodies, as well as other properties of the glycopro-
tein, have shown that gE is the antigen responsible for 
Fe binding activity (Baucke & Spear, 1979; Para et al, 
1982). 
2. 
8 
C3b receptors. Cells infected with HSV-1, but not HSV-2, 
have been found to express receptors for the C3b compo-
nent of complement. These receptors are not expressed on 
cells infected with the mutant strain HSV-1 (MP), which 
lacks gC, and are blocked by monoclonal antibodies direc-
ted against gC, but not any of the other HSV-1 glycopro-
teins. For these reasons, gC appears to be partially or 
totally responsible for C3b receptor activity (Friedman 
et al, 1984). 
IMMUNOLOGIC REACTIVITY OF RSV GLYCOPROTEINS 
(a) On the surface of intact virions 
Humans and experimental animals which have recovered from RSV 
infections are known to produce antibodies which neutralize 
the infectivity of RSV (Plummer, 1964; Pauls & Dowdle, 1967). 
The targets for neutralizing antibodies are believed to be 
antigenic determinants on the surface of the virion envelope 
because : 
1. The virion envelope is essential for infectivity ( Stein 
et al, 1970; Sarmiento et al, 1979) and is impermeable to 
micromolecules and electrolytes (Roizman & Furlong, 
1974). Hence, neutralizing antibodies do not cause neu-
tralization by attaching to non-envelope proteins. 
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2. Analysis of purified virions has shown that they contain 
four major and several minor glycoproteins in the enve-
lope (Glorioso et al, 1983) and labelling of the virion 
by several methods has shown that the glycoproteins are 
at the external surface of the virion (Olshevsky & 
Becker, 1972; Sarmiento et al, 1979; La Thangue et al, 
1984). 
3. Antibodies raised to the individual RSV glycoproteins 
also neutralize the virion (Powell !:!_~, 197 4; 
Vestergaard & Norrild, 1989; Eberle & Courtney, 1980(a); 
Spear 1985). 
(b) In the plasma membrane of infected cells 
The presence of viral specific determinants on the surface of 
RSV infected cells has been shown using several different 
techniques including complement mediated immune cytolysis 
(Glorioso et al, 1983), antibody-dependent cell-mediated cyto-
toxicity (ADCC) (Norrild, Shore & Nahmias, 1979; Norrild & 
Pedersen, 1982), immunofluorescence (Hayashi et al, 1973, 
Glorioso & Smith, 1977; Norrild et al, 1978(b)) and detection 
of the Fe and C3b receptors (Baucke & Spear, 1979; Friedman~ 
al, 1984). The incorporation of these viral glycoproteins 
into the plasma membrane of infected cells plays an important 
role in the destruction of infected cells by antibody depen-
dent immune effector reactions (Shore et al, 1979). 
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TWO SEROTYPES OF RSV 
The existence of two serotypes of RSV, type 1 (RSV-1) and type 2 
(HSV-2), has been firmly established on the basis of antigenic and 
biological differences (Plummer, 1964; Nahmias & Dowdle, 1968; 
Figuera & Rawls, 1969; Rawls, 1973). 
HSV-1 and RSV-2 also differ in the base composition and sequence 
homology of their DNAs (Ludwig et al, 1972) and the use of restric-
tion endonucleases has demonstrated that the electrophoretic pro-
files of different RSV-1 strains could be readily distinguished 
from the corresponding profiles of RSV-2 strains (Hayward et al, 
1975; Buchman et al, 1978; 1979). There are also differences in 
the electrophoretic mobilities of many of the structural and non-
structural polypeptides of the two serotypes (Morse et al, 1978; 
Ruyechan et al, 1979). 
Despite these differences, RSV-1 and HSV-2 show many similarities. 
For instance, there is considerable homology between their DNAs 
(Kieff et al, 1972; Draper et al, 1984; Swain et al, 1985) and most 
of the major glycoproteins contain type-common as well as type-
specific regions (Zezulak & Spear, 1983; Koussoulas et al, 1984; 
Eisenberg et al, 1985, Spear, 1985). 
PROBLEMS ARISING FROM TWO SEROTYPES OF RSV 
For a number of years studies have been conducted on the social and 
environmental factors related to the development of cervical carci-
11 
noma. It was noticed that this cancer has an epidemiologic pattern 
very similar to that of venereal diseases, and it was suspected 
that carcinoma of the cervix may be totally or partially caused by 
an infectious agent which is transmitted during sexual inter-
course. 
Interest in determining the incidence of type 1 and type 2 RSV 
antibodies in cervical cancer patients was stimulated by the find-
ing that over 95% of RSV strains recovered from the female genital 
tract are type 2 (Nahmias et al, 1969) and by the observation that 
a group of women with known genital herpetic infection had a higher 
than expected rate of cervical anaplasia (Naib et al, 1969). 
However, the immunological cross-reactivity between both the sur-
face and internal antigens of the two virus types, and the exten-
sive immunity of the general population to HSV-1, have been major 
problems in seroepidemiological studies attempting to define the 
relationship of HSV-2 to cervical carcinoma (Rawls et al, 1970; 
Nahmias et al, 1970; Seth et al, 1978). For this reason the need 
has arisen to develop a type-specific diagnostic test which will be 
able to distinguish between patients that have been infected with 
HSV-1, HSV-2 or both HSV-1 and HSV-2. 
PRODUCTION OF ANTISERA TO THE MAJOR GLYCOPROTEINS OF HSV-1 
The viral surface glycoproteins of RSV have been shown to be the 
major if not exclusive targets of neutralizing antibodies (Sim & 
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Watson, 1973; Courtney & Benyesh-Melnick, 1974; Honess et al, 1974; 
Powell et al, 1974; Norrild et al, 1978(b».several procedures have 
been used to obtain antisera reacting mainly with antigenic deter-
minants specified by individual viral glycoproteins (Table I). 
(a) Glycoprotein C (gC) 
Spear produced antiserum to gC by injecting a suspension of 
HSV-1 (F) envelope proteins in Freund' s adj uvant into rabbits 
and adsorbing the resultant antiserum with HSV-1 (MP)-infected 
cell homogenates. (HSV-l(MP) is a mutant strain lacking gC 
(Spear, 1976)). 
specific for gC. 
The resultant antiserum was not entirely 
The VP 2/3 region of HSV-1 which is equivalent to the VP 123 
region of HSV-1 (Dreesman et al, 1979; Eberle & Courtney, 
1980(a)) and consists of glycoproteins gA/gB and gC, as well 
as a non-glycosylated protein (Eberle & Courtney, 1980 (a)), 
was isolated by means of SDS-polyacrylamide gel electrophore-
sis (SDS-PAGE). The appropriate section of PAA gel containing 
the VP 2/3 region was cut out, macerated and injected with 
Freunds incomplete adjuvant into rabbit~. The resultant anti-
serum was tested by neutralization against HSV-1 and HSV-2 and 
was shown to be comparatively but not totally specific for 
HSV-1 (Powell et al, 1974; Powell & Watson, 1975). 
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Crossed immunoelectrophoresis of RSV antigens obtained from 
infected cells solubilized with the non-ionic detergent, 
Triton X-100, shows Ag-6 (ie gC) in HSV-1 but not HSV-2. 
Monospecific antiserum was produced against Ag-6 by intracuta-
neous inoculation of the corresponding immunoprecipitate into 
rabbits (Vestergaard & Norrild, 1978). The antibodies to Ag-6 
were absolutely type-specific for HSV-1 by the reactions in 
rocket immunoelectrophoresis, but the plague reduction test 
showed a slight cross-reactivity with HSV-2. 
Antiserum raised to gC, which was purified using preparative 
PAGE and SDS-hydroxylapatite chromatography, was found to be 
specific for gC (Eberle & Courtney, 1980(a)). 
More recently, monoclonal antibodies to gC have been produced 
(Pereira et al, 1980; Showalter et al, 1981; Pereira et al, 
1982(b); Chan, 1983; Goldstein et al, 1983; La Thangue et al, 
1984; Marlin et al, 1985). These monoclonal antibodies were 
specific for HSV-1. 
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TABLE 1 - ANTIBODY PREPARATIONS TO INDIVIDUAL HSV-1 
SPECIFIED GLYCOPROTEINS (Adapted from Norrild, 1980) 
Reactive 
to Glyco-
protein 
gC 
gB 
gE 
gD 
Method of Preparation Reference 
Adsorption of polyspecific Spear, 1976 
serum with HSV-l(MP) infected 
cells. 
Inununization with the poly-
peptide gC. 
Immunization with immuno-
precipitate Ag-6 from crossed 
immunoelectrophoretic gels. 
Monoclonal antibodies 
Immunization with the immuno-
precipitate Ag-11 from cross 
immunoelectrophoretic gels. 
Innnunization with the poly-
peptide gA/gB. 
Monoclonal antibodies 
Immunization with purified 
gE. 
Monoclonal antibodies 
Powell, et al, 1974 
Powell & Watson, 
1975, Eberle & 
Courtney, 1980 (a) 
Vestergaard & 
Norrild, 1978 
1,2,3,6,7,8,10 (a) 
Norrild et al, 
1978, 1979 
Vestergaard & 
Norrild, 1979 
Eberle & Courtney, 
1980 ( a) 
2,3,6,9 (a) 
Baucke & Spear 1979 
4 (a) 
Immunization with the immuno- Watson & Wildy, 
precipitate of band II antigen 1969 
isolated in Ouchterlony gels. 
Inununization with the poly-
peptide gD. 
Immunization with the immuno-
precipitate Ag-8 from crossed 
immunoelectrophoretic gels. 
Immunization with purified 
protein CP-1 
Monoclonal antibodies 
Powell & Watson, 
1975 
Vestergaard & 
Norrild, 1979 
Cohen et al, 1978 
1,2,3,4,5,6,8 (a) 
(a) Monoclonal antibodies were produced by the following:-
1 - Pereira et al, 1980 6 Chan, 1983 
2 - Showalter et al, 1981 7 Goldstein et al, 1983 
3 - Pereira et al, 1982 8 La Thangue et al, 1984 
4 - Balachandran et al, 1982 9 Kousoulas et al, 1984 
5 - Eisenberg et al, 1982 10 - Marlin et al, 1985 
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(b) Glycoprotein B (gB) 
Antibodies to Ag-11 of HSV-1 (an alternative designation for 
gB) have been produced by inoculating rabbits with the immuno-
precipitate of Ag-11. HSV-1 infected cells were solubilized 
in Triton X-100 and the resultant solution was subjected to 
crossed immunoelectrophoresis against polyspecific antiserum 
to HSV-1. The immunoprecipitate corresponding to Ag-11 was 
cut out of the wet, unstained agarose and disrupted by sonica-
tion. The disrupted gel was mixed with Freund' s incomplete 
adjuvant and injected intracutaneously into rabbits. The 
resultant serum was specific for a glycopolypeptide with a 
molecular weight of 125K which was common to HSV-1 and HSV-2 
(Norrild et al, 1978; Vestergaard & Norrild, 1979). 
The HSV-1 glycoprotein, gA/ gB, has been purified by means of 
preparative PAGE followed by SDS-HTP chromatography. Anti-
serum raised to this glycoprotein, in rabbits, was found to be 
specific for gA/gB and was cross-reactive with HSV-2 (Eberle & 
Courtney, 1980(a)). 
Monoclonal antibodies have also been produced to gB (Showalter 
et al, 1981; Pereira et al, 1982(b); Chan, 1983; Kousoulas ~ 
al, 1984). Some of these antibodies are type specific, but 
most are type-connnon. 
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(c) Glycoprotein E (gE) 
Affinity .chromatography was used to isolate the Fe-binding 
glycoprotein of HSV-1, glycoprotein E (gE) (Baucke & Spear, 
1979). After elution from the affinity column, gE was puri-
fied further by preparative polyacrylamide gel electrophore-
sis. Antibody produced to purified gE neutralized HSV-1, but 
only in the presence of complement. 
A glycoprotein which is functionally and antigenically related 
to glycoprotein E of HSV-1 has been isolated from cells infec-
ted with HSV-2. This glycoprotein is clearly not identical to 
gE of HSV-1 because of differences shown in their apparent 
molecular weights and because of antigenic differences shown 
by neutralization assays (Para et al, 1982). 
Monoclonal antibodies have only been produced to gE of HSV-2 
(Balachandran et al, 1982, Pereira et al, 1982(b)), and these 
are specific for HSV-2. 
(d) Glycoprotein D (gD) 
Watson and Wildy prepared an antiserum to VP 8/9(gD) of HSV-1. 
They obtained a fraction giving a single (Band II) precipitin 
band with antiserum to herpes infected cells in immunodiffu-
sion reactions. Gel containing the single band was cut from 
the immunodiffusion plates, pulverized in an equal volume of 
Freunds incomplete adjuvant and injected into rabbits (Watson 
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& Wildy, 1969). The resultant antiserum was reactive with 
HSV-1 and HSV-2 (Powell et al, 1974; Powell & Watson, 1975). 
Antisera to VP8/9(gD) was also prepared by disrupting virus 
particles using SDS, urea, and dithiothreitol, and electro-
phoresis of the structural virus polypeptides on 7% polyacryl-
amide gels. After electrophoresis, segments of gel containing 
VP8/9 were pooled and homogenized in Freund's incomplete adju-
vant prior to injection into rabbits. The antiserum reacted 
with HSV-1 and HSV-2 antigens but was more reactive with HSV-1 
(Powell & Watson, 1975). 
The immunoprecipitate produced to Ag-8 (gD) of HSV-1 by cros-
sed immunoelectrophoresis of Triton X-100 solubilized HSV-1 
infected cells against HSV-1 antiserum, was cut from the un-
stained wet gel. The gel was disrupted by sonication, mixed 
with Freunds incomplete adj uvant and injected into rabbits 
(Vestergaard & Norrild, 1979). The antiserum reacted with 
both HSV-1 and HSV-2, but was more reactive with HSV-1. 
The CP-1 antigen (gp52 or gD) of HSV-1 was purified using a 
six-step procedure involving centrifugation, precipitation 
with ammonium sulphate, calcium phosphate chromatography, CM 
Sephadex C25 chromatography, DEAE - cellulose 23 chromatogra-
phy, and a second step of calcium phosphate chromatography 
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(Cohen et al, 1978). Antiserum raised in rabbits to CP-1 
(anti-CP-1) contained type-common neutralizing antibodies. 
Monoclonal antibodies have been produced to glycoprotein gD of 
HSV-1 and HSV-2 (Pereira et al, 1980; Showalter et al, 1981; 
Balachandran et al, 1982; Pereira et al, 1982(b); Eisenberg~ 
' 
a 1, 1982; Chan, 1983; La Thangue, 1984). These monoclonal 
antibodies have been shown to be both type-specific and type-
common, showing that gD contains both type-common and type-
specific antigenic determinants (Dietzschold et al, 1984; 
Eisenberg et al, 1985). 
THE NEED FOR A TYPE-SPECIFIC DIAGNOSTIC TEST FOR HSV 
As mentioned earlier, the need to develop a type-specific diagnos-
tic test for screening patients for past infection with either HSV-
1, HSV-2 or both HSV-1 and HSV-2, arose from seroepidemiological 
studies attempting to define the relationship of HSV-2 to cervical 
carcinoma. Such a test for antibodies to HSV-1 or HSV-2 would 
require the purification of relatively large amounts of antigens 
containing exclusively or predominantly type-specific antigenic 
sites. A major obstacle to the development of such a test has been 
the difficulty in separating glycoprotein antigens of HSV-1 from 
host cell and other viral proteins, as well as fran one another. 
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PURIFICATION OF GLYCOPROTEIN C (gC) OF HSV-1 
Until recently, when studies using cross-reactive monoclonal anti-
bodies and polyclonal antisera specific for gC showed that HSV-1 gC 
(gC-1) and HSV-2 gC ( gC-2) do share limited antigenic homology 
(Zezulak & Spear, 1983; Zweig et al, 1983(a), 1983(b)), glycopro-
tein C (gC) of HSV-1 appeared to be the most likely candidate for 
an HSV-1 specific antigen, since serological tests performed with 
antisera raised to gC-1 showed that it contained almost exclusively 
HSV-1 specific sites (Powell et al, 1974, Spear, 1976; Vestergaard 
& Norrild, 1978; Vestergaard & Grauballe, 1979; Eberle & Courtney, 
1980; Goldstein et al, 1983; Schrier et al, 1983). Thus, several 
techniques have been used in attempts to obtain purified prepara-
tions of gC in quantities which are suitable for use in diagnostic 
procedures. The techniques that have been used are as follows : 
(a) Hydroxylapatite chromatography 
Fused rocket and crossed immunoelectrophoresis of fractions 
obtained from hydroxylapatite chromatography of crude HSV-1 
antigen showed that a subfraction of Ag-6 (gC) could be sepa-
rated from the other HSV-1 antigens. The product was used in 
an enzyme-linked immunosorbent assay (ELISA) and was shown to 
react only with HSV-1 antisera (Vestergaard & Grauballe, 
1979). 
An antigen produced by the same method was found to be HSV-1 
specific in inducing delayed hypersensitivity (DH) reactions 
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in mice. Mice immunized with HSV-1 gC did not respond to 
challenge with HSV-2, nor did mice immunized with HSV-2 re-
spond to challenge with HSV-1 gC (Schrier, Pizer & Moorhead, 
1983). 
(b) Gel-bound lectin affinity chromatography 
When lysates from HSV-1 and HSV-2 infected cells were subjec-
ted to affinity chromatography on soybean and Helix pomatia 
lectins, glycoprotein C (gC) was found to bind to the lectins 
and was eluted with N-acetyl-galactosamine (GalNAc). Affinity 
chromatography permitted a high degree of purification of the 
type-specific glycoprotein with respect to both host cell 
components and other viral proteins (Olofsson, Jeansson & 
Lycke, 1981; Svennerholm et al, 1984). 
Antigens purified by Helix pomatia lectin affinity chromatog-
raphy have been used in an enzyme-linked immunosorbent assay 
(ELISA). The type specificity of the antigens was assessed by 
double-immunodiffusion precipitation in gel against rabbit 
HSV-1 and HSV-2 hyper immune sera, and by ELISA with human 
reference sera containing antibodies to either type of HSV. 
The results showed that the antigens were specific for the 
type-specific antibodies of HSV-1 and HSV-2, respectively 
(Svennerholm et al, 1984). 
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(c) Preparative-PAGE and hydroxylapatite chromatography in the 
presence of sodium dodecyl sulphate 
The major glycoprotein region of HSV-1 (VP123) was purified by 
preparative PAGE (Prep-PAGE) and further fractionated into two 
major and two minor components by chromatography of the isola-
ted VP123 region on SDS-hydroxylapatite columns. The two 
major components (gC and gA/gB) were purified free of other 
polypeptides and used to prepare specific antisera to these 
glycoproteins (Eberle & Courtney, 1980). No tests were per-
formed to determine the type-specificity of the products. 
(d) HSV-1 glycoproteins, gC, gB and gD have each been purified by 
means of immunoadsorption chromatography using monoclonal 
antibodies directed against the respective glycoproteins 
(Eisenberg et al, 1982; Roberts et al, 1985). 
(e) Recent advances in recombinant DNA technology now make it 
possible to produce virtually unlimited quantities of purified 
viral antigens without resorting to large-scale cultivation of 
the infectious pathogen. Using this technology, the HSV-1 
glycoprotein, gD, has been produced in Escherichia Coli (Weis 
et al, 1983) and in the genetically engineered mammalian cell 
line gD 10.2 (Berman et al, 1985). Although, to date, there 
are no reports of the production of gC by this procedure, it 
should be the obvious method of the future for producing large 
22 
quantities of RSV type-specific antigens for use in diagnostic 
tests. 
THE AIM OF THE PRESENT WORK 
The aim of the present work was to develop a procedure for purify-
ing the type-specific proteins of HSV-1 and HSV-2, and to use these 
antigens in a suitable diagnostic procedure for testing sera for 
the presence of antibodies to either HSV-1 or HSV-2. 
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CHAPTER I: PRODUCTION OF HERPES SIMPLEX VIRUS 
1.1. INTRODUCTION 
1.1.1. Growth of Herpes Simplex Virus 
A wide variety of animals can be infected with herpes 
simplex virus (RSV), experimentally. Rabbits and mice 
are particularly susceptible, but the virus has also been 
used to infect many other species of mammals including 
rats, hamsters, guinea pigs and cotton rats. Embryonated 
eggs are also susceptible to experimental infection with 
RSV (Darlington & Granoff, 1973). 
Until the development of cell culture techniques (Enders, 
Weller & Robbins, 1949) RSV production and infectivity 
experiments were performed using live animals. The de-
velopment of cell culture techniques at this time was 
largely due to the discovery and use of antibiotics as 
well as the production of media which would support cell 
growth in vitro. As a result of these improved cell 
culture techniques, and because of the inconvenience of 
using large numbers of live animals, RSV production and 
infectivity experiments are now performed almost exclu-
sively in cell culture. The host range of herpes virus 
infectivity for cell cultures frequently parallels the in 
vivo host range, although the virus is usually found to 
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TABLE 1.1 - GROWTH OF HERPES SIMPLEX VIRUS IN CELL CULTURES 
(Taken from Darlington & Granoff, 1973) 
CELL DONOR 
Human 
Rabbit 
CELL TYPE 
Human amnion 
Human fibroblast 
Rabbit Kidney 
Rabbit lung 
REFERENCE 
Ousterhout & Tamm (1959) 
Enders (1953) 
Barski et al (1955) 
Sosa-Martinez et al (1955) 
Kaplan (1957) 
Szanto ( 1960) 
Rat Rat lung Szanto (1960) 
Mouse Mouse fibroblasts Scherer (1953) 
Cat Feline kidney Crandell (1959) 
Pig Swine kidney Hancock et al (1959) 
Hamster Hamster kidney 
Chinese hamster 
Tortoise Tortoise kidney 
Marmoset Marmoset kidney 
Chick Chick embryo 
Malignant Cells HeLa 
KB 
HEp-2 
Rous sarcoma 
Watson & Wildy (1963) 
Hampar & Ellison (1963) 
Fauconnier (1963) 
Schur & Holmes (1965) 
Stulberg & Schapira (1953) 
Stoker (1959) 
Scherer & Syverton (1954) 
Hinze & Walker (1961) 
Kaplan (1957) 
Nankervis et al (1959) 
1. l. 2. 
25 
infect a greater number of cell species than animals 
(Darlington & Granoff, 1973). A list of cells which 
support herpes simplex virus replication appears in Table 
1.1. 
Production of RSV for the purification and study of its 
membrane glycoproteins has been performed in several 
different cell types. Some of the more common cell types 
that have been used in this work are: rabbit cornea 
cells (Vestergaard, 1979; Vestergaard et al, 1977), HEp-
2 and Vero cells (Eberly & Courtney, 1980 & 1981; Spear, 
1976) and Baby Hamster Kidney (BHK-21) cells (Jeansson, 
Elwig & Nelsson, 1979; Cohen, Ponce de Leon & Diggelman, 
1980; Olofsson, Jeansson & Lycke, 1981; Svennerholm et 
al, 1984). In the present work, both HEp-2 and BHK-21 
cells were initially evaluated for the production of RSV, 
and BHK-21 cells were found to be more suitable because 
they grew better and yielded an adequate amount of 
virus. 
Purification of Herpes Simplex Virus 
Analyses of chemical and some biological properties of 
herpes viruses requires purified virions. However, her-
pes viruses are notoriously difficult to purify for a 
number of reasons which stem from several biological 
features of these viruses 
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1. They are unstable and tend to lose their envelopes 
easily. 
2. They have a tendency to aggregate. 
3. A large proportion of the progeny virus remains 
intracellular. 
4. On account of the cell associated nature of the 
virus, cellular debris, and in particular membrane 
vesicles, often contaminate preparations of purified 
virus (Gentry & Randall, 1973). 
The solution to the problem of purity has depended on 
improved methods of preparation. Some of the techniques 
which have been used in attempts to purify enveloped 
herpes viruses are as follows : 
1. Caesium chloride (CsCl) density gradient centrifuga-
tion (Spring & Roizman, 1967; Sydiskis, 1969). 
2. Centrifugation on cushions of 60% (w/w) sucrose 
followed by dilution of the virus containing band 
and pelleting of the virus by high speed centrifuga-
tion (Spear, Keller & Roizman, 1970). 
3. Sucrose or potassium tartrate density gradient cen-
trifugation (Abodeely, Lawson & Randall, 1970). 
4. Density gradient centrifugation in colloidal silica-
polyethylene glycol (Klingeborn & Pertoft, 1972). 
5. Separation of cell nuclei from infected cell cyto-
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plasm followed by centrifugation of the cytoplasm on 
dextran 10 gradients to separate virions from most 
cellular contaminants and sub-virion particles. 
Flotation of the partially purified virions through 
a discontinuous sucrose gradient removes most of the 
remaining contaminants (Spear & Roizman, 1972; 
Strnad & Aurelian, 1976). 
6. Centrifugation in density gradients of polyvinyl-
pyrrolidone-coated colloidal silica (Percoll) 
(Svennerholm et al, 1980). 
It appears that the technique of Spear and Roizman 
(1972), and also used by Strnad & Aurelian (1976), has 
been the most successful of these techniques in yielding 
purified herpes virions (Roizman & Furlong, 1974). 
In the present work, CsCl density gradient centrifugation 
of HSV-1 extracted from BHK-21 cells, produced a good 
yield of infectious virus. The addition of 1% foetal 
calf serum to the Cs Cl solution (Roizman & Roane, 1964; 
Spring & Roizman, 1967; Lancz & Sample, 1985) was suffi-
cient to protect the virus from disassembly and inactiva-
tion (Spring & Roizman, 1967). However, an electron 
microscopic study of the two light scattering bands for-
med by CsCl density gradient centrifugation revealed that 
the bands contained a considerable amount of cellular 
material as well as the viral and sub-viral particles. 
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On account of the difficulty encountered in obtaining 
purified herpes simplex virions, and because a large 
proportion of the RSV specific glycoproteins are incor-
porated into the membranes of the host cells, (Heine, 
Spear & Roizman, 1972; Olshevsky & Becker, 1972; 
Glorioso & Smith, 1977; Pauli & Ludwig, 1977) and would 
be lost by purification of the virus, it was decided to 
proceed with the purification of RSV glycoproteins, using 
a method that did not require prior purification of the 
virus. 
1.2. METHODS AND RESULTS 
The first stage in the production of herpes simplex virus was 
to obtain a suitable host cell line. Initially HEp-2 and BHK-
21 cells were evaluated for the production of RSV and BHK-21 
cells were favoured. The growth rate of BHK-21 cells in 10% 
MEM at 37°C was determined to calculate the cell concentration 
at the time of infection with HSV. 
1.2.1. Growth of herpes simplex virus in BHK-21 cell cultures 
A. Growth curve of BHK-21 cells in 10% MEM 
The growth rate of BHK-21 cells in 10% MEM was 
studied by growing BHK-21 cell cultures in twelve 
identical culture flasks (Appendix 2. l. 2). Each 
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flask was seeded with 5 ml of BHK-21 cell suspension 
containing 2, 0 x 105 cells/ml in 10% MEM, and then 
incubated at 37°C. At 12 hourly intervals 2 flasks 
were removed from the incubator and the cells har-
vested and counted (Appendix 2.1.4). 
B. Growth of HSV-1 and HSV-2 in BHK-21 cell cultures at 
37°c. 
The growth of HSV-1 and HSV-2 in BHK-21 cell cultur-
es at 37°C was studied by inoculating confluent cell 
monolayers with a range of virus dilutions. A range 
of virus dilutions was used to investigate the pos-
sibility of interference of virus production by 
defective interfering particles at the concentra-
tions of virus used (Huang & Wagner, 1966; Huang & 
Baltimore, 1977; Kang et al, 1978). 
BHK-21 cell cultures were grown in eight culture 
flasks. When confluent, they were inoculated with 2 
ml of RSV suspension as follows: 
I 
Bottle 
Bottle 
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Virus Type Concentration of Virus 
in Inoculum 
TCID50/ml 
1 HSV-1 106. 5 
2 HSV-1 105.5 
3 HSV-1 104.5 
4 HSV-1 103.5 
5 HSV-2 105.5 
6 HSV-2 104. 5 
7 HSV-2 103.5 
8 HSV-2 102. 5 
The virus was al lowed to adsorb to the cells for 1 
hour at 37°C before adding 20 ml of maintenance 
medium (Appendix 1.1.3 (d)) to each bottle and con-
tinuing incubation at 37°C. 
A 1 ml sample of the maintenance medium was removed 
from each culture flask at various time intervals 
and titrated on BHK-21 cells (Appendix 2.1.7). 
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Results 
BHK-21 cells grown in 10% MEM at 3 7 °C showed an initial 
drop in the number of live cells at 12 hours after seed-
ing. After this, the number of live cells increased at a 
constant rate of approximately 106 cells every 12 hours 
(Figure 1.1). The number of cells per flask reached a 
maximum at 60 hours after seeding and began to drop 
thereafter. The results show that there is approximately 
a 5-fold increase in the number of live cells after 60 
hours at 37°C (Table 1.2, Figure 1.1). 
The amount of infectious virus released into the growth 
medium was similar for HSV-1 and HSV-2 (Figure 1.2). At 
all the dilutions of inoculum used, there was a latent 
period of between 9 and 15 hours post-infection. After 
15 hours post-infection the amount of virus in the medium 
increased at a steady rate until 56 hours post-infection 
when the experiment was stopped. 
No plateau of virus titre was reached despite the fact 
that the cells showed 100% cytopathic effect (CPE). 
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TABLE 1.2 - CELL COUNTS OF BHK-21 CELLS GROWN IN 10% MEM AT 37°C 
Time of Incubation Total Cell Count (Cells/Flask) 
(Hours) Flask 1 Flask 2 Average 
0 1.0 X 106 1. 0 X 106 1.0 X 106 
12 0. 825 X 106 0.675 X 106 0.75 X 106 
24 1.23 X 106 1. 75 X 106 1.49 X 106 
36 2.83 X 106 3.05 X 106 2.94 X 106 
48 3.83 X 106 4.23 X 106 4.03 X 106 
60 4.65 X 106 5. 68 X 106 5.17 X 106 
72 5.10 X 106 4.83 X 106 4.97 X 106 
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Discussion 
When BHK-21 cell cultures were inoculated with a range of 
virus dilutions, the amount of extracellular virus in the 
culture medium only began to increase by 15 hours post-
infection. (Figure 1.2). The latent period was shown to 
be between 9 and 15 hours for HSV-1 and HSV-2. This is 
in agreement with previous reports (Darlington & Granoff, 
1973; Fenner et al, 1974). 
No plateau of virus titre in the culture medium was rea-
ched during this experiment despite all the cells showing 
a cytopathic effect. This is compatible with a continual 
accumulation of infectious virus being released into the 
culture medium. 
Although the amount of virus in the culture medium does 
not give an accurate indication of the growth of RSV in 
BHK-21 cells, the results show that because there was no 
reduction in the yield of infectious virus at any of the 
concentrations of inoculum used (Figure 1.2), interfer-
ence due to defective interfering (DI) particles would 
not be a consideration in the present work. 
1.2.2. 
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Test for mycoplasma infection in BHK-21 cell culture 
Mycoplasmas are known to be common contaminants of cell 
cultures which may produce various abnormal changes in 
cells growing in vitro (Hayflick, 1972; Chanock & Tully, 
1980), or they may go undetected because the contaminated 
culture grows well and appears normal by ordinary light 
microscopy. The BHK-21 cells used in the present work 
were investigated for mycoplasma infection as it was 
realized that mycoplasma infection could interfere with 
the results obtained. HeLa cells, which are known to be 
infected with mycoplasma (Macpherson & Allner, 1960; 
Seman & Dmochowski, 1975), were used as a positive con-
trol with which to compare the BHK-21 cells. The test 
was performed according to the method of Chen (Appendix 
2.1.5) which makes use of a DNA-specific fluorescent 
stain, Hoechst 33258 (Appendix l.l.5(g)) (Chen, 1977). 
H-stain (Hoechst 33258) is known to specifically bind to 
DNA-protein complexes of cells (Latt, 1973). The stain 
has a maximum excitation wavelength of 360 nm and emits 
light in the range of 490-500 nm, giving a bright 
greenish-yellow fluorescence. Cells that are not infec-
ted with mycoplasma show bright greenish-yellow, fluores-
cent nuclear components (nuclei, micronuclei and chromo-
somes) which contrast with the dark cytoplasmic surroun-
ding, which cannot be differentiated from the intercellu-
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lar spaces. The major DNA components of the cytoplasmic 
mitochrondria are not visible except by using special 
filters (Chen, 1977). Although the nuclear components of 
mycoplasma infected and uninfected cells appear the same, 
the cytoplasm of infected cells is no longer dark but 
contains discrete patches of fluorescence. 
a 
b 
FIGURE 1.3 - (a) HeLa cells, and (b) BHK-21 cells, stained with the 
DNA-specific fluorescent stain Hoechst 33258. 
n = nuclei; m mycoplasma 
1.2.3. 
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Results 
Both HeLa cells and BHK-21 cells were stained with H-
stain (Append ix 2. 1. 5). After staining, the nuclei of 
both cell types fluoresced brightly when illuminated at 
360 nm (Figure 1.3). The brightly stained nuclei of the 
BHK-21 cells contrast with the dark background of the 
cytoplasm which contains no fluorescent material (Figure 
l.3(b)), while the cytoplasm of the HeLa cells contains a 
considerable amount of fluorescent material dispersed in 
discrete patches (Figure 1. 3(a)). The results of this 
test proved that the BHK-21 cells were free of mycoplasma 
infection. 
A study of the stability of HSV-1 and HSV-2 when stored 
in a variety of media at 4°C. 
The aim of the present work was to identify and purify 
type-specific glycoproteins of herpes simplex virus type-
1 (HSV-1) and type-2 (HSV-2). As these glycoP,roteins are 
known to be constituents of the virion envelope (Spear & 
Roizman, 1972; Olshevsky & Becker, 1972; Roizman & 
Furlong, 1974; Sarmiento et al, 1979), it is necessary to 
purify the herpes virions with intact envelopes. Purifi-
cation of live virus is a means of ensuring that the 
envelopes are intact because the virion envelope is es-
sential for infectivity (Stein et al, 1970; Sarmiento et 
3!.!,, 1979). However, the envelope of RSV is particularly 
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labile (Gentry & Randall, 1973), and so it was necessary 
to find a suitable medium for preserving the virus in its 
infectious state during the purification procedure (Chap-
ter 1.2.5). 
Water has been used for many years as the suspending 
medium of choice for herpesvirus (Munk & Ackermann, 1953; 
Cook & Sears, 1970) and this has been confirmed by more 
recent tests (Nerurkar et al, 1983). A 1 M Na2S04 solu-
tion has also been shown to be a suitable medium for 
maintaining the infectivity of HSV, particularly at rai-
sed temperatures (Wallis & Melnick, 1965). Therefore, 
distilled water, l M Na2S04 solution and the cell growth 
medium (10% MEM) were tested for their ability to main-
tain HSV in its infective state when stored at 4°C. 
The procedure used is illustrated in the Flow diagram 
(Figure 1.4) and was as follows: 
(a) BHK-21 cell cultures · were infected with HSV-1 and 
HSV-2 and harvested at 24 hours by freezing and 
thawing (40 ml of each infected cell suspension). 
(b) The infected cell suspensions were collected and 10 
ml of each of HSV-1 infected and HSV-2 infected cell 
suspensions were removed and stored at 4°C. 
(c) The remaining suspension was centrifuged at 10 K rpm 
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for 10 min to sediment the cellular material and 10 
ml of supernatant fluid was removed from each tube 
and stored at 4°C. 
(d) The pellets of cellular material were resuspended in 
10 ml of physiological saline. Each of these sus-
1 
pensions was divided into two equal amounts (i e to 
give 4 separate suspensions). 
(e) These suspensions were centrifuged at 10 K rpm for 
10 min and the supernatant fluids discarded. One of 
the HSV-1 infected pellets and one of the HSV-2 
infected pellets were each resuspended in 10 ml of 1 
M Na 2S04 solution while the remaining pellet of each 
were resuspended in 10 ml of distilled H20. 
(f) All four of these suspensions were centrifuged at 10 
K rpm for 10 min. 5 ml of each supernatant fluid 
was removed and stored at 4°C. 
(g) The pellets were resuspended in the remaining super-
natant fluid and stored at 4°C. 
(h) 0, 1 ml aliquots were removed from each of the 12 
stored samples at various intervals and titrated on 
BHK-21 cell cultures (Appendix 2.1.8). 
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FIGURE 1.4 FLOW DIAGRAM - STABILITY OF HSV IN DIFFERENT MEDIA. 
1 M Na2 
I 
HSV-1 or HSV-2 infected 
BHK-21 cell suspension . . ~~~~~~-
Centrifuge at low speed. 
Resuspend infected cell pellet 
in physiological saline. 
! 
Split into two equal volumes. 
Centrifuge at low speed . 
Discard SNF. 
l 
I 
I 
S04 - Resuspend pellets - Distilled H2o 
I 
Centrifuge 
A 
at low speed-~ 
Store SNF 
at 4°c . 
Resuspend pellets and 
store at 4°c. 
I Samples I - Titrate in BHK-21 cells. 
Store 
at 4°c. 
Store SNF 
at4°c. 
Store SNF 
at 4°c . 
43 
Results 
Live HSV could be detected for up to 150 days when the 
virus was stored in 10% MEM at 4°C (Figure 1.5(a)). 
However, during this time, the amount of live virus de-
creased by approximately 99%. Using distilled water and 
1 M N a 2 S04 solution, live virus could be . detected for 
between 50 and 90 days, with the loss of infectivity 
varying according to the virus type and the suspending 
medium (Figure 1.5(b) and (c)). 
The effectiveness of these different media for maintain-
ing the infectivity of HSV when stored at 4°C was compar-
ed by calculating the survival rate over a seven week 
period (Table 1.3). A summary of the results in Table 
1. 3 is given in Table 1. 4. 
following : -
These results reveal the 
1. The media, in order of their ability to preserve the 
infectivity of HSV at 4°C, are:-
(a) For HSV-1: Dist. H20 > 10 % MEM > 1 M Na2 S04. 
(b) For HSV-2: 1 M Na2 S04 > 10%MEM > Dist. H20• 
(Table 1. 3). 
2. The overall ability of each medium to preserve the 
infectivity of both HSV types was : 
Dist. H20 > 1 M Na2 S04 > 10%MEM (Table 1.4). 
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3. In 10% MEM and 1 M Na 2 S04, HSV-2 was considerably 
more stable than HSV-1. In distilled water, HSV-1 
was more stable than HSV-2. 
4. Using 10% MEM and lM Na2 S04, both HSV types were 
JUOre stable when cell debris was present. The oppo-
site was found to be true for distilled water (Table 
1. 3). 
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TABLE 1.3 - APPROXIMATE SURVIVAL RATE OF RSV STORED IN VARIOUS 
SUSPENDING MEDIA AT 4°C 
Virus Sample Suspending Starting RSV cone Approx. 
Medium Cone. of after 7 Survival Rate 
RSV weeks ( c) 
at 4 -°C 
(d) (d) 
RSV-1 with cells (a) 10% MFM. 104.35 103.45 0.133 
HSV-1 w-out cells (b) 10% MEM 104.25 103.10 0.07 
HSV-2 with cells 10% MEM 104.o 103.675 0.473 
HSV-2 without cells 10% MFM 103.6 103.125 0.335 
RSV-1 with cells Dist R20 101. 6 0 0 
HSV-1 without cells Dist R20 101.0 101.0 1.0 
HSV-2 with cells Dist R20 102. 4 101. 25 0.071 
RSV-2 without cells Dist R20 101.5 101.25 0.562 
HSV-1 with cells l M Na2S04 103.0 101.0 0.01 
RSV-1 without cells 1 M Na2S04 102 .5 0 0 
HSV-2 with cells l M Na2S04 103.0 103. 0 1.0 
HSV-2 without cells 1 M Na2S04 103.0 102.5 0.316 
a) With cells. 
suspension. 
BRK-21 cell debris was left in the virus 
b) Without cells. The virus suspension was centrifuged at lOK 
rpm for 10 min to sediment the cell debris. The supernatant 
fluid was retained and stored. 
c) Survival rate= RSV concentration after 7 weeks 
Starting concentration 
(d) Units = TCID50/0. l ml. 
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TABLE 1 .4 - A SUMMARY OF RESULTS SHOWN IN TABLE 1. 3 
Virus Suspending Average Survival Survival Rate for 
Medium Rate for Each RSV in Each Medium 
Virus Type (a) (b) 
RSV 1 10% MEM 0.102 0.253 
HSV-2 10% MEM 0.404 
HSV-1 Dist HzO 0.5 0.41 
HSV-2 Dist H20 0.317 
HSV-1 1M Na2S04 0,005 0,332 
' 
HSV-2 lM Naz S04 0,658 
(a) Values calculated by averaging the survival rate with cells 
and the Survival Rate without cells for each virus type in 
each of the different media (See Table 1.3). 
(b) Values ota~ned by averaging the values in (a). 
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Discussion 
The results of this experiment demonstrate that the two 
RSV types were suited to different suspending media for 
the preservation of their infectivity at 4°C (Figure 
l.5(a-c), Table 1.3). However, by taking an average 
value for the survival rate of both RSV types in each 
medium, distilled water is found to be the best medium 
for the storage of RSV at 4°C(Table 1.4). The next best 
medium was 1 M Naz S04, with 10% MEM. giving the lowest 
survival rate. However, it is felt that this result 
cannot be taken as an accurate comparison of the ability 
of these media to preserve RSV in its infective state 
because of the difference in starting concentration of 
virus in each medium. For instance, approximately 100 
times more virus was stored in 10% MEM than in the other 
two media. 
A comparison was made of the effect of storing the virus 
in the presence of cellular material and without it. The 
reason for this was to determine whether the presence of 
cellular material caused any protective effect on the 
virus. The results showed that in 10% MEM and 1 M 
Naz S04 solution, both RSV types were more stable in the 
presence of cellular material than without it, whereas 
the opposite was true in distilled water. The protective 
effect of cellular material was to be expected from pre-
1.2.4. 
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vious reports (Gentry & Randall, 1973; Rawls, 1979; 
Lancz & Sample, 1985). However, the reasons for the 
observations using distil led water are not clear. A 
possible explanation is that the "cell free material" did 
in fact contain a considerable quantity of cellular de-
bris. This is shown in the electron micrographs of the 
virus taken at a later stage of purification (Figure 
1. 9). 
Conclusion 
The three media used in this experiment are all able to 
preserve the virus in its infective state over quite 
considerable periods, when stored at 4°C. 
Experiment to test different methods for the optiIDUm 
release of infectious RSV from BHK-21 cells. 
Herpes simplex virus is a very cell associated virus 
which is very difficult to extract from its host cells. 
Therefore, the first step in purifying the virus was to 
establish a suitable means of extracting the virus from 
the host cells without causing excessive damage to the 
virions. RSV is relatively heat labile, and so, as far 
as possible, all of the procedures described below were 
performed at approximately 4 °C in an effort to prevent 
loss of infectivity. 
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Three different methods of extracting HSV-2 were compared 
in this experiment. These were: 
1) Freezing and thawing 
2) A Dounce homogenizer, and 
3) Ultrasonication. 
The experimental procedure is illustrated in the flow 
diagram in Figure 1.6. 
Method 
(a) One medical flat bottle of HSV-2 infected BHK-21 
cells was harvested at 24 hours post-infection by 
freezing and thawing. The cell suspension was col-
lected and spun at 10 K rpm for 10 minutes. 
( b) The supernatant fluid was removed and stored at 4 °C 
and the pellet of cellular debris was resuspended in 
15 ml of lnM phosphate buffer, pH 7,4. 
(c) The pellet was mixed thoroughly and then divided 
into 12 separate aliquots of 1 ml each. These ali-
quots were numbered 1-12. 
(d) Aliquots 1-5 were frozen and thawed from one to five 
times, respectively, and then stored at 4°C. 
(e) Aliquots 6-10 were ultrasonicated for 5, 10, 15, 20 
and 30 seconds, respectively (Appendix 2.1.9), and 
then stored at 4°C. 
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(f) Aliquots 11 and 12 were homogenized 5 and 10 times 
respectively and stored at 4°C. 
(g) Each of the aliquots were titrated on BHK-21 cells 
(Appendix 2.1.8) in order to determine which treat-
ment gave the most efficient release of infectious 
virus. 
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FIGURE 1.6 FLOW DIAGRAM - EXTRACTION OF HSV FROM INFECTED CELLS. 
(5 X l ml 
HSV-2 (MS) infected BHK-21 cells in 
growth medium. 
Centrifuge at low speed. 
Cell debris pellet. SNF 
Resuspend in lmM phosphate buffer, pH 7,4. 
aliquots) (5 X l ml aliquots) (2 X l ml aliquots) 
1 1 1 
Freeze and thaw. Ultrasonicate. Homogenize. 
Titrate samples (See Figure 1.7 and Table 1.5) 
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Results 
Titration of the products obtained by the different ex-
traction procedures investigated demonstrated that the 
highest titre of infectious RSV was released by ultra-
sonication for 10 seconds (Figure 1. 7 and Table 1.5). 
Ultrasonication for 5 seconds and 15 seconds were also 
shown to give a satisfactory release of virus. 
The amount of infectious virus released by freezing and 
thawing was significantly less than by ultrasonication, 
and the titre of infectious virus · decreased with the 
number of cycles of freezing and thawing. 
Homogenizing the cells gave a yield of infectious virus 
of the same order as freezing and thawing. 
Discussion 
Ultrasonication of HSV-2 infected BHK-21 cells was shown 
to be the most effective means of extracting the virus 
from infected cells. Under the conditions used in this 
experiment, ul trasonication for 10 seconds was found to 
give the optimum yield of infectious virus, while ultra-
sonication for 5 seconds and 15 seconds gave the next 
best yields (Table 1. 5). It would seem that the time of 
ultrasonication required for the optimum release of in-
fectious RSV depends on a compromise between the amount 
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of virus released from the infected cells and the rate at 
which the virion envelopes are disrupted by the ultra-
sound. This is because the envelope of RSV, which is 
easily broken ( Cook & Stevens, 1970; Spear & Roizman, 
1972; Gentry & Randall, 1973) and which is required for 
viral infectivity ( Stein et al, 1970; Abodeely et al, 
1970; Norrild et al, 1978(a)) is likely to be damaged by 
the physical stresses caused by ultrasonication. 
Likewise, the observation that the amount of infectious 
virus decreased with each cycle of freezing and thawing 
would indicate that this procedure severely disrupts the 
virus envelope. 
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TABLE 1.5 - AMOUNT OF INFECTIOUS RSV RELEASED USING VARIOUS 
EXTRACTION PROCEDURES (See Figure 1.7). 
EXTRACTION PROCEDURE USED AMOUNT OF HSV 
RELEASED FRCM CELLS 
(TCID50/0. l ml) 
Starting material - infected BHK-21 104.63 
cells in 10% MEM 
Supernatant fluid after centrifuga- 103.5 
tion at 10 K RPM for 10 min 
Infected cell pellet resuspended in 103.83 
phosphate buffer 
Freeze and thaw X 1 104 17 
. . 
X 2 103.5 
X 3 103.17 
X 4 102. 5 
X 5 102. 83 
Ultrasonicate x 5 sec 104.83 
X 10 sec 105. 17 
X 15 sec 104.83 
X 20 sec 102. 5 
X 30 sec 101.5 
Homogenize x 5 103. 75 
X 10 104. 17 
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Herpes simplex virus purification by caesium choride 
density gradient centrifugation 
At the start of this work it was thought that a pure 
preparation of herpes simplex virus would be necessary in 
order to distinguish and purify RSV specific proteins. 
For this reason, caesium chloride (CsCl) density gradient 
centrifugation was used to further purify HSV-1 which had 
been extracted from BHK-21 cells (Chapter 1.2.4). 
Method 
The procedure for purifying HSV-1 by caesium chloride 
density gradient centrifugation is described in detail in 
Appendix 2.1.11. Briefly, HSV-1 infected growth medium 
was centrifuged at 25 K rpm for 120 minutes to sediment 
the virus into a cushion of CsCl solution at the bottom 
of the tube. After centrifugation, the growth medium was 
discarded and the CsCl cushion was incorporated in equal 
amounts into two pre-formed CsCl density gradients (Fig-
ure 2.1.3). These two density gradients were then cen-
trifuged at 40 K rpm for 20 hours at 4°c: After centri-
fugation, the two light scattering bands (Figure 1. 8) 
were removed from one of the two gradients using a pas-
teur pipette. These two bands were centrifuged to form 
pellets which were stained and viewed in the electron 
microscope (Appendix 2.1.12). The second density gradi-
ent was fractionated into 15 drop fractions and each 
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fraction was titrated on BHK-21 cells to determine the 
position of infectious RSV particles (Appendix 2 .1. 8). 
The refractive index of each fraction was measured with 
an Abbe Refractometer, and the density determined by 
reference to a graph of refractive index against density 
(Appendix 2.1.10, Figure 2.1.2). 
Results 
After CsCl density gradient centrifugation of HSV-1 in-
fected material at 40 K rpm for 20 hours, two light scat-
tering bands were visible when the tubes were viewed 
under a fluorescent light (Figure 1. 8). When the con-
tents of these bands were viewed in the electron micro-
scope (Appendix 2. 1. 12), the less dense ( top) band was 
shown to contain enveloped virions (Figure 1.9(a)), while 
the more dense (bottom) band contained RSV related spher-
ical particles (Figure l.9(b)). However, both of these 
bands also contained a large amount of cellular mat-
erial. 
Titration of fractions from the second tube showed a peak 
of RSV infectivity within a density range of between 
1,2225 g/cm3 and 1,2775 g/cm3 (Figure 1.10). 
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i-----cTop band 
i------cBottom band 
FIGURE 1.8 - Two light scattering bands formed when HSV-1 was 
centrifuged on CsCl density gradients at 40 K rpm for 
20 hours. 
.' 
FIGURE 1.9 - Electron micrographs of material from (a) 
the top band, and (b) the bottom band of 
HSV-1 infected material after CsCl density 
gradient centrifugation at 40 K rpm for 20 
hours (Figure 1.8). 
The top band contained enveloped virions (V) 
and a significant amount of cellular materi-
al (cm). The bottom band consisted mainly 
of RSV related spherical particles (sp) and 
cellular material (cm). A comparison can be 
made between a virion (V) contained in the 
bottom band and the spherical particles. 
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F r a c t i o n  
N u m b e r  
F i g u r e  1 . 1 0  H S V - 1  e x t r a c t e d  f r o m  B H K - 2 1  c e l l s  w a s  c e n t r i f u g e d  o n  a  c a e s i u m  c h l o r i d e  
( C s C l )  d e n s i t y  g r a d i e n t  ( 1 . 2  - 1 . 5  g / c m
3  
)  a t  4 0 K  r p m  f o r  2 0  h o u r s . A f t e r  
c e n t r i f u g a t i o n , t h e  C s C l  d e n s i t y  g r a d i e n t  w a s  f r a c t i o n a t e d  i n t o  1 7  f r a c t i o n s .  
E a c h  f r a c t i o n  w a s  t i t r a t e d  f o r  i n f e c t i o u s  v i r u s  ( o - o )  a n d  t h e  r e f r a c t i v e  
i n d e x  ( R I )  o f  e a c h  f r a c t i o n  w a s  r e a d  o n  a n - A b b e  r e f r a c t o m e t e r . T h e  d e n s i t y  
o f  t h e  f r a c t i o n s  (  •  •  )  w a s  o b t a i n e d  f r o m  t h e  g r a p h  o f  R l  a g a i n s t  D e n s i t y  
( F i g u r e  2 . 1 . 2  )  .  
( - - - - )  - B e s t  l i n e  t h r o u g h  t h e  d e n s i t y  v a l u e s .  
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Discussion 
Caesium chloride density gradient centrifugation of HSV-1 
extracted from BHK-21 cells yielded two bands when viewed 
under fluorescent light. Electron microscopy revealed 
that these bands contained enveloped virions and HSV 
related spherical particles respectively (Figure 1.9). 
However, both bands also contained a significant amount 
of host cell material which indicated that this method 
would not be suitable for purifying HSV. 
The HSV related spherical particles found in the more 
dense (bottom) band (Figure l.9(b)) were not investigated 
further but it should be noted that other workers have 
also reported undefined structures in cells infected with 
various representatives of the herpes virus group 
(Abraham & Teftmeyer, 1970). Some of these structures 
have been described as dense bodies (Cooks & Stevens, 
1968), bizarre viral forms (Nii, Morgan & Rose, 1968), 
and electron-dense spherical particles (Stannard, 1970). 
Little is known about the composition of these struc-
tures. 
The peak of HSV infectivity was within a density range of 
between 1,2225 g/cm3 and 1,2775 g/cm3 (Figure 1.10). 
Previously reported values for the bouyant density of 
HSV-1 in Cs Cl lie within the range of 1,234 g/ cm3 to 
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1,285 g/ cm3 (Gentry & Randall, 1973). Spring & Roizman 
report that CsCl density gradient centrifugation of HSV 
yielded two bands, with the virion containing band having 
a bouyant density of 1,27 g/cm3 (Spring & Roizman, 
1967). 
It has previously been reported that CsCl solution causes 
disruption of the herpes virions (Spring & Roizman, 1967) 
and that it is necessary to stabilize the virions by 
treatment with formaldehyde prior to centrifugation in 
CsCl. However, in the present work, the virus remained 
viable with the incorporation of 1% foetal calf serum to 
the CsCl solution (Roizman & Roane, 1964; Spring & 
Roizman, 1967; Lancz & Sample, 1985). 
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1. 3 SUMMARY 
Baby hamster kidney (BHK-21) cells were chosen as a suitable 
host for the production of HSV-1 and HSV-2 for the following 
reasons : 
(a) The cells grew well in 10% MEM at 37°C and were shown to 
be free of mycoplasma infection. The presence of myco-
plasma in the host cells may have interfered with the 
aims of the present work. 
(b) Both HSV-1 and HSV-2 grew well in BHK-21 cells, with a 
good yield of infectious virus • . 
On account of the lability of HSV, it was necessary to find a 
suitable medium for storing the virus which would minimize the 
loss of infectivity during the extraction procedures. Distil-
led water and 1 M Naz S04 solution were found to be the best 
media for the preservation of HSV infectivity (Table 1. 4). 
10% MEM maintained the infectivity of HSV for at least 22 
weeks when stored at 4 °C ( Figure 1. 5 (a)) and was used for 
storing HSV during the extraction of virus from infected 
cells. 
Three different methods of extracting virus from infected 
cells were compared and, of these, ul trasonication was found 
to be the most effective method (Figure 1. 7). A time of 10 
seconds was found to give the optimum yield of infectious 
virus under the conditions tested. This is a compromise be-
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tween the max imum release of virus from cells and the minimum 
disruption of released virions. 
CsCl density gradient centrifugation of HSV-1 provided concen-
trated, live herpes virus with a significant amount of cellu-
lar products. 
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CHAPTER II: RADIOLABELLING AND ANALYSIS OF RSV PROTEINS 
2.1 INTRODUCTION 
2.1.1 Labelling of Viruses with Radioactive Isotopes 
The extreme sensitivity of detection of radioisotopic 
tracers has been exploited to great advantage by virolo-
gists. Since the tracer experiments of Cohen in 1948, 
viruses have been isotopically labelled to study their 
composition, sites of synthesis, replication, recombina-
tion and assembly. 
Viral protein can be isotopically labelled by providing 
the host cells with labelled amino acids or some other 
structural component of the protein required (e g label-
led glucosamine for glycoproteins) in the growth medium, 
for uptake into the intracellular pool. The choice of 
amino acid or structural substance is determined by the 
amount present in the viral protein under investigation 
and by its availability in high specific activity (Henry, 
1967). 
Analysis of purified HSV-1 by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE) has reveal-
ed that between 4 and 22 hours post-infection, at least 
four major glycoproteins and several minor ones are syn-
thesized (Spear, Keller & Roizman, 1970; Heine et al, 
68 
1974). The four major HSV-1 glycoproteins are derived 
from four antigenically distinct precursor polypeptides 
which migrate at different rates to their product poly-
peptides in SDS-PAGE (Spear, 1976). · 
Several investigators have reported that after about four 
hours post-infection with RSV, the host cell ceases to 
produce its own proteins and is used entirely to produce 
viral proteins (Sydiskis & Roizman, 1968; Spear, Keller & 
Roizman, 1970; Heine, Spear & Roizman, 1972; Spear, 
1976). It has also been reported that the major glyco-
protein region of HSV-1 in SDS-PAGE, which is composed of 
glycoproteins gA/gB and gC (Eberle & Courtney, 1980) is 
the predominant glycoprotein region in both the virions 
and in RSV infected cells (Spear, 1975; Spear, 1976; 
Eberle & Courtney, 1980). Therefore, both because the 
viral glycoproteins can be specifically labelled and 
because pur.ification of the virus results in a loss of 
much of the major glycoprotein region; there is no need 
to purify the virus before isolating the glycoproteins. 
To further ensure the isotopic labelling of the RSV pro-
teins without labelling cellular proteins, BHK-21 cell 
cultures should be infected with a high multiplicity of 
infection at confluency to ensure a minimum of cell 
growth after infection and to ensure that as many cells 
2.1.2 
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as possible would initially be infected. Medium contain-
ing the radiolabelled substance should only be supplied 
at four hours post-infection, by which time the host 
cells should incorporate all of the label into the viral 
proteins. Then, in order to eliminate the presence of 
labelled precursor polypeptides, mentioned earlier, the 
radioactive medium should be removed from the cell cul-
tures and replaced with normal (unlabelled) medium for 
the last four hours before harvesting the cells (i e from 
24 to 28 hours post-infection). 
Analytical sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SOS-PAGE) 
Polyacrylamide gel electrophoresis in the presence of 
sodium dodecyl sulphate (SDS-PAGE) is the major technique 
used for analyzing the proteins from herpes simplex virus 
(RSV) infected cells in the present work. The technique 
was originally described by Ornstein & Davis (Ornstein, 
1964; Davis, 1964) and is now the most widely used method 
for determining the molecular weights of proteins. The 
negatively charged SDS molecules bind extensively to the 
polypeptide chains of proteins causing them to unfold and 
dissociate. The molecular weights of the constituent 
polypeptide chains can be determined by comparing their 
electrophoretic mobilities on SDS-polyacrylamide (PAA) 
gels to the mobilities of well characterized marker pro-
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teins of known molecular weights. The procedure is sim-
ply and rapidly carried out and requires only microgram 
amounts of proteins. 
The relationship between the mobility of a protein and 
its molecular weight was first observed in an SOS-phos-
phate buffer system, in which log. molecular weight was 
found to be inversely related to mobility (Shapiro, 
Vinuela & Maizel, 1967). This observation has since been 
confirmed by other workers using continuous and discon-
tinuous buffer systems (Laemmli, 1970; Payne, 1973). 
Therefore, it is possible to obtain the unknown molecular 
weight of a protein from its mobility on PAA gel, using a 
plot of the mobilities of known marker proteins against 
the logarithm of their molecular weights (Chapter 
2.2.1). 
For any given PAA gel, the relationship between the 
mobility of proteins and their molecular weights does not 
apply within the higher and lower molecular weight ran-
ges. It is, therefore important to use PAA gels of opti-
mum porosity ( acrylamide concentration) for an accurate 
determination of molecular weight. The most suitable 
acrylamide concentrations for the different molecular 
weight ranges are : 15% PAA - m.wt. below 40,000; 10% PAA 
- m.wt. 10,000 - 70,000; 5% PAA - m.wt 25,000 - 250,000 
(Payne, 1976). 
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The use of SDS-PAGE for determining the molecular weights 
of polypeptides is dependent on a mechanism for SOS-pro-
tein interactions which is common to al 1 proteins, and 
such a mechanism has been demonstrated. It has been 
shown that a variety of different proteins bind 1,4 
grams of SDS per gram of protein when treated with an 
SDS-monomer concentration above 0,02% (8 x 14-4M) (Pitt-
Ri vers & Impiombato, 1968; Reynolds & Tanford, 1970). 
This corresponds to approximately one SDS molecule to two 
amino acid residues (Payne, 1976). 
Protein/SDS complexes appear to behave as rodlike parti-
cles in which the length of the particle is proportional 
to the molecular weight of the polypeptide chain 
(Reynolds & Tanford, 1970; Fish, Reynolds & Tanford, 
1970). However, these are not necessarily fully extended 
molecules but may contain a high degree of secondary 
structure. 
Glycoproteins have been shown to have a decreased SDS 
binding ratio which generally leads to decreased electro-
phoretic mobility and incorrect molecular weight determi-
nations (Pitt-Rivers & Impiombato, 1968). For this rea-
son, the molecular weights of glycoproteins determined by 
SDS-PAGE are referred to as apparent molecular weights. 
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The presence of disulphide bonds limits the unfolding of 
polypeptide chains which may lead to decreased SOS-bin-
ding and lower electrophoretic mobilities (Pitt-Rivers & 
Impiombato, 1968; Reynolds & Tanford, 1970). However, 
it is possible to break the disulphide bonds by treating 
proteins with SOS in the presence of 2-mecaptoenthanol as 
a reducing agent. 
2.2 METHODS AND RESULTS 
2.2.1 Calibration curves established using SDS-PAGE of mixtures 
of known molecular weight marker proteins on 7,5% and 10% 
PAA gels. 
In order to analyse and determine the molecular ~ig hts 
of proteins which were separated by analytical SOS-PAGE 
(Appendix 2. 2.1) it was necessary to establish calibra-
tion curves by electrophorezing proteins of known molecu-
lar weights on both 7,5% and 10% PAA gels, which were the 
gel concentrations used in the present work. 
done as follows:-
This was 
( a) Mixtures comprised of high molecular weight (HMW) 
marker proteins or low molecular weight (LMW) marker 
proteins (Appendix 1.2.l(d)) were treated as speci-
fied. 2 t11, 3 µ 1, 4 µ 1 and 5 µ l amounts of each 
mixture were electrophoresed separately on both 7,5% 
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and 10% PAA gels (Appendix 2. 2.1) to determine the 
optimum amount required for a satisfactory result 
(Figure 2.2). 
(b) After electrophoresis, the gels were fixed (Appen-
dix 2.2.l(d)) and then stained with Coomassie bril-
liant blue (CBB) stain (Appendix 2.2.2(a)). 
( c) The distances from the beginning of the running gel 
to each of the protein bands and to the dye marker 
were measured (Figure 2.1) and the Rf value for each 
protein was calculated using the equation:-
Rf = Distance travelled by protein (mm) 
Distance travelled by dye marker (mm) 
(d) Using the known molecular weights of the marker 
proteins (Appendix 1.2.3) and the Rf values obtained 
from the PAA gels, graphs were drawn of log. mole-
cular weight against Rf ( Figure 2. 3 and 2. 4). From 
these graphs it is possible to determine the molecu-
lar weights of unknown proteins electrophoresed on 
7, 5% or 10% PAA gels, within the molecular weight 
ranges of these gels. 
dye 
marker 
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FIGURE 2.1 - Diagram illustrating the measurements required in 
order to calculate Rf for a particular protein p. 
Rf= Distance travelled by rotein ( ) 
Distance travelled by dye marker z 
Results 
The results of electrophorezing high molecular weight and low mole-
cular weight marker proteins on 7,5% and 10% PAA gels are given in 
Table 2.1 and 2.2 and Figure 2.3 and 2.4. The coefficient of cor-
relation between the Rf values and the log. molecular weight valu-
es was 0,994 in both cases, showing a close correlation between the 
two parameters (Figure 2.3 and 2.4). 
FIGURE 2.2 - High molecular weight (HMW) and low 
molecular weight (I.MW) marker proteins were 
electrophorezed on (a) 10% PAA gel, and (b) 
7,5 PAA gel. The gels were stained with 
Coomassie brilliant blue stain (Appendix 
2.2.2.A). 
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TABLE 2.1 - SOS-PAGE OF PROTEINS WITH KNOWN MOLECULAR 
WEIGHTS ON 10% PAA GEL 
PROTEIN MOLECULAR LOG m.wt. AVE. DISTANCE 
WEIGHT MIGRATED ( mm) 
(m.wt.) (a) 
Thyroglobulin 330000 5.5185 3.25 
Ferritin 220000 5.3424 7.75 
(Half Unit) 
Albumin 67000 4.8261 72. 50 
Catalase 60000 4. 7782 77. 50 
Lactate 36000 4.5563 114. 40 
Dehydrogenase 
Ferritin Subunit 18500 4. 26 72 174.50 
Phosphorylase b 94000 4.9731 43.63 
Albumin 67000 4.8261 63.63 
Ovalbumin 43000 4.6335 98.25 
Carbonic 30000 4.4771 142.50 
Anhydrase 
Trypsin 20100 4.3032 183.25 
Inhibitor 
Kl -Lactalbumin 14400 4 .1584 204.75 
Rf 
(b) 
0.015 
0.035 
0.331 
0.354 
0.522 
o. 796 
0 .182 
0.266 
0.411 
. 
o. 596 
0.766 
0.856 
(a) Distances measured from scanning densitometer scan of the PAA 
gels. 
(b) Rf= Distance travelled by protein 
Distance travelled by phenol red 
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TABLE 2.2 - SOS-PAGE OF PROTEINS WITH KNOWN MOLECULAR 
WEIGHTS ON 7.5% PAA GEL 
PROTEIN MOLECULAR LOG m.wt. A VE. DISTANCE 
WEIGHT MIGRATED (mm) 
(m.wt.) 
Thyroglobulin 330000 5.5185 
Ferritin 220000 5.3424 
(Half Unit) 
Albumin 67000 4.8261 
Catalase 60000 4. 7782 
Lactate 36000 4.5563 
Dehydrogenase 
Ferritin Subunit 18500 4.2672 
Phosphorylase b 94000 4.9731 
Albumin 67000 4.8261 
Ovalbumin 43000 4.6335 
Carbonic 30000 4.4771 
Anhydrase 
Trypsin 20100 4.3032 ) 
Inhibitor ) 
) 
a -Lactalbumin 14400 4 .1584 ) 
(a) Distances measured directly from PAA gel. 
(b) Proteins migrate as a single band. 
(a) 
-
4.85 
33.50 
36.0 
51.0 
66.0 
19.0 
28.8 
41.0 
54.0 
61.5 
(c) Distance migrated was too small to measure. 
( c) 
( b) 
Rf 
-
0.067 
0.465 
0.50 
0.708 
0.917 
0.279 
0.424 
0.603 
o. 794 
0.904 
5.6 
5.4 
+,,I 
.c. 
0) 5.2 
(1) 
~ 
:i... 5.0 ro 
:J 
() 
(1) 
- 4.8 0 
~ 
0) 
0 4.6 
..J 
4.4 
4.2 
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• Thyroglobulin 
I 
• Ferritin {~ unit) I 
I 
\ 
\ 
\ 
\ 
\ 
\ 
'o Phosphorylase b 
Albumin D • Albumin 
Ovalbumin ° 
Lactate Dehydrogenase 
Carbonic Anhydrase 
Inhibitor 
Ferritin Subunit 
a - Lactalbumin 
0.2 0.4 0.6 0.8 1.0 
Figure 2.3 Calibration curve established using the HM W and LMW marker 
protein mixtures on a 10 % PAA gel. 
Coefficient of correlation = 0.994. 
( •) - High molecular weight (HMW) protein markers. 
( o) - Low molecular weight (LM W) protein markers. 
5.6 
5.4 
... 
.c 
0, 5.2 
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I,., 5.0 
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:, 
0 
Cl) 4.8 
-0 
:E 
o, 4.6 
0 
..J 
4.4 
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f Ferritin (\ unit) 
' 
' 
' 
' 
' 
' 
' 
0.2 
Phosphorylase b 
Catalase 
Ovalbumin D 
Carbonic Anhydrase 
Trypsin Inhibitor 
Dehydrogenase 
D 
... 
Ferritin Subunit 
0.4 0.6 0.8 1.0 
Figure 2.4 Calibration curve established using the HM W and LM W marker 
protein mixtures on a 7.5 % PAA gel. 
Coefficient of correlation = 0.994. 
(.a.) - High molecular> weight (HMW) protein markers. 
( o) - Low molecular weight (LM W) protein markers. 
2.2.2 
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Labelling of Herpes Simplex virus Type 1 (HSV-1) and 
Type 2 (HSV-2) with either (3H) - glucosamine or (14c) -
amino acids. 
(a) BHK-21 cell cultures were grown in culture flasks 
until the cells were confluent. At confluency, the 
growth medium was discarded and the cells infected 
with RSV (either HSV-1 or HSV-2) at a multiplicity 
of infection of approximately 1, 0 TCID50 per cell. 
The inoculum was distributed over the entire cell 
monolayer so that as many cells as possible would be 
infected. The cell cultures were then incubated at 
37°C for one hour to allow adsorption of virus to 
the cells. 
(b) After one hour, maintenance medium was added to the 
flasks for a further three hours at 37°C. 
( c) At four hours post-infection the maintenance medium 
was replaced with an equal volume of maintenance 
medium supplemented with either (3H) - glucosamine 
(2,8 µCi/ml) or (14c)-amino acids (2,8 µCi/ml). 
Incubation was continued at 37°C. 
(d) At 24 hours post-infection, the medium containing 
the radioisotope was replaced with an equal volume 
of normal (i e without radioisotopes) maintenance 
medium and incubation was continued at 37°C. 
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(e) At 28 hours post-infection, the maintenance medium 
was discarded and the HSV infected cells were washed 
twice with cold, sterile PBS to remove any remaining 
medium. 
( f) The infected cell monolayers were then solubilized 
in LMW sample buffer (Appendix 1.2.l(d)). In order 
to completely solubilize the proteins, the solution 
was heated at 100°C for 10 minutes. 
(g) The solubilized material was stored at -70°C in 
ampoules containing 1 ml each. 
(h) The radiolabelled products were analysed by SDS-PAGE 
on both 7,5% and 10% PAA gels. After electrophore-
sis, the PAA gels were stained with either Coomassie 
brilliant blue stain (CBB) or silver stain (Appen-
dix 2.2.2) and photographed (Figure 2.5 - 2.11). 
Identical gels, which were electrophorezed in para-
llel with the stained gels, were impregnated with 
EN3HANCE (Appendix 2.2.4) and dried (Appendix 
2. 2. 3). Any radio labelled proteins were identified 
by exposing Kodak X-Omat MA or Kodak X-Omat AR5 film 
to the dried gels (Figure 2.5 - 2.11). 
(i) The molecular weights of radiolabelled proteins were 
determined using calibration curves plotted using 
molecular weight markers which were electrophorezed 
simultaneously on the same PAA gels (Figures 2. 5 -
2.11) (See Chapter 2.2.1). 
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Results 
The radiolabelled products of HSV-1, HSV-2 and mock in-
fected BHK-21 cells, which had been grown in the presence 
of either (3H)-glucosamine ((3H)-gln) or (1 4c)-amino 
acids ( ( 14c)-aa), were analyzed by SDS-PAGE. The pro-
ducts were initially analyzed on 10% PAA gel before chan-
ging to 7, 5% PAA gel which was' more suitable for the 
molecular weight range of the RSV glycoproteins under 
investigation (Chapter 2.3). 
The electrophoretic patterns produced using SDS-PAGE 
were similar for all the different radiolabelled products 
when the PAA gels were stained for protein (Figure 2.5 -
2.11). The most noticable difference between the HSV 
infected cells and the uninfected cells was the presence 
of a characteristic polypeptide band, the major caps id 
protein (MCP), in both HSV-1 and HSV-2 infected cells, 
which was not present in the uninfected cells (Fig.2.5 -
2.11). The molecular weight of the MCP was calculated to 
be 132 Kand 138 K for HSV-1 and HSV-2, respectively, on 
10% PAA gel (Figure 2.5 & 2.6). On 7, 5% PAA gel, the 
molecular weight of the MCP was calculated to be 153 K 
and 147 K for HSV-1 and HSV-2, respectively (Figure 
2. 11). (The discrepancy between the molecular weight 
values obtained on 10% and on 7.5% PAA gels is discussed 
in Chapter 2.3). Apart from the MCP, it was difficult to 
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distinguish any other RSV specific polypeptide bands 
using protein stain. 
Although the products appeared very similar when stained 
for protein, autoradiography revealed that there were 
significant differences in the radiolabelled polypeptides 
of each product (Figure 2.5 - 2.11). 
(14c)-amino acid labelled products: 
Autoradiography showed that the electrophoretic patterns 
of the (14c)-aa labelled proteins in the three products 
(i e HSV-1, HSV-2 and mock infected BHK-21 cells) were 
similar on 10% and 7,5% PAA gels, although better resolu-
tion was obtained with 10% PAA gel (Figure 2.9 and 2.11). 
However, molecular weight determinations of these pro-
teins differed considerably between the 10% and the 7,5% 
PAA gels (Table 2.3 - See Chapter 2.3). 
The HSV-1 infected cells incorporated (14c)-aa into a 
limited number (approximately 29) of those polypeptides 
that are visible using protein stain (approximately 50) 
(Figure 2.5, 2.9 & 2.11). The molecular weights of the 
(14c)-aa labelled polypeptides are given in Table 2.3. 
In HSV-2 and mock infected BHK-21 cells, the (14c)-aa was 
incorporated into almost all of the polypeptides that 
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were identified using protein stain (Figure 2.6, 2.7, 2.9 
and 2.11). A comparison of the autoradiographs of HSV-2 
and mock infected cells shows that many of the ( 14c)-aa 
labelled polypeptides coincide, indicating that in the 
HSV-2 infected cells many host cell specific polypeptides 
were labelled (See Chapter 2.3). 
(3H)-glucosamine labelled products: 
SOS-PAGE of the (3H)-gln labelled products of HSV-1, HSV-
2 and mock infected cells on 10% and 7, 5% PAA gels and 
subsequent autoradiography showed that the electrophore-
tic patterns of the (3H)-gln labelled polypeptides were 
different for each of the three products (Figure 2.5-2.8 
and 2.10). 
HSV-1 infected cells incorporated (3H)-gln into four 
major glycoproteins and approximately five minor glyco-
proteins (Figure 2.5 and 2.10). HSV-2 infected cells, 
electrophorezed on 10% PAA gel, incorporated (3H)-gln 
into two major glycoproteins and approximately eight 
minor glycoproteins ( Figure 2. 6). However, on 7, 5% PAA 
gel, these HSV-2 infected cells appeared to have 
incorporated the label into several more polypeptides 
than on the 10% PAA gel (Figure 2.10 and Table 2.4). 
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The autoradiographs of mock infected cells electrophorez-
ed on 10% and 7,5% PAA gels are noticeably different. On 
10% PAA gel, no (3H)_gln labelled polypeptides were visi-
ble by autoradiography (Figure 2. 7) while on 7 ,5% PAA 
gel, as many as eleven polypeptides were visible (Figure 
2.10 and Table 2.4). 
A comparison of the molecular weights of the ( 3H )-gln 
labelled polypeptides determined from the 10% and the 
7 ,5% PAA gels is given in Table 2.4. The results show 
that 
(a) There were more radiolabelled polypeptides visible 
on the 7,5% PAA gel than on the 10% PAA gel, and 
(b) The molecular weights determined from the 7, 5% PAA 
gels were higher than those from 10% PAA gels (See 
Chapter 2.3). 
FIGURE 2.5 - HSV-1 infected BHK-21 cells were 
grown in the presence of either (3H)-
glucosamine ((3H)-gln) or (14c)-amino acids 
((14c)-aa). The radiolabelled cells were 
solubilized and electrophorezed on 10% PAA 
gels. After electrophoresis, the gels were 
stained with Coomassie brilliant blue stain 
and photographed (a) before being impregnated 
with EN3HANCE, dried and exposed to Kodak-Omat 
MA X-ray film (b). 
FIGURE 2.5 (a) - Coomassie blue 
TraGks 1 and 4 - High molecular weight (HMW) 
protein markers (Appendix l.2.3(a)). 
Track 2 - Labelled with (3H)-gln. 
Track 3 - Labelled with (14c)-aa. 
FIGURE 2.5(b) - Autoradiograph 
Track 1 - Labelled with (3H)-gln. 
Track 2 - Labelled with (14c)-aa. 
Arrow indicates the major capsid protein 
(MCP) 
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A solid-phase radioimmunoassay method has been developed for the detection 
of rubella virus-specific immunoglobulin G (IgG) and IgM antibodies in human 
serum specimens. Purified rubella virus was adsorbed onto polystyrene balls, 
and antibodies that attached to the virus-treated balls were detected by subse-
quent binding of 12.'I-labeled anti-human gamma or anti-human mu immuno-
globulins. A total of 77 serum specimens were tested. Binding ratios between 
positive and negative sera were as high as 22 in the IgG assay but rarely 
exceeded 3 in the IgM assay. The sensitivity of the IgG assay was found to be 16 
to 256 times higher than that of the rubella virus hemagglutination inhibition 
test. The IgG radioimmunoassay can be readily adopted for routine diagnostic 
use. The IgM radioimmunoassay, however, due to its lower sensitivity, must be 
modified before being routinely applied. 
The accurate diagnosis of rubella virus infec-
tions is a major concern of virus diagnostic 
laboratories. Virus hemagglutination inhibi-
tion (HD and complement fixation (CF) tests 
are widely used for this purpose. The results 
obtained, however, are not always conclusive. 
One problem occasionally encountered is 
whether a low HI titer is due to a rubella infec-
tion or to incomplete removal of nonspecific 
hemagglutination inhibitors from the serum 
(15). Another problem arises from the times 
serum specimens are collected after appearance 
of clinical rubella symptoms. If the first speci-
men is collected later than 4 or 5 days after 
onset of rash, a significant rise in rubella anti-
body titers between the first and subsequent 
samples often cannot be detected (21) . This 
makes diagnosis of a recent infection difficult. 
In uncomplicated and postnatal rubella infec-
tions, specific immunoglobulin M (IgM) anti-
bodies are detectable for only 3 to 8 weeks after 
onset of rash (20, 21). Thus, if rubella-specific 
IgM antibodies can be demonstrated, a recent 
infection is indicated. Several methods have 
been proposed for detecting such antibodies, 
including separation oflgM and IgG by sucrose 
density gradient centrifugation or column chro-
matography followed by HI testing of the sepa-
rated immunoglobulins (9, 11, 32), reduction of 
IgM with 2-mercaptoethanol with subsequent 
tection of IgM antibodies by indirect immuno-
fluorescence (5, 12, 20). Most virus diagnostic 
laboratories have not, however, found any of 
these techniques consistently reliable or practi-
cal enough for the testing of large numbers of 
serum specimens. 
In contrast, detection of viral antigens and 
viral antibodies by radioimmunoassay (RIA) 
techniques is highly sensitive and specific (10, 
16, 18, 19, 24-27, 29, 30, 35). Furthermore, a 
refinement of the RIA technique has involved 
the detection of class-specific viral antibodies 
(4, 6-8). Recently, a solid-phase RIA for IgM 
and IgG class antibodies against bovine serum 
albumin (BSA) in chickens was described by 
Viljanen et al. (33); BSA was coupled onto a 
paper disk and antibodies trapped by the anti-
gen were detected by their capacity to bind 125I-
labeled anti-chicken mu or anti-chick:en 
gamma immunoglobulin. In the present work, 
this method was further developed for the assay 
of virus-specific human antibodies, using poly-
styrene balls as the solid phase. Presented in 
this paper is a practical and reliable RIA proce-
dure for detecting rubella virus-specific IgG an-
tibodies in serum specimens. Also included are 
preliminary results for detection of rubella-spe-
cific IgM antibodies using the same methodol-
ogy. 
comparison of HI titers of treated and untreated MATERIALS AND METHODS 
serum (2), Staphylococcus aureus absorption of Antigen purification. The RA 27/3 strain of ru-
IgG from serum samples followed by HI testing bella virus was grown in suspension cultures of 
of the IgM-containing supernatant (1), and de- BHK-21/13S cells (13). The cultures were harvested 
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at 3 days postinfection, and cells were removed by 
low-speed centrifugation. The supernatant was clar-
ified by centrifugation at 8,000 x g for 15 min, and 
the pH was immediately adjusted to 8.0 . An Amicon 
402 apparatus containing an XM-300 membrane was 
then used at 4°C to concentrate the virus solution 
approximately 15- to 20-fold. Virus was recovered 
from the Amicon concentrate by pelleting through 
15 ml of 20% sucrose in TSE buffer (0 .01 M tris-(hy-
droxymethyl)aminomethane, 0:15 M NaCl, and 
0.002 M ethylenediaminetetraacetate, pH 9.0) onto a 
3-ml layer of60% sucrose in TSE buffer. Centrifuga-
tion was for 2 hat 25,000 rpm in a Spinco SW27 rotor 
at 4°C. Sucrose was removed by dialysis against TSE 
buffer. The hemagglutination titer of the purified 
virus varied from 64 to 512, and the protein content, 
determined by the method of Lowry et al. (22), was 
300 to 1,000 µ.g/ml. 
Serum specimens. A series of serum specimens 
was obtained from six army trainees who had devel-
oped an acute clinical rubella infection with signifi-
cant increases in HI and CF antibody titers. A total 
of 26 specimens was collected. Other sera consisted 
of 51 specimens selected from our virus diagnostic 
laboratory. Included were 32 specimens that were 
negative in the rubella HI test and 19 specimens 
that had HI titers of 128 or less. All serum specimens 
were stored at -20°C until used . 
'
25I-labeled anti-human gamma and anti-human 
mu immunoglobulins. Human IgG and IgM were 
purified as described by Viljanen et al. (33). Briefly, 
human serum immunoglobulins were precipitated 
with sodium sulfate and chromatographed on Seph-
adex G-200. IgM fractions were twice recycled on 
Sephadex G-200 . IgG fractions were further purified 
by diethylaminoethyl-cellulose chromatography. In 
immunoelectrophoresis and immunodiffusion tests 
against anti-human sera, the IgG and IgM prepara-
tions each gave only one precipitation arc. These 
preparations were then used to immunize sheep. 
The immune sera obtained were purified by the use 
of immunoabsorbents (33). The final preparations of 
anti-human gamma and anti-human mu immuno-
globulins were free of other serum proteins and anti-
bodies. 
The anti-immunoglobulins were labeled with '25I-
isotope according to the method of Hunter and 
Greenwood (17), with modifications according to 
Viljanen et al. (33) . Specific activities ranged from 
30 to 100 µ.Ci/ µ.g. After iodination, the anti-immu-
noglobulin preparations were supplemented with 
1 % normal sheep serum. Degradation products re-
sulting from radioactive decay were removed weekly 
by chromatography on Sephadex G-200. Peak frac-
tions were pooled and stored at 4°C until required. 
Under these conditions, the labeled anti-immuno-
globulins were found to remain active for 4 to 8 
weeks. 
RIA procedure. Purified rubella virus was ad-
sorbed onto polystyrene balls (6.4 mm in diameter; 
Precision Plastic Ball Co., Chicago, Ill.) by incubat-
ing balls submerged in an antigen solution at room 
temperature for 16 h . The protein concentration of 
the rubella antigen solution was 110 µ.g/ml, unless 
otherwise indicated. Phosphate-buffered saline 
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(PBS), pH 7.35, was used as diluent. After incuba-
tion, the balls were air dried and stored at 4°C. 
Fourfold serial dilutions of serum specimens were 
pipetted in 0.2-ml volumes into 4-ml disposable plas-
tic tubes (Nunc Products, Roskilde, Denmark). The 
serum samples were diluted with PBS, pH 7 .35, 
containing 1 % BSA, fraction V (1 % BSA-PBS). A 
polystyrene ball with adsorbed rubella antigen was 
then added to each tube. Buffer blanks (balls incu-
bated with 1 % BSA-PBS and no serum) and a titra-
tion of rubella antibody-positive and -negative con-
trol sera were included in each test. 
After incubating at 37°C for 1 h , the serum dilu-
tions were aspirated off and the balls were washed 
twice with 5 ml of tap water. A 0.2-ml volume of 125I-
labeled anti-human gamma or mu immunoglobulin 
was then added to each tube . The labeled antibody 
preparations were diluted to 30,000 cpm/0.2 ml with 
Eagle minimum essential medium supplemented 
with 0.5% lactalbumin hydrolysate, 10% heat-inac-
tivated calf serum, and antibiotics as described by 
Rosenthal et al. (26). After incubation at 37°C for 1 
h, the radioactive solutions were aspirated off and 
the polystyrene balls were washed as described 
above. The balls were then placed in clean plastic 
tubes, and bound radioactivity was counted in an 
LKB Wallac 1280 gamma counter. 
CF and HI tests. Rubella antigen was prepared 
for the CF test according to the alkaline extraction 
procedure described by Halonen et al. (13). Sever's 
microtechnique (28) was used, with veronal-buffered 
saline containing 0.1% gelatin used as diluent. The 
optimal dilution of antigen was estimated according 
to the standardized CF technique (3). Standardiza-
tion of erythrocyte suspensio11s was done as in the 
HI test (31) . For the HI test, rubella hemagglutinin 
was prepared in BHK-21/13S cells maintained in a 
medium containing BSA and no serum (14). HI 
tests were performed by microtechnique according 
to the modified test used at the Center for Disease 
Control, Atlanta, Ga. (31) . CF and HI titers are 
expressed as reciprocals, except in Tables l and 2, 
where log2 values are used. 
RESULTS 
RIA solid phase. Although data presented in 
this report were obtained from experiments in 
which polystyrene balls were used, first at-
tempts to establish a rubella RIA technique 
involved polyvinyl microtiter plates as the solid 
phase. When rubella virus was simply air dried 
in the wells of polyvinyl plates, there was a 
visible loss of antigen during washings. Fixa-
tion of the antigen by absolute methanol treat-
ment for 5 min at room temperature reduced 
such losses. With fixed antigen, however, non-
specific adsorption of serum immunoglobulins 
was extensive and could not be reduced by 
treatment of the fixed antigen with blocking 
agents such as normal sheep serum, 1 or 4% 
BSA, or 0.1% gelatin (23) . Such nonspecific ad-
sorption of immunoglobulins resulted in high 
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background counts per minute, which made 
evaluation of test results difficult. Pretreat-
ment of the plates with blocking agents before 
antigen fixation was also tested without benefi-
cial results. 
When rubella virus antigen was methanol 
fixed in wells of polystyrene microtiter plates, 
subsequent adsorption of nonspecific immuno-
globulins was reduced approximately 80% com-
pared with the polyvinyl plates. The disadvan-
tage of using polystyrene plates as the RIA 
solid phase, however, was that the individual 
wells were difficult to cut out for radioactive 
counting. Preliminary tests were then con-
ducted using more easily handled polystyrene 
balls, to which rubella antigen had been ad-
sorbed. The RIA results obtained were indenti-
cal to those with the polystyrene plates; conse-
quently, for practical purposes, polystyrene 
balls were chosen as the RIA solid phase. 
At this point it is relevant to note that poly-
styrene balls have been used as the solid phase 
of a RIA method developed to detect hepatitis B 
antigen and antibody (M. Goldfield, personal 
communication). In addition, Abbott Laborato-
ries (Chicago, Ill .) presently has available hep-
atitis B antigen and antibody RIA kits that also 
utilize polystyrene balls as the solid phase. 
When the polystyrene balls used in this study 
were compared with those kindly provided by 
Abbott Laboratories, no significant differences 
were noted. 
Antigen adsorption onto polystyrene balls. 
Optimal RIA results were obtained when the 
polystyrene balls were incubated in a rubella 
virus antigen solution containing 110 µ,g of pro-
tein per ml (Fig. 1). Using an antigen concen-
tration of 330 µ,g of protein per ml did not 
significantly enhance the specificity or sensitiv-
ity of the assays. With lower antigen concentra-
tions of 27.5 or 6.9 µ,g of protein per ml, how-
ever, assay sensitivity was decreased. Metha-
nol fixation of the antigen on the balls was also 
tried without obtaining any improvement in 
the RIA results. Altering the pH of the antigen 
diluent did have some effect, since using a pH 
of 8.35 or 9.0, rather than the usual 7.35, did 
increase the binding of specific immunoglobu-
lins. Unfortunately, the binding of nonspecific 
immunoglobulins also increased in the same 
proportion. 
When polystyrene balls were incubated at pH 
7.35 in an antigen solution containing 110 µg of 
protein per ml, approximately 20% of the total 
protein became adsorbed. At the same time, the 
rubella hemagglutination titer of the antigen 
solution decreased between 70 and 80%, indi-
cating that there was some preferential adsorp-
tion of the virus hemagglutinin. It was found 
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Fm. 1. Effect of protein concentration on adsorp-
tion of purified rubella virus antigen on polystyrene 
balls. Balls adsorbed at each rubella virus protein 
concentration were incubated with dilutions of a ru-
bella antibody-positive serum and tested for binding 
of rubella-specific IgG antibodies (upper) or IgM 
antibodies (lower) . I , 6.9 µg of protein per ml; II, 
27.5 µg of protein per ml; Ill, 110 µg of protein per 
ml; N, 330 µg of protein per ml; V, 0 µg of protein 
per ml . In each panel , buffer blanks are designated 
as Bl . 
that an antigen solution could be used for ad-
sorption only once, since the sensitivity of the 
assays decreased markedly after a second ad-
sorption with fresh balls. 
Incubation with serum dilutions. Best assay 
results were obtained when antigen-adsorbed 
balls were incubated with serum specimens 
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that had been diluted with 1 % BSA-PBS, pH 
7.35. Differences were actually found to be 
small, however, when the pH of the diluent was 
between 6.0 and 9.0. Various incubation times 
and temperatures were also tested. For both 
the IgG and IgM assays, increasing the incuba-
tion time or temperature resulted in greater 
binding of immunoglobulins from both rubella 
antibody-positive and -negative sera. For the 
IgG assay, the greatest difference between posi-
tive and negative sera was obtained by over-
night incubation at room temperature. In the 
IgM assay, however, nonspecific immunoglobu-
lin binding increased to such an extent with 
longer incubations that best results were ob-
tained from a 1-h incubation at 37°C. For prac-
tical reasons, a 1-h incubation at 37°C was used 
for both assays . 
Incubation with 1251-labeled anti-human 
immunoglobulins. Dilutions containing 15,000, 
30,000, 60,000, and 120,000 cpm/0.2 ml were 
tested. The binding ratios between rubella 
antibody-positive and -negative serum samples 
were almost identical in each case. The dilution 
containing 120,000 cpm/0.2 ml was used in the 
experiments in Fig. 1, whereas the dilution 
containing 30,000 cpm/0.2 ml was used 
throughout the remainder of this study. Dilu-
tion of the labeled anti-immunoglobulins with 
supplemented Eagle minimum essential me-
dium (see Materials and Methods) was found to 
be essential, since background counts per min-
ute levels increased greatly if the dilution was 
done with PBS. The effects of time and temper-
ature on this step of the assays were not tested , 
since an incubation of 1 h at 37°C was found to 
be adequate . 
Assay results. Background levels of the IgG 
and IgM assays were determined in three dif-
ferent ways. First, polystyrene balls with ad-
sorbed control antigen (material obtained from 
supernatants of uninfected cells) were incu-
bated with rubella antibody-positive and-nega-
tive control sera. Second, balls with adsorbed 
rubella antigen were incubated with negative 
control serum; and, third, balls with no ad-
sorbed antigen were incubated with positive 
and negative control sera. In each case, the 
background binding levels of human IgG and 
IgM were reproducibly low. There was a 
marked difference, however, between the two 
assays. In the IgM assay, background levels 
were two to three times higher than in the IgG 
assay. Such higher nonspecific binding of IgM 
from serum samples, compared with that of 
IgG, has also been observed in other class-spe-
cific antibody RIA procedures (4) . 
Evaluation of assay results was done by 
means of binding ratios, which were calculated 
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by dividing the counts per minute of the serum 
specimen by the counts per minute of the ru-
bella antibody-negative control serum at the 
same dilution. The highest serum dilution hav-
ing a binding ratio of3 .0 was chosen as the titer 
end point in the IgG assay. In the IgM assay, a 
binding ratio of 1.5 was selected with the prov-
iso the counts per minute of the end point dilu-
tion also be 1.5 times the average counts per 
minute of all the negative control serum dilu-
tions. End point titer values were obtained 
from the counts per minute versus the dilution 
curve of each serum specimen. Titer values are 
expressed as reciprocals, except in the figures 
and tables, where log2 values are used. 
Intra-assay variation was studied by testing 
both a rubella antibody-positive and -negative 
control serum in 10 parallel determinations. 
The coefficients of variation of the counts per 
minute at each fourfold dilution were ±7.5% in 
the IgG assay and ±6.2% in the IgM assay. 
Variation in the assigned end point titer of a 
positive control serum was also tested and was 
found to be twofold in 15 separate IgG and IgM 
assays. 
A comparison of the rubella HI antibody test 
and the rubella RIA IgG antibody test is shown 
in Table 1. The 32 serum specimens that were 
negative in the HI test were also negative in 
the RIA IgG test. Of the 19 specimens with an 
HI titer of 128 or less, 18 were highly positive in 
the RIA IgG test. One serum specimen having 
an HI titer of 8 was found to be negative in the 
RIA IgG test. The titer end points of the RIA 
IgG test were 16 to 256 times higher than the 
titer end points of the HI test, indicating that 
the RIA procedure is the more sensitive of the 
two techniques. The 51 serum specimens used 
in the experiments of Table 1 were also tested 
in the RIA IgM test, and all were found to be 
negative. 
The development of rubella-specific RIA IgG 
and IgM antibodies in a series of serum speci-
T ABLE 1. Rubella HI and RIA IgG antibody titers of 
51 serum specimens• 
HI titer (log, No. of serum specimens 
value) <3• 9 10 11 12 
< 3 32 
3 1 
4 1 2 
5 4 3 3 1 
6 2 1 
7 1 
• The specimens were selected to represent 32 
specimens with negative HI results and 19 speci-
mens with relatively low HI titers. 
• RIA IgG titer (log2 value). 
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mens collected from a rubella patient is shown 
in Fig. 2. The early rise and rapid fall of ru-
bella-specific IgM antibodies and the slower 
rise of rubella-specific IgG antibodies are 
clearly demonstrated. A comparison of rubella 
HI, CF, RIA IgG, and RIA IgM antibody titers 
of 21 serum specimens collected from five ru-
bella patients is shown in Table 2. The rapid 
development and early decline of IgM antibod-
ies and the slower development of IgG antibod-
ies is also apparent in these sera. Also demon-
strated in Table 2 is the fact that both rubella 
class-specific antibody assays are much more 
sensitive than the rubella HI and CF tests. 
DISCUSSION 
The solid-phase RIA methodology described 
in the present study is both practical and relia-
ble as a test for detecting rubella virus-specific 
antibodies in serum specimens. A distinct ad-
vantage of the procedure is that serum speci-
mens can be tested without any pretreatment, 
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Fm. 2. Development of rubella virus-specific RIA 
IgG antibodies (upper) and RIA IgM antibodies 
(lower) in a series of serum specimens from a patient 
with an acute clinical rubella infection. S erum speci-
mens were obtained at: I , 3 days; II, 10 days; III, 17 
days; N,24 days; V , 49 days, after onset of rash. ( +) 
Rubella antibody-positive control serum;(-) rubella 
antibody-negative control serum. 
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TABLE 2. Rubella HI, CF, RIA IgM, and RIA IgG 
antibody titers in a series of serum specimens 
taken from five rubella patients 
Titer (log, value) 
Days after 
Patient onset of RIA 
rash HI CF 
IgM IgG 
V.V. 0 3 < 2 3 3 
7 8 3 14 15 
14 8 4 14 15 
21 6 5 13 15 
V.T. 0 < 3 < 2 <3 < 3 
6 9 2 13 17 
12 8 3 13 17 
68 9 3 <3 17 
V.S. 1 4 <2 13 <3 
12 9 4 16 14 
14 9 4 15 14 
21 9 4 15 14 
S.S. 3 5 < 2 6 7 
10 8 4 12 13 
21 9 4 12 13 
26 8 4 11 13 
37 9 4 <3 14 
R.T. 1 6 < 2 10 < 3 
7 9 < 2 14 15 
15 9 4 12 15 
26 9 4 10 15 
since nonspecific inhibitors of the rubella he-
magglutinin do not interfere. Once rubella vi-
rus-treated polystyrene balls and radioactively 
labeled antisera are available, the RIA method 
is simple to perform and specimens can be eval-
uated within 1 day. Since the assay results are 
recorded in printed form as counts per minute, 
there is no need for visual evaluation, as is the 
case with the rubella HI test. 
Preliminary rubella RIA experiments were 
conducted with polyvinyl microtiter plates; this 
material, however, proved to be unsatisfactory 
as the RIA solid phase. When polystyrene balls 
were used, a marked improvement in the speci-
ficity and sensitivity of the rubella class-spe-
cific antibody assays was obtained. End point 
titers of positive sera in both the RIA IgG and 
the RIA IgM tests were very high (Tables 1 and 
2), and in neither case were false-positive re-
sults seen in a test series of 77 specimens. 
Positive-to-negative serum-binding ratios in 
the rubella RIA IgG test were consistently 
high, occasionally being 20 or more. Binding 
ratios in the RIA IgM test, however, rarely 
reached the level of3.0. The difference between 
the two assays is due, first, to background lev-
els being two to five times higher in the RIA 
IgM test and, second, to a slightly lower specific 
binding in the RIA IgM test compared with the 
RIA IgG test. In spite of these difficulties, the 
RIA IgM test clearly demonstrated the early 
; 
, 
: 
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rise and rapid decline of rubella-specific lgM 
antibodies after onset of clinical rubella symp-
toms (Fig. 2, Table 2). The later appearance 
and subsequent persistence of rubella-specific 
IgG antibodies in the same serum specimens 
was also clearly demonstrated by the RIA IgG 
test. 
In recent years, evidence has been accumu-
lating that viruses may play a role in the etiol-
ogy and/or pathogenesis of certain progressive 
neurological disorders (for a brief review, see 
reference 34). A sensitive and reliable assay is a 
necessary prerequisite for detection of low lev-
els of antiviral antibodies that may be produced 
in the central nervous system. The rubella RIA 
IgG test would appear to fulfill these criteria, 
since it is 16 to 256 times more sensitive than 
the conventional rubella HI test (Table 1). 
In summary, the RIA procedure described 
herein for the detection of rubella-specific IgG 
antibodies is feasible for clinical use. The same 
conclusion, however, cannot be drawn for the 
RIA detection of rubella-specific IgM antibod-
ies. Although the results presented demon-
strate that anti-rubella IgM antibodies can be 
measured with the described RIA methodology, 
further work is required to optimize the test 
conditions. In the present report, antibody lev-
els detected by the RIA procedure are expressed 
in conventional serum titer values. By select-
ing a proper serum dilution and comparing its 
RIA counts per minute with a suitable standard 
curve, it may be possible to express the specific 
antibody content of a test serum in terms of 
micrograms per milliliter, as has been done in 
the case of chicken antibodies to BSA (33). Ex-
periments to improve the rubella RIA lgM test 
and to quantitate both the lgG and IgM assays 
are currently in progress. 
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FIGURE 2.6 - HSV-2 infected BHK-21 cells 
Treated as described in the legend to Figure 
2.5. 
FIGURE 2.6(a) - Coomassie blue 
Tracks 1 and 4 - HMW protein markers. 
Track 2 - Labelled with ( 3H)-gln. 
Track 3 - Labelled with c14c)-aa. 
FIGURE 2.6(b) - Autoradiograph 
Track 1 - Labelled with (3H)-gln. 
Track 2 - Labelled with (1 4c)-aa. 
Arrow indicates MCP. 
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FIGURE 2.7 - Mock infected BHK-21 cells 
Treated as described in the legend to Figure 
2.5. 
FIGURE 2.7(a) - Coomassie blue 
Tracks 1 and 4 - HMW protein markers. 
Track 2 - Labelled with (3H)-gln. 
Track 3 - Labelled with (14c)-aa. 
FIGURE 2.7(b) - Autoradiograph 
Track 1 - Labelled with (3H)-gln. 
Track 2 - Labelled with ((1 4c)-aa. 
Arrow indicates MCP. 
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FIGURE 2.8 - HSV-1, HSV-2 and mock-infected 
BHK-21 cells were grown in the presence of 
(3H)-gln. The radiolabelled cells were 
solubilized and electrophorezed on 10% PAA 
gels. After electrophoresis, the gels were 
treated as described in the legend to Figure 
2.5. 
FIGURE 2.8(a) - Coomassie blue 
Track 1 - HSV-1 infected cells. 
Track 2 - HSV-2 infected cells. 
Track 3 - Mock infected cells. 
Track 4 - HMW protein markers. 
FIGURE 2.8(b) - Autoradiograph 
Track 2 - HSV-1 infected cells. 
Track 2 - HSV-2 infected cells. 
Track 3 - Mock infected cells. 
Arrow indicates MCP. 
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FIGURE 2.9 - HSV-1, HSV-2 and mock infected 
BHK-21 cells were grown in the presence of 
(14c)-aa and treated as described in the legend 
for Figure 2.8. 
FIGURE 2.9(a) - Coomassie blue 
Track 1 - HSV-1 infected cells. 
Track 2 - HSV-2 infected cells. 
·Track 3 - Mock infected cells. 
Track 4 - HMW protein markers. 
FIGURE 2.9(b) - Autoradiograph 
Track 1 - HSV-1 infected cells. 
Track 2 - HSV-2 infected cells. 
Track 3 - Mock infected cells. 
Arrow indicates MCP. 
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FIGURE 2.10 - HSV-1, HSV-2 and mock infected 
BHK-21 cells were grown in the presence of 
(3H)-gln. The radiolabelled cells were 
solubilized and electrophorezed on 7, 5% PAA 
gels. After electrophoresis one gel was 
stained with silver stain (a) while a second 
gel was impregnated with EN3HANCE and exposed 
to Kodak X-Omat AR5 
FIGURE 2.lO(a) - Silver stain 
Track 1 - HMW protein markers. 
Track 2 - HSV-1 infected cells. 
Track 3 - HSV-2 infected cells. 
Track 4 - Mock infected cells. 
FIGURE 2.lO(b) - Autoradiograph 
Track 1 - HSV-1 infected cells. 
Track 2 - HSV-2 infected cells. 
Track 3 - Mock infected cells. 
Arrow indicates MCP. 
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FIGURE 2.11 - HSV-1, HSV-2 and mock infected 
BHK-21 cells were grown in the presence of 
(14c)-aa. The radiolabelled cells were treated 
as described in the legend to Figure 2.10. 
FIGURE 2.ll(a) - Silver stain 
Track 1 - HMW protein markers. 
Track 2 - HSV-1 infected cells. 
Track 3 - HSV-2 infected cells. 
Track 4 - Mock infected cells. 
FIGURE 2.ll(b) - Autoradiography 
Track 1 - HSV-1 infected cells. 
Track 2 - HSV-2 infected cells. 
Track 3 -Mock infected cells. 
Arrow indicates MCP. 
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TABLE 2.3 - MOLECULAR WEIGHTS OF HSV-1 PROTEINS LABELLED WITH 
(14c) AMINO ACIDS 
PROTEIN MOLECULAR WEIGHT x 10-3 (DALTONS) 
NUMBER 
10% PAA (a) 7.5% PAA ( b) 
1 0 s ( g) 0 s 
2 0 s 0 s 
3 0 S 0 s 
4 130.3 164.10 
5 (f) 112. 2 153.10 
6 - (c) 141. 30 
7 100.7 134,90 
8 (gp) 95.5 124.50 
Q (gp) 86.1 117.50)(e) 
10 - 113.50) 
11 82.22 104. 70 
12 78.52 100.00 
13 74.99 92.26 
14 (gp) 69 .18 83. 18 
15 65. 77 78.52 
17 (gp) 61.66 71. 61 
18 (gp) 58.21 66.07 
19 (gp) 56.23 63.83 
20 (gp) 51.88 57.54 
21 47.86 48.42 
22 (gp) 41.02 41.69 
23 39.36 38.90 
24 36.31 36.31 
25 29.51 - (d) 
26 22.65 - (d) 
27 16.98 - (d) 
28 16.41 - (d) 
29 14.45 27.86 
(a) Values calculated from the autoradiograph shown in Figure 
2. 5. 
(b) Values calculated from the autoradiograph shown in Figure 
2.11. 
(c) Protein not visible on autoradiograph of 10% PAA gel. 
(d) These protein bands were compressed into a single band, m.wt. 
27860. 
(e) Not clearly resolved. Possibly a single protein. 
(f) Major capsid protein (MCP). 
(g) 0 S Off Scale, The molecular weights of these proteins were 
too high to be determined on 10% and 7,5% PAA gels. 
(gp) Glycosylated protein, 
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TABLE 2.4 - THE APPARENT MOLECULAR WEIGHTS OF HSV-1, HSV-2 AND MOCK 
INFECTED BHK-21 CELL PROTEINS LABELLED WITH (3H) GLUCO-
SAMINE 
MOLECULAR WEIGHTS X 10-3 (DALTONS) 
BHK - 21 CELLS INFECTED WITH 
HSV - 1 HSV - 2 MOCK I 
10% 7,5% 10% 7,5% 10% 7,5% 
PAA (a) PAA (b) PAA (c) PAA (b) PAA (d) PAA ( b) 
- (e) 0 S (g) - (e) 0 S 
- (e) 149.60(g) - (e) 149.60(e) 
98.86 127.400 101. 20 131. 80 - (e) 136.50 
89 .13 117. 400 97.20 124.50 - ( e) 125.90 
69.98 86.700 91. 20 113. 50 - (e) 117. 50 
60.95 76.380 86.10 102.30(h) - (e) 109.60 
58.88 73.280 82.22 82.22 - (e) 102.30 
56.23 68.390 66.07 76. 74 - ( e) 88.10 
54.33 66.070 59.57 73.28 - (e) 80.35 
48. 98) (f) 58.88 55.59 68.30 - (e) 62.37 
4 7. 32) 41. 21 42.17 54.95(h) 12.59 54.95 
12.74 50.12 
( a) Values calculated from the autoradiograph in Figure 2.5(b). 
(b) Values calculated from the autoradiograph in Figure 2.lO(b). 
( c) Values calculated f rcxn the autoradiograph in Figure 2.6(b). 
(d) Values calculated from the autoradiograph in Figure 2.7(b). 
(e) Not visible on 10% PAA gel - See Chapter 2.3. 
(f) Possibly a single band. 
(g) Host cell specific protein. 
(h) Possibly host cell specific protein 
0 S Off-Scale. Protein molecular weight is too high to be determ-
ined on 10% or 7.5% PAA gel 
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2.3 DISCUSSION 
Analytical SDS-PAGE was used in conjunction with autoradiog-
raphy as a means of analyzing the products of HSV-1, HSV-2 and 
mock infected BHK-21 cells grown in the presence of either 
( 3H)-glucosamine (( 3H)-gln) or ( 14c)-amino acids (( 14c)-aa). 
The molecular weights of the polypeptide bands were determined 
by using calibrated graphs plotted from the molecular weight 
markers which were electrophorezed with the radiolabelled 
proteins. 
There was little apparent difference between the electrophore-
tic patterns of HSV infected and uninfected cells when the PAA 
gels were stained with protein stain (Figure 2.5 -2.11). The 
most noticeable difference was the presence of the major cap-
s id protein (MCP) in both HSV-1 and HSV-2 infected cells, but 
not in uninfected cells. The apparent molecular weight of the 
MCP on 10% PAA gel was determined to be 132 K and 138K, for 
HSV-1 and HSV-2, respectively (Figure 2.5 & 2.6). The equiva-
lent values on 7,5% PAA gel were 153 Kand 147 K, respectively 
(Figure 2 .11). It has previously been reported that the MCP 
has a molecular weight of approximately 155 K (Spear & 
Roizman, 1972, Cassai, Sarmiento & Spear, 1975; Cohen et al, 
1980), and that the MCP of HSV-1 has a slightly faster elec-
trophoretic mobilj_ty than the corresponding protein found in 
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HSV-2 caps ids ( Cassai, Sarmiento & Spear, 1975; Cohen et al, 
1980). 
Throughout the present work, several differences were notice-
able between the results obtained for analytical SOS-PAGE 
using 10% PAA gel and 7,5% PAA gel. 
(a) More proteins were shown by autoradiography with the 7,5% 
PAA gel than with the 10% PAA gel. This was most notice-
able when mock infected cells labelled with (3H)-gln were 
electrophorezed (Figure 2.7 and 2.10). The probable 
reason for this discrepancy was that a more sensitive X-
ray film was used for autoradiography of the 7, 5% PAA 
gels (Kodak X-Omat AR5) than was used for the 10% PAA 
gels (Kodak X-Omat MA). 
(b) The molecular weights of polypeptides determined from 10% 
PAA gels were considerably lower than those determined 
from 7 ,5% PAA gels (Table 2.3). The reason for this is 
that, with the calibration of gels (Figure 2.3 & 2.4) the 
relationship between Log. molecular weight and Rf de-
parts from linear at high molecular weights. With more 
concentrated PAA gels the departure from a linear rela-
tionship occurs at lower molecular weights than with less 
concentrated PA.A gels. Some of the proteins of interest 
in the present work (i.e. MCP, glycopr-oteins gC and gB) 
have molecular weights which fall on the non-linear sec-
97 
tion of the calibrated graph for 10% PAA gel (Figure 
2.3). As no molecular weight standards were available 
within the range of 100 K to 200 K, it was not possible 
to plot the non-linear section of the graph accurately, 
and so the values within this range are not accurate 
using 10% PAA gel. For this reason, it was decided to 
use 7,5% PAA gels which are more suitable for the molecu-
lar weight range required in the present work. 
(14c)-Amino Acid Labelled Products 
The results obtained for the ( 14c)-aa labelled products 
reveals that the HSV-1 infected cells incorporated (14c)-
aa into approximately 29 polypeptides (Table 2.3). This 
means that not all of the polypeptides which were visible 
using protein stain had incorporated the ( 14c )-aa label 
(Figure 2.5). A comparison of the autoradiographs of 
HSV-1 and mock infected cells shows clearly that the HSV-
1 infected cells had not incorporated ( 14c)-aa into host 
cell proteins (Figure 2.ll(b) track 1 and track 3). This 
suggests that the ( 14c)-aa label · was only incorporated 
into viral specific polypeptides, which is in agreement 
with previous reports which state that RSV infection 
stops the production of host cell proteins (Sydiskis & 
Roizman, 1968; Spear, Keller & Roizman, 1970; Heine, 
Spear & Roizman, 1972; Spear, 1976; Fenwick, Morse & 
Roizman, 1979). Purified virions of HSV-1 have previous-
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ly been reported to contain between 23 and 33 polypepti-
des (Spear & Roizman, 1973; Heine et al, 1974) while 
cells infected with HSV-1 have been shown to contain 
approximately 50 infected cell polypeptides. (Honess & 
Roizman, 1973; Morse et al, 1978). A comparison of the 
present results with those reported previously is given 
in Table 2.5. 
The HSV-2 infected cells appeared to have incorporated 
the (14c)-aa into almost all of the polypeptides that 
were visible using protein stain (Figure 2.6 and 2.9). A 
comparison of the autoradiographs of HSV-2 and mock in-
fected cells revealed that many of the host cell polypep-
tides had incorporated the (14c)-aa label in HSV-2 infec-
ted cells (Figure 2. ll(b) track 2 and track 3). In the 
light of the fact that HSV-2 strains have been found to 
inhibit the synthesis of both DNA and protein of the host 
cell more rapidly than HSV-1 strains (Fenwick et al, 
1979) the most probable explanation for the incorporation 
of ( 14c)-aa into host cell proteins is that the HSV-2 
inoculum did not contain enough virus to produce 100% 
infection of cells initially (MOI of approximately 1 
TCID50/ cell). Hence, the uninfected cells would have 
continued to grow normally for some time after adding the 
radiolabelled medium, thus labelling host cell polypep-
tides. 
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(3H)-Glucosamine Labelled Products 
Initial electrophoresis of the (3H)-gln labelled products 
on 10% PAA gel revealed different electrophoretic pat-
terns for HSV-1 and HSV-2 infected cells by autoradiogra-
phy, while the mock infected cells appeared to have no 
labelled glycoproteins (Figure 2.5-2.8, Table 2.4). This 
suggested that it would be easy to identify the viral 
specific glycoproteins of HSV-1 and HSV-2 because they 
would not be confused with host cell glycoproteins. 
However, electrophoresis of the same products on 7,5% PAA 
gel showed that (3H)-gln had been incorporated into seve-
ral mock infected cell polypeptides (Figure 2. 10). The 
reason for this discrepancy has been discussed earlier. 
Autoradiography of the (3H)-gln labelled HSV-2 infected 
cell product after electrophoresis on 7, 5% PAA ge 1, re-
vealed a greater number of labelled polypeptides than had 
been visible on the 10% PAA gel (Table 2. 4). Some of 
these extra proteins appear to be host cell specific 
proteins (Figure 2.10, Table 2.4). This is in agreement 
with the finding that (3H)-gln labelled host cell poly-
peptides were visible on 7,5% PAA gels but not on 10% PAA 
gels. (The reason for the presence of labelled host cell 
proteins in HSV-2 infected cell products has been discus-
sed earlier.) The electrophoretic patterns of ( 3H)-gln 
labelled HSV-1 polypeptides were similar on the two types 
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of gel used, although the 10% PAA gel gave better resolu-
tion (Figure 2.5 and 2.10). As mentioned earlier, the 
molecular weights of these polypeptides, determined from 
the two types of gel, differed considerably. However, 
the molecular weight values obtained from the 7, 5% PAA 
gel are comparable with published values (Table 2.6). 
Conclusion 
1. HSV-l infected BHK-21 cells were labelled satisfac-
torily, in that the radioisotopes were only 
incorporated into viral specific proteins. 
2. HSV-2 infected BHK-21 cells were not satisfactorily 
labelled in that many of the host cell proteins 
incorporated the radioisotopes. The probable reason 
for this is that the amount of virus in the inoculum 
was not sufficient to infect all the cells initial-
ly. Hence, the uninfected cells would have continu-
ed to grow normally and incorporate the radioiso-
topes into host cell proteins. 
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TABLE 2.5 - A COMPARISON OF REPORTED VALUES FOR THE MOLECULAR 
WEIGHTS OF HSV-1 PROTEINS. 
A B C D 
ICP m.wt VP m.wt VP m.wt ICP m.wt 
1 221 1-2 260 1 275 1 0 s 
2 205 3 260 2 260 2 0 s 
3 194 4 177 3 260 3 0 S 
4 170 5 157 4 184 4 164.10 
5 151 6 149 5 155 5 153.10 
6 146 6.5 130 6 146 6 141,30 
7 139 7 129 7 126 7 134,90 
7,5 132 8 126 8 126 8 124,50 
8 128 8,5 119 9 112 9 117, so 
9 122 9 llS 10 98 10 113, so 
10 117 10 100 11 93 11 104,70 
11 114 11 94 12 87 12 100,00 
12 111 12 91 13 78 13 92, 16 
13 109 12,3 88 14 78 14 83,18 
14 106 12,6 86 15 71 15 78,52 
15 103 13 82 16 65 16 75,86 
16 101 14 80 17 59 17 71, 61 
17 92 14,5 76 18 57 18 66,07 
18 88 15 73 19 53 19 63,83 
19 78 15,5 70 20 so 20 57,54 
20 77 15,8 69 21 44 21 48,52 
21 72,5 16 68 22 37 22 41,69 
23 71 17 62 23 33 23 38,90 
24 68 18 59 24 25 24 36,31 
25 64 19E 57 25 29,51 
26 61,S 19C 55 26 22,65 
27 58 20 51 27 16,98 
28 56 21 47 28 16,41 
29 55 21h -
31 52 22 39 
32 51,5 23 36 
33 so 
34 49,5 
35 46,5 
36 42,5 
37 39 
38 37 
39 36 
40 33,7 
41 32 
43 26,5 
44 24,S 
A. 
B. 
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Results of Morse et al, 1978. The proteins used for m.wt. 
calibration were B ', B , and a subunits of E.Coli RNA polymer-
ase, bovine serum albumin, and soybean trypsin inhibitor (T 1) 
(Boehringer Mannheim, Indianapolis, Ind.) with molecular 
weights of 165 K, 155 K, 39 K, 69 K, and 21 K, respectively. 
Results of Heine et al, 1974. Figures taken from Norrild, 
1980. Molecular weights determined by electrophoresis on 
polyacrylamide gels cross-linked with DATD. The proteins used 
form.wt. calibration were Myosin, B-Galactosidase, Catalase, 
Heavy chains, Ovalbumin, Alcohol dehydrogenase, and Lysozyme 
(Heine et al, 1974). 
C. Results of Spear & Roizman, 1972. The proteins used form.wt. 
determination were Myosin, B-Galactosidase, Lactoperoxidase, 
Bovine Serum albumin, Ovalbumin, and a - Chrymotrypsinogen A, 
with molecular weights of 220 K, 130 K, 92,6 K, 68 K, 43 Kand 
25,7 K, respectively. PAA gels cross-linked with N, N'-methy-
lenebisacrylamide. 
D. Results of the present work. Taken from Figure 2. 11. The 
proteins used for them.wt. determination are listed in Appen-
dix 1.2.3. PAA gels were cross-linked with N, N'-methylenebi-
sacrylamide. 
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m.wt. - molecular weights x 10-3 
0 S Off-scale, The molecular weights of these proteins were 
too high to be determined on 7,5% and 10% PAA gels, 
VP Virion polypeptide - i.e. Fran purified virions of HSV-1, 
I C P - Infected cell polypeptide - i.e. From cells infected with 
HSV-1. 
/ 
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TABLE 2.6 - A COMPARISON OF THE APPARENT MOLECULAR WEIGHTS OF 
HSV-1 GLYCOPROTEINS 
GLYCOPROTEIN APPARENT MOLECULAR WEIGHT x 10-3 (DALTONS) 
DESIGNATION 
(a) EXPERIMENTAL (b) LITERATURE (c) 
gB 127,4 122 
gC 117 ,5 110 
gE 86,7 85 
gD 68,4 57 
(a) See Chapter 3~.1 for a discussion of the designations given to 
HSV-1 glycoproteins. 
(b) Values derived from the present work using 7,5% PAA gel 
(Figure 2.10). 
(c) Values obtained from Haarr & Marsden, 1981 and Hope et al, 
1982 (See Chapter 3.1.1). 
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CHAPTER THREE - PURIFICATION OF HERPES SIMPLEX VIRUS 
TYPE 1 (HSV-1) GLYCOPROTEINS 
3.1. INTRODUCTION 
3.1.1. The glycoproteins of HSV-1 
HSV-1 has been reported to contain five major glycopro-
teins; Heine et al, 1974; Spear, 1976; Cohen et al, 1978; 
Bauke & Spear, 1979). These glycoproteins have been 
given various designations by different groups of resear-
chers (Table 3. 1). However~ the nomenclature of Spear 
has now been agreed upon as the provisional designations 
by a group of participants at the Herpesvirus Workshop 
held in 1978 in Cambridge, England (Spear, 1976). In the 
present work, the major glycoproteins of HSV-1 have been 
designated, in order of decreasing molecular weight, as 
gB, gC, gE and gD (Figure 3.l(a)). It should be noted 
that at no time in the present work was any evidence 
obtained for two species of glycoprotein comprising the 
gA/gB glycoprotein as has been previously reported (Spear 
1976; Bauke & Spear, 1979; Pereira et al, 1980). Some 
researchers have designated the glycoproteins gA/ gB be-
cause of the difficulty of distinguishing between the 
glycoproteins gA and gB (Eberle & Courtney, 1980 (a) ).More 
recently, Glorioso et al, have stated that HSV encodes 
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TABLE 3.1 - DESIGNATIONS AND MOLECULAR WEIGHTS OF THE MAJOR HSV-1 GLYCOPROTEINS 
Accepted 
glycoprotein 
designation 
( a) 
gC 
gB ( c) 
gE 
gD 
Other 
designations 
VP 8 
Ag-6 
VP 2/3 
VP 2/3 
GllO 
gA (c) 
gA/gB ( c) 
Ag-11 
Gl22 
CP-1 
Ag-8 
VP 8/9 
G57 
Apparent 
m.wtxl0-3 
(Dal tons) 
130 
129 
131 
ND (b) 
126 
llO (d) 
126 
ll9 
126 
N.D. (b) 
122 (d) 
65-80 
67-85 (d) 
59 
59 
N.D.(b) 
44-59 
57 (d) 
Reference 
Eisenberg et al, 1979 
Heine et al, 1974 
Vestergaard & 
Grauballe, 1979 
Powell et al 1974 
Powell & Watson, 1975 
Haarr & Marsden, 1981 
Spear, 1976 
Bauker & Spear, 1979 
Eisenberg et al, 1979 
Spear 1976 
Glorioso et al, 1983 
Norrild et al, 1979 
Haarr & Marsden, 1981 
Bauke & Spear, 1979 
Hope et al, 1982 
Eisenberg et al, 1979 
Cohen et al, 1978 
Norrild et al, 1979 
Powell & Watson, 1975 
Haarr & Marsden, 1981 
(a) The nomenclature accepted as the provisional designations of 
the HSV-1 glycoproteins at the Herpesvirus Workshop held in 
Cambridge, England in 1978. 
(b) Not done. 
(c) gA and gB are now recognized to be different forms of the same 
protein. The protein is now designated gB (Roberts et al, 
1985). 
(d) SDS-PAGE on PAA gels cross-linked with MBA. 
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for at least four antigenically distinct glycopeptides 
designated gC, gA/gB, gE and gD with corresponding appar-
ent molecular weights of 129 K, 126 K, 80 K and 58 K. 
Although initial studies indicated that gA and gB were 
antigenically distinct and separate gene products, recent 
evidence suggests that gA and gB are different forms of 
the same polypeptide (Glorioso et al, 1983). Thus, the 
most recent designation for glycoprotein gA/gB is gB 
(Roberts et al, 1985) and gA, which is the precursor of 
gB, is designated pgB. 
It is important to note that there has been a large dis-
crepancy between results published by different groups 
working with the glycoproteins of HSV. This discrepancy 
chiefly concerns the apparent molecular weights of the 
HSV-1 glycoproteins, gC and gB. Several groups have 
reported gC as having a larger apparent molecular weight 
than gB (Heine et al; Spear, 1976; Bauke & Spear, 1979; 
Eisenberg et al, 1979; Glorioso et al, 1983, 1984; 
Roberts et al, 1985), while other groups have reported 
that the opposite is true (Spear & Roizman, 1972; Heine 
et al, 1974; Haarr & Marsden, 1981; Marsden et al, 1984). 
This discrepancy was first reported by Heine et a 1, and 
is caused by the use of different cross-linkers in the 
preparation of polyacrylamide gels (Heine et al, 1974). 
Therefore, those groups that have used diallyltartardia-
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mide (DATD) as a cross-linker, report that gC has a lar-
ger apparent molecular weight than gB, while those groups 
that have used methylenebisacrylamide (MBA) (Appendix 
1. 2. 2 (a)) report the opposite. This phenomenon appears 
to only affect glycosylated proteins (Heine et al, 
1974). 
MBA was used as the cross-linker in preparing PAA gels 
for the present work, and so the designation of glycopro-
teins and comparison of results are taken from those who 
have used the same PAA gel system (Marsden et al, 1984) 
(See Figure 3.1). 
Some of the techniques that have been used for the puri-
fication of glycoproteins gC and gB are preparative poly-
acrylamide gel electrophoresis (Prep-PAGE), hydroxylapa-
tite chromatography in the presence of sodium dodecyl 
sulphate (SDS-HTP), and gel bound lectin affinity chroma-
tography. 
FIGURE 3 .1 
HSV-1 infected BHK-21 cells, grown in the presence of 
(3H)-glycosamine, were harvested and solubilized with IMW 
sample buffer (Chapter 2.2.2). This material was elec-
trophorezed on (a) 10% PAA gel cross-linked with MBA and, 
(b) 10% PAA gel cross-linked with DATD. 
The figure shows the autoradiographs of the resultant 
gels after electrophoresis, and their corresponding den-
s i tometer scans. The densitometer scans show that the 
more dense band (gB) has a larger apparent molecular 
weight than the less dense band (gC) in (a), and that the 
opposite is true in (b). 
distinguished according 
Glycoproteins gC and gB were 
to the radioactive content of 
their respective bands as shown by the intensity of these 
bands on the autoradiographs. This method of disting-
uishing the glycoproteins is similar to that used by 
Heine et al (1974), but is not entirely satisfactory. 
The most conclusive method of distinguishing between 
these proteins would be the use of monoclonal antibodies 
directed against each protein (Spear, personal communi-
cation). 
The glycoproteins in (a) are designated according to Hope 
et al (1982) and Marsden et al (1984), and in (b) are 
designated according to Bauke & Spear (1979) and Glorioso 
et al ( 1983). The designation of glycoproteins in the 
present work is as shown in (a). 
a 
gB,. 
gc-. 
gE, 
gR 
b 
gC . 
gB'" 
gD. 
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Preparative polyacrylamide gel electrophoresis 
(Prep-PAGE) 
Prep-PAGE was initially used to isolate a large molecular 
weight polypeptide of HSV-1 (Courtney & Benyesh-Melnick, 
1974) and has since been used for the partial purifica-
tion of the major glycoprotein regions of HSV-1 and HSV-2 
(V~ 123 and VP 119, respectively) (Dreesman et al, 1979; 
Eberle & Courtney, 1980(a)). The system is the same as 
that used for analytical SDS-PAGE (Chapter 2) except that 
electrophoresis is performed in an apparatus which allows 
for preparative amounts of material and the collection of 
proteins eluted from the PAA gel (Figure 2.3.1). 
Hydroxylapatite chromatography in the presence of sodium 
dodecyl sulphate (SDS-HTP) 
Some workers have used hydroxylapatite chromatography as 
a means of selectively isolating the HSV-1 specific gly-
coprotein, gC (Vestergaard & Grauballe, 1979; Schrier, 
Pizer & Moorhead, 1983). However, other workers, who 
used Prep-PAGE as an initial purification step, utilized 
the technique of hydroxylapati te chromatography in the 
presence of sodium dodecyl sulphate (Moss & Rosenblum, 
1972) to purify the HSV-1 glycoprotein, gC, from other 
glycosylated and non-glycosylated proteins (Eberle & 
Courtney, 1980(a)). 
3.1.4. 
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This technique involves adsorption of protein-SDS com-
plexes onto hydroxylapatite and elution with 0.1% SDS, 
lnM dithiothreitol (DTT) and a gradient of sodium phos-
phate. A useful feature of the technique is that pro-
teins do not all elute in order of molecular weight. 
Thus, polypeptide separations on hydroxylapatite are 
different from those obtained by polyacrylamide gel elec-
trophoresis or gel filtration in SDS (Moss & Rosenblum, 
1972). HA Ul trogel (Appendix 1. 3.1) which has similar 
properties to hydroxylapatite was used in the present 
work. 
Gel-bound lectin affinity chromatography 
The specificity of lectins for various saccharide resi-
dues makes them useful as affinity adsorbents for the 
fractionation of glycoproteins. 
RSV glycoproteins have been characterized by their bin-
ding to concanavalin A ( Con A), wheat germ, soybean and 
Helix pomatia lectins (Ponce de Leon, Hessle & Cohen, 
1973; Jeansson, Elwing & Nilsson, 1979; Olofsson, 
Jeansson & Lycke, 1981). Con A and wheat germ lectins 
have affinity for the internal a -mannose and n-acetyl-D-
glucosamine (GlcNAc) respectively, of oligosaccharides, 
while soybean and Helix pomatia lectins both have affini-
ty for n-acetyl-D-galactosamine (GalNAc). 
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Con A affinity chromatography was used to selectively 
remove RSV-induced antigens from extracts of infected BHK 
cells (Ponce de Leon, Hessel & Cohen, 1973). Two broad 
groups of viral-induced antigens were isolated from Con 
A. Group 1 included two antigens which bound to Con A 
and were dissociated by a -methyl-D-mannoside ( a MM). 
Group II contained three antigens which bound to Con A 
by a non-specific or electrolytic mechanism and were only 
eluted using 2M NaCl. 
Wheat germ lectin has been used to purify and concentrate 
HSV-1 glycoproteins from non-glycosylated proteins 
(Jeansson, Elwing & Nilsson, 1979). However, this proce-
dure did not differentiate between the different glyco-
proteins of HSV-1 and four antigens were detected in the 
glycoprotein eluate when tested against HSV-1 antiserum. 
When lysates from HSV-1 and HSV-2 infected cells were 
subjected to affinity chromatography on soybean and Helix 
pomatia lectins, one of the virus-specified glycopro-
teins, probably glycoprotein C, bound to the lectins and 
was eluted with N-acetyl-galactosamine (GalNAc). The 
affinity chromatography permitted a high degree of puri-
fication of the type specific glycoproteins of HSV-1 and 
HSV-2 with respect to both host cell components and other 
viral glycoproteins (Olofsson, Jeansson & Lycke, 1981; 
3.1. 5 
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Svennerholm et al, 1984). Antigens purified by Helix 
pomatia lectin were used in an enzyme-linked immunosor-
bent assay (ELISA) with human reference sera to both 
types of HSV. The results correlated completely with the 
results of virus typing and showed that Helix pornatia 
lectin affinity chromatography was suitable for purifying 
type-specific antigens of HSV-1 and HSV-2 (Svennerholm et 
al, 1984). 
The aim of the present work was to obtain preparations of 
the HSV-1 glycoproteins, gC and gB, free from any other 
viral or host cell proteins. 
HSV-1 infected BHK-21 cells were grown in the presence of 
(3H)-glucosamine and were solubilized in SDS and 2-mer-
captoethanol at 28 hours post-infection (Chapter 2.2.2). 
The first step in the purification of glycoproteins gC 
and gB was to isolate them from each other and from the 
other glycoproteins of HSV-1. This was accomplished by 
two cycles of Prep-PAGE which successfully separated 
these glycoproteins, but the resultant solutions stil 1 
contained non-glycosylated proteins. 
Therefore, the next step of purification was to remove 
the non-glycosylated proteins from the glycoprotein solu-
tions. Hydroxylapatite chromatography in the presence of 
114 
SOS (Chapter 3.2.2) and gel-bound lectin affinity chroma-
tography (Chapter 3.2.3) were used, but did not success-
fully purify the glycoproteins. 
As the difficulties encountered in purifying the HSV-1 
glycoproteins by gel-bound lectin affinity chromatography 
could have resulted from the use of SOS for solubilizing 
the infected cell proteins, the technique was repeated 
using HSV-1 membrane proteins solubilized in Triton X-100 
(Chapter 3.2.5). Wheat germ lectin affinity chromatogra-
phy of this material resulted in the purification of 
several HSV-1 glycoproteins from the non-glycosylated 
proteins. 
3.2 METHODS AND RESULTS 
3.2.1 Preparative Polyacrylamide Gel Electrophoresis (Prep-
PAGE) 
Polyacrylamide gel electrophoresis (Chapter 2.1.2) can be 
adapted for preparative purposes by using the apparatus 
shown in Figure 2. 3.1. The Prep-PAGE apparatus is con-
nected to the other instruments shown in the diagram, 
which allow for the recording and collection of material 
eluted from the PAA gel. The technique used in Prep-PAGE 
is essentially the same as that used for analytical SOS-
PAGE (Appendix 2. 2.1) except that a different apparatus 
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is used and no "wick" gel is required. 
described in detail in Appendix 2.3.1. 
The method is 
Prep-PAGE was used for the following purposes:-
A. 
B. 
Prep-PAGE of HSV-1, HSV-2 and mock infected BHK-21 
cells labelled with either (14c)-amino acids or 
(3H)-glucosamine. 
HSV-1, HSV-2 and mock infected BHK-21 cells which 
had been grown in the presence of either (3H)-gluco-
samine or (14c)-amino acids and stored at -70°C 
(Chapter 2.2.2) were electrophorezed separately in 
the Prep-PAGE apparatus. A 1,0 ml volume of solubi-
lized material was mixed with 0,3 ml of 100% glycer-
ol and phenol red and applied to the 7, 5% PAA gel 
(Figure 2.3.1). Electrophoresis was performed at 
constant current (8 mA) and 5 ml fractions were 
collected at a flow rate of 8. 0 ml/hr. Each frac-
tion was assayed for radioactivity (Appendix 2.3.5) 
and the elution profile of each product was drawn by 
plotting counts per minute (CPM) against fraction 
number (Figure 3.2). 
Separation of HSV-1 glycoproteins by Prep-PAGE 
HSV-1 infected BHK-21 cells, which had been grown in 
the presence of (3H)-glucosamine, solubilized in LMW 
sample buffer (Appendix 1.2.l(d)) and stored at 
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-70°C (Chapter 2.2.2) were electrophorezed in the 
Prep-PAGE apparatus so as to separate the glycopro-
teins from each other. A 1, 0 ml aliquot of the 
solubilized material was mixed with 0,3 ml of 100% 
glycerol and phenol red and applied to the PAA gel. 
The procedure described in (A) was repeated, and 
from the elution profile that was drawn, the peaks 
of radioactivity were determined and the constituent 
fractions were pooled separately (Peaks I, II and 
III respectively (Figure 3.3)). 
The pooled fractions were concentrated by the fol-
lowing procedure: 
(a) Pervaporation to reduce the volume to approxi-
mately 10 ml (Appendix 2.3.7). 
(b) Dialysis against the reservoir buffer (Appendix 
1.2.l(c)) to reduce the buffer salts. 
(c) Lyophilization (Appendix 2.3.6). 
(d) Resuspension in the required volume of I.MW 
sample buffer (i.e. 1, 0 ml) for a repeat cycle 
of Prep-PAGE electrophoresis. 
Peaks I, II and III were then electrophorezed separ-
ately in the Prep-PAGE apparatus according to the 
procedure described in (A). After electrophoresis 
the fractions constituting the major peak of radio-
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activity in each case (Figure 3. 4) were pooled and 
stored at -20°C in the presence of 0.001 M phenyl-
methylsulphonyl fluoride (PMSF) (Appendix 1.3.6). 
RESULTS 
A. 
B. 
Prep-PAGE of HSV-1, HSV-2 and mock infected BHK-21 
cells labelled with either (14c)-amino acids or 
(3tt)- glucosamine. 
The elution profiles of the six different radiola-
belled products (Chapter 2.2.2) after electrophore-
sis in the Prep-PAGE apparatus are shown in Figure 
3.2. These elution profiles record the different 
radiolabelled polypeptides of each of the products, 
as has been discussed earlier (Chapter 2.2.2). 
Separation of HSV-1 glycoproteins by Prep-PAGE 
Prep-PAGE of HSV-1 infected BHK-21 cell proteins 
labelled with (3H)-glucosamine produced four peaks 
of radioactivity (Figure 3.3). The first and lar-
gest peak of radioactivity eluted with the phenol 
red and probably contained (3H)-glucosamine which 
had not been incorporated into proteins. The three 
following peaks are named peak I, II and III, res-
pectively (Figure 3.3). Analytical SOS-PAGE showed 
that peak I consists of several of the intermediate 
and low molecular weight HSV-1 glycoproteins (Figure 
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3.6). Peak II consists mainly of the HSV-1 glyco-
protein, gC, but also contains some of glycoprotein, 
gB. Peak III consists mainly of glycoprotein, gB, 
but also some of glycoprotein, gC (See Chapter 3.1.1 
for the designations of these proteins). 
Peaks I, II and III were concentrated and individu-
ally electrophorezed in the Prep-PAGE apparatus. 
This second cycle of Prep-PAGE further purified the 
glycoproteins contained within each peak with re-
spect to the other glycoproteins (Figure 3.4). The 
fractions within the major peaks of radioactivity 
were pooled and stored in the presence of O, 001 M 
PMSF (Appendix 1.3.6) at -20°C until required. 
Analytical SDS-PAGE of the pooled fractions consti-
tuting peaks II and III, showed that after the sec-
ond cycle of Prep-PAGE they each contained only one 
species of glycoprotein (Figure 3. 7 (b)). However, 
they still contained several non-glycosylated pro-
teins (Figure 3.7(a)). 
FIGURE 3.2 - Prep-PAGE ELUTION PROFILES OF HSV-1, HSV-2 
AND MOCK INFECTED CELL PROTEINS LABELLED 
WITH EITHER (3H)-gln OR (14c)-aa 
HSV-1, HSV-2 and mock infected cells which had been grown 
in the presence of ( 3H)-glucosamine or ( 14c)-amino acids, 
were solubilized and electrophorezed in the preparative 
PAGE apparatus containing a 7,5% PAA gel (Figure 2.3.1). 
The samples were electrophorezed at constant current 
(8 mA), and 5 ml fractions of eluant were collected at a 
flow rate of 8 ml/hr. Fractions were assayed for radio-
activity and the elution profiles drawn by plotting 
counts per minute (CPM) for each fraction. 
(a) - Cells labelled with (3H)-glucosamine. 
(b) - Cells labelled with ( 14c)-amino acids. 
(o--o) 
- HSV-1 infected cells. 
(0 -0) - HSV-2 infected cells. 
( ... _ ... ) 
- Mock infected cells. 
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FIGURE 3.3 - Prep-PAGE ELUTION PROFILE OF HSV-1 
INFECTED CELL PROTEINS LABELLED 
WITH (3H)-gln 
HSV-1 infected BHK-21 cells which had been 
grown in the presence of (3H)-glucosarnine were 
solubilized and electrophorezed in the Prep-
PAGE apparatus as described in the legend to 
Figure 3.2. 
Fractions 8, 12 and 21 were analyzed by SDS-
PAGE (Figure 3.5). 
Fractions within peaks I, II and III were pool-
ed as follows:-
Peak I Fractions 5-12 
Peak II Fractions 13-18 
Peak III - Fractions 19-27 
These pooled samples were concentrated and re-
electrophorezed (Figure 3.4) as well as being 
analyzed by SDS-PAGE (Figure 3.6). 
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FIGURE 3.4 - Prep-PAGE ELUTION PROFILES OF 
PROTEINS WITHIN PEAKS I, II AND 
III 
Peaks I, II, and III (Figure 3.3) were concen-
trated and again electrophorezed in the Prep-
PAGE apparatus, as described in the legend to 
Figure 3.2. After electrophoresis the frac-
tions constituting the major peaks of radio-
activity were pooled and analyzed by SDS-PAGE 
(Figure 3.7). The remainder of each peak was 
stored in the presence of 0,001 M PMSF at -20°C 
until required for further purification. 
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FIGURE 3.5 - ANALYTICAL SDS-PAGE OF FRACTIONS 
COLLECTED DURING Prep-PAGE 
HSV-1 infected cell proteins labelled with 
(3H)-gln were subjected to electrophoresis in a 
Prep-PAGE apparatus (Figure 3.3). A fraction 
from each peak of radioactivity (Fractions 8, 
12 and 21) was analyzed by SDS-PAGE and auto-
radiography. 
Figure 3.S(a) - Silver Stain 
Track 1 - High molecular weight (HMW) marker 
proteins. 
Track 2 - HSV-1 infected BHK-21 cell proteins 
labelled with (3H)-gln. This is the 
starting material that was applied to 
the Prep-PAGE apparatus. 
Track 3 - Fraction 8 
Track 4 - Fraction 12 
Track 5 - Fraction 21 
Figure 3.S(b) - Autoradiograph 
Track 1 - HSV-1 infected cell proteins labelled 
with (3H)-gln 
Track 2 - Fraction 8 
Track 3 - Fraction 12 
Track 4 - Fraction 21 
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FIGURE 3.6 - ANALYTICAL SDS-PAGE OF PEAKS I, II 
and III 
HSV-1 infected cell proteins labelled with 
(3H)-gln were subjected to electrophroesis in a 
Prep-PAGE apparatus (Figure 3.3). The frac-
tions within each peak of radioactivity were 
pooled (Peaks I, II and III) and a sample of 
each pool was analyzed by SDS-PAGE and auto-
radiography. 
Figure 3.6(a) - Silver Stain 
Track 1 - HMW marker proteins. 
Track 2 - HSV-1 infected BHK-21 cell proteins 
labelled with (3H)-gln. 
Track 3 - Peak I 
Track 4 - Peak II 
Track 5 - Peak III 
Figure 3.6(b) - Autoradiograph 
Track 1 - HSV-1 infected BHK-21 cell proteins 
labelled with (3H)-gln 
Track 2 - Peak I 
Track 3 - Peak II 
Track 4 - Peak III 
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FIGURE 3.7 - ANALYTICAL SDS-PAGE OF PEAKS II 
AND III 
HSV-1 infected cell proteins labelled with 
(3H)-glucosamine were electrophorezed in a 
Prep-PAGE apparatus (Figure 3.3). The frac-
tions within the peaks of radioactivity (peaks 
I, II and III) were pooled and concentrated. 
Each peak was then subjected to a second cycle 
of electrophoresis in the Prep-PAGE apparatus 
(Figure 3.4). The fractions within each peak 
of radioactivity were pooled and stored at 
-20°C in the presence of 0,001 M PMSF. Samples 
of peak II and peak III were analyzed by SDS-
PAGE and autoradiography. 
Figure 3.7(a) - Silver Stain 
Track 1 - HMW marker proteins 
Track 2 - Peak III 
Track 3 - Peak II 
Track 4 - HSV-1 infected BHK-21 cell proteins 
labelled with (3H)-gln 
Figure 3.7(b) - Autoradiograph 
Track 1 - Peak III 
Track 2 - Peak II 
Track 3 - HSV-1 infected BHK-21 cell proteins 
labelled with (3H)-gln 
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DISCUSSION 
Two cycles of Prep-PAGE, using 7,5% PAA gel, were suffi-
cient to produce solutions of the HSV-1 glycoproteins, gC 
and gB, free of contamination by any of the other HSV-1 
glycoproteins (Figure 3. 7 (b)). However, analytical SOS-
PAGE revealed that these solutions contained a signifi-
cant amount of non-glycosylated proteins (Figure 3.7(a)). 
As the aim of the present work was to produce pure prep-
arations of glycoproteins, gC and gB, further purifica-
tion of these solutions was necessary. 
Purification of HSV-1 glycoproteins, gC and gB, from non-
glycosylated proteins using hydroxylapatite chromatogra-
phy in the presence of sodium dodecyl sulphate (SDS-HTP) 
Hydroxylapatite chromatography in the presence of sodium 
dodecyl sulphate (SDS-HTP) has previously been used to 
separate the HSV-1 glycoproteins gA/gB (gB) and gC from 
each other and from non-glycosylated proteins (Eberle & 
Courtney, 1980 (a)). Therefore, an attempt was made to 
use SDS-HTP to purify the glycoproteins from non-glycosy-
lated proteins, and also to confirm the separation of gC 
and gB by this means. In the present work HA Ul trogel 
(Appendix 1.3.1) was used instead of normal hydroxylapa-
tite. HA Ultrogel is reported to have the same proper-
ties as hydroxylapatite but better flow properties on 
account of being embedded in agarose beads (1KB Cata-
logue). 
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The procedure was as follows:-
( a) The HA Ul trogel column and the samples for chromato-
graphy were prepared as described in Appendix 
2.3.2. 
(b) 20 ml of HSV-1 glycoprotein, gC solution (Figure 3.4 
Peak II) was applied to the HA Ultrogel column at a 
flow rate of 8 ml/hr. 
(c) The adsorbed proteins were then eluted from the 
column over a six hour period using a linear gradi-
ent of increasing phosphate molarity from 0,1-0,5 M 
phosphate buffer, pH 6,4, with 0,1% SDS and 1 rnM 
dithiothreitol (DTT) at a flow rate of 15 ml/hr. 
(d) 5 ml fractions were collected and 0,1 ml aliquots of 
each fraction were assayed for radioactivity (Appen-
dix 2.3.5). The elution profile of counts per min-
ute (CPM) against fraction number was then drawn 
(Figure 3.8). 
(e) The procedure was repeated using the following sam-
ples:-
(i) 20 ml of HSV-1 glycoprotein, gB, solution (Fig-
ure 3.4 Peak III). 
(ii) 20 ml of HSV-1 glycoprotein mixture (Figure 3.4 
Peak I). 
(iii) A mixture containing 10 ml of gC solution and 
10 ml of gB solution (Figure 3. 4 Peak II and 
Peak III). 
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RESULTS 
SDS-HTP of the major peaks of radioactivity obtained by Prep-
PAGE (Peaks I, II and III, Figure 3.4) demonstrated that the 
glycoproteins contained within these peaks were all eluted 
from HA Ultrogel over the same range of phosphate molarity -
between 0,25 Mand 0,39 M phosphate (Figure 3.8). 
When a mixture of peak II and peak III was applied to the HA 
Ultrogel column, the glycoproteins eluted as a single peak of 
radioactivity (Figure 3.9). Analytical SDS-PAGE of fractions 
from this peak (Fractions 7, 9, 10 and 12, Figure 3.9) confir-
m·ed that glycoproteins gC and gB eluted together and were not 
separated by this technique (Figure 3.10). 
FIGURE 3.8- HYDROXYLAPATITE CHROMATOGRAPHY OF 
HSV-1 GLYCOPROTEINS IN THE PRESENCE 
OF SDS (SDS-HTP) 
HSV-1 glycoproteins were separated by Prep-PAGE 
into peaks I, II and III (Figure 3.4). 20 ml 
of each peak was applied separately to an HA 
Ultrogel column and eluted with a linear gradi-
ent of increasing phosphate molarity from 0,1 -
0,5 M phosphate buffer, pH 6,4, with 0,1% SDS 
and 1 uM DTT (----). 0,1 ml aliquots of each 
fraction were assayed for radioactivity and the 
elution profiles of counts per minute (CPM) 
against fraction number were drawn. 
(o~o) - Low molecular weight glycoproteins 
(Peak I). 
(~~~) - Glycoprotein gC (Peak II). 
(•~•) - Glycoprotein gB (Peak III). 
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FIGURE 3.9 - SDS-HTP CHROMATOGRAPHY OF A 
MIXTURE OF HSV-1 GLYCOPROTEINS, 
gC and gB 
A mixture of 10 ml of Peak II (gC) and 10 ml of 
Peak III (gB) (See Figure 3.4) was applied to 
an HA Ultrogel column and eluted according to 
the legend in Figure 3.8. Fractions 7, 9, 10 
and 12 were analyzed by SDS-PAGE and autoradio-
graphy (Figure 3.10). 
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FIGURE 3.10 - AUTORADIOGRAPH OF FRACTIONS ELUTED FROM 
HA-ULTROGEL AND ANALYZED BY SDS-PAGE 
Fractions 7, 9, 10 and 12 (Figure 3.9) were concentrated 
and electrophorezed on 7,5% PAA gel. After electrophore-
sis the PAA gel was impregnated with EN3HANCE, dried and 
exposed to Kodak X-Omat AR 5 film. 
Track 1 - Fraction 7 
Track 2 - Fraction 9 
Track 3 - Fraction 10 
Track 4 - Fraction 12 
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DISCUSSION 
The major glycoprotein region of HSV-1 (VP 123), which 
consists of a , non-glycosylated protein and glycoproteins 
gA/gB (gB) and gC, has previously been isolated by Prep-
PAGE and then further fractionated by SDS-HTP chromatog-
raphy. The constituent proteins of VP 123 were reported 
to elute separately from the hydroxylapatite column and 
within narrow ranges of phosphate molarity. Thus, puri-
fied solutions of gC and gA/gB were obtained (Eberle & 
Courtney, 1980(a)). 
The technique of Eberle and Courtney was used to remove 
non-glycosylated proteins from the glycoprotein solutions 
of gC and gB. However, the glycoproteins were found to 
elute over a much wider range of phosphate molarity than 
had previously been reported, and all the HSV-1 glycopro-
teins were found to elute within approximately the same 
phosphate molarity range (Figure 3.8). SDS-HTP chromato-
graphy of a mixture of the gC and gB solutions confirmed 
that these glycoproteins eluted within the same phosphate 
molarity range (Figure 3.9 and 3.10). These results show 
that:-
(a) SDS-HTP chromatography using HA-Ultrogel was not 
suitable for separating HSV-1 glycoproteins, gC and 
gB. 
3.2.3 
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(b) Since glycoproteins gC and gB were eluted over such 
a wide range of phosphate molarity, SDS-HTP would 
not be suitable for purifying the glycoproteins with 
respect to non-glycosylated proteins. 
Purification of HSV-1 glycoproteins, gC and gB, from non-
glycosylated proteins using gel-bound lectin affinity 
chromatography. 
Lectins are proteins which have the ability to react 
reversibly with specific sugar residues and such proteins 
have been isolated from a variety of plants and inverte-
brates. They are not only distinguished by their origins 
and structures but, most importantly, by their affinities 
for different carbohydrate moieties (Sharon & Lis, 1972; 
Lis & Sharon, 1973). 
Only the terminal residue of an oligosaccharide is invol-
ved in binding with the lectin and the binding reaction 
is analogous to the interaction between an antibody and 
an antigen. The bond between the lectin and the specific 
sugar residue is broken by solutions of high ionic stren-
gth or by solutions containing a competitive binding 
substance (Sharon & Lis, 1972). 
A. 
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Wheat germ lectin affinity chromatography 
Wheat germ lectin is a protein which has been ex-
tracted from wheat germ. The active wheat germ 
lectin consists of two identical subunits at neutral 
pH, with a total molecular weight of about 35,000. 
This dimer dissociates below pH 3.5 to form monomers 
with a molecular weight of approximately 17,500. 
Wheat germ lectin contains two binding sites per 
subunit which are highly specific for N-acetylgluco-
samine (Nagata & B~rger, 1974). 
Wheat germ lectin sepharose 6MB (Appendix 1.3.2) has 
previously been used effectively to obtain relative-
ly pure and concentrated preparations of HSV-1 gly-
coproteins (Jeansson, Elwing & Nilsson, 1979) and so 
was chosen as a means of purifying glycoproteins 
from non-glycosylated proteins. 
The HSV-1 glycoproteins gC and gB were separated by 
means of Prep-PAGE and stored in solution at -20°C 
(Chapter 3.2.l(B)). Samples of these glycoprotein 
solutions were prepared for wheat germ lectin (WGL) 
affinity chromatography by dialyzing overnight 
against 0, 1 M glycine/NaOH, pH 8,8, containing 1% 
Triton X-100 and 0,02 M NaN3. The wheat germ lectin 
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sepharose 6 MB column was prepared as described in 
Appendix 2.3.3(A). 
A sample containing 20 ml of glycoprotein gC solu-
tion (Peak II, Figure 3. 4), was applied to the WGL 
column after dialysis, at a flow rate of 20 ml/hr. 
The column was then washed with 50 ml of equi libra-
tion buffer (Appendix 1.3.5). After washing, the 
bound proteins were eluted with 20 ml of elution 
buffer, ( equilibration buffer containing 1 % Triton 
X-100 (w/v) and 0,2 M n-acetyl glucosamine). The 
same flow rate was used throughout. Fractions of 5 
ml were collected and O, 1 ml aliquots of each frac-
tion were assayed for radioactivity (Appendix 
2.3.5). An elution profile of counts per minute 
against fraction number was drawn (Figure 3.11). 
When it was found that the bound glycoprotein failed 
to elute in the buffer containing O, 2 M n-acetyl 
glucosamine (GlcNAC), attempts were made to elute 
the protein using the following buffers:-
(a) Equilibration buffer containing 1% Triton X-
100, 1 M NaCl and 0,5 M glucosamine. 
(b) Equilibration buffer containing 1% Triton X-100 
and 2 M NaCl. 
B. 
135 
(c) Equilibration buffer containing 1% Triton X-
100, 2 M NaCl and 0,2 M n-acetyl glucosamine. 
(d) 1,4 M KCN containing 0,4 M NaCl, 1% Triton X-
100 and 0,2 M n-acetyl glucosamine. 
Fractions of 5 ml were collected and assayed for 
radioactivity. The elution profile of the entire 
experiment was drawn (Figure 3.11). 
The experiment was repeated with 20 ml of glycopro-
tein gB solution (Peak III, Figure 3.4). An attempt 
was made to elute the glycoprotein using 20 ml of 
equilibration buffer containing 0,4 M NaCl, 1% 
Triton X-100 and 0,2 M n-acetyl glucosamine (Figure 
3.12). Another attempt was made to elute the glyco-
protein, using the same elution buffer, but contain-
ing O, 5 M GlcNAc. 
Helix pomatia lectin affinity chromatography 
Most viral glycoproteins contain N-glycosidic link-
ages between their oligosaccharide chains and their 
peptides. However, HSV has been found to possess 
one glycoprotein which contains alkali-sensitive 
chains, indicating an 0-glycosidic linkage between 
the oligosaccharide chains and the peptide 
(Olofsson, Jeansson & Lycke, 1981). 
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Heli~ pomatia lectin, which has been isolated from 
the albumin gland of the snail Helix pomatia 
(Hammarstrom & Kabat, 1969), is known to bind N-
acetylgalactosamine (GalNAc) residues which are 
commonly found in glycosaccharides 0-glycosidically 
linked to peptides. This property of Helix pomatia 
lectin was utilized in purifying the one glycopro-
t ein of HSV containing 0-glycosidic linkages 
(Olofsson, Jeansson & Lycke, 1981). This glycopro-
tein has been identified as glycoprotein C (gC) 
(Olofsson et al, 1983; Svennerholm et al, 1984). 
For this reason, Helix pomatia lectin (HPL) was used 
as a means of purifying the HSV-1 specific glycopro-
tein, gC, from contaminating non-glycosylated poly-
peptides after the glycoproteins had been separated 
by Prep-PAGE (Chapter 3.2.l(B)). 
The Helix pomatia lectin sepharose 6MB column and 
the glycoprotein samples were prepared for affinity 
chromatography as described in Appendix 2.3.3(B). 
After dialysis, 20 ml of glycoprotein, gB, solution 
( Figure 3. 4 Peak III) was applied to the gel bound 
HPL column at a flow rate of 10 ml/hr. The column 
was then washed with 20 ml of equilibration buffer 
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(Appendix 1. 3. 5) at a rate of 20 ml/hr in order to 
remove any unadsorbed proteins. The adsorbed pro-
teins were eluted with 20 ml of equilibration buffer 
containing 1% Triton X-100 and 0,05 M n-acetyl-
D-galactosamine (GalNAc), at the same flow rate. 
Fractions of 5 ml were collected throughout, and 
assayed for radioactivity. The elution profile of 
CPM against fraction number, was drawn (Figure 
3.13). 
When the radiolabelled protein failed to elute in 
the presence of O, 05 M GalNAc, an attempt was made 
to elute using 20 ml of equilibration buffer con-
taining 0,4 M NaCl, 1% Triton X-100 and 0,1 M 
GalNAc. 
RESULTS 
A. Wheat germ lectin affinity chromatography 
Application of the HSV-1 glycoprotein gC (Figure 3.4 
Peak II) to the gel bound WGL column, resulted in 
the adsorption of all (3H)-gln labelled proteins to 
the column (Figure 3.11). However, attampts to 
elute the adsorbed proteins using O, 2 M GlcNAc in 
the ~quilibration buffer (according to Jeansson, 
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Elwing & Nilsson, 1979) proved ineffective, as no 
radiolabelled material was eluted (Figure 3.11). 
For this reason, several different buffers were used 
in attempts to elute the adsorbed proteins from the 
gel-bound lectin. Buffers containing up to five 
times the recommended concentration of GlcNAc 
(Jeansson, Elwing & Nilsson, 1979) failed to elute 
the adsorbed proteins. 
Eventually, a buffer containing the chaotropic CN-
ion (1,4 M KCN + 0,4 M NaCl+ 1% Triton X-100 + 0,2 
M GlcNAc) was successful in eluting the radiolabeled 
protein from the column (Figure 3. 11). However, 
analytical SDS-PAGE of the eluant revealed that the 
protein had been broken down. (Results not shown). 
The HSV-1 glycoprotein, gB, (Figure 3.4 Peak III) 
was also adsorbed to the gel-bound WGL column and 
attempts to elute the adsorbed protein with O, 2 M 
GlcNAc in equilibration buffer resulted in a small 
amount of (3H)-labelled protein being eluted (Figure 
3.12). A further attempt to elute the bound glyco-
protein, using an increased concentration of GlcNAc 
(0,5 M), was not successful. 
B. 
139 
Helix pornatia lectin affinity chromatography 
When a solution containing the HSV-1 glycoprotein, 
gB, (Figure 3.4 Peak III) was applied to a gel-bound 
HPL column, almost all of the radiolabelled protein 
was eluted without adsorbing to the lectin (Figure 
3.13). A small sample of the HPL Sepharose 6 MB gel 
was assayed for radioactivity and was found to con-
tain a small amount of radiolabelled protein. The 
bound glycoprotein was not eluted in the presence of 
either 0,05 M or 0,1 M GalNac (Figure 3.13). 
FIGURE 3.11 - WHEAT GERM LECTIN AFFINITY 
CHROMATOGRAPHY OF HSV-1 
GLYCOPROTEIN C (gC) 
The HSV-1 glycoprotein, gC (Figure 3.4 Peak II) 
was applied to a column containing 8 ml of 
wheat germ lectin Sepharose 6 MB. After wash-
ing, attempts were made to elute the adsorbed 
protein using 20 ml of the following buffers:-
1. Equilibration buffer containing 1% Triton 
X-100 and 0,2 M GlcNAc. (Elute 1) 
2. Equilibration buffer containing 1% Triton 
X-100, lM NaCl and 0,5 M GlcNAc. (Elute 
2) 
3. Equilibration buffer containing 1% Triton 
X-100 and 2 M NaCl. (Elute 3) 
4. Equilibration buffer containing 1% Triton 
X-100, 2 M NaCl and 0,2 M GlcNAc • . (Elute 
4) 
5. 1,4 M KCN + 0,4 M NaCl + 1% Triton X-100 + 
0,2 M GlcNAc. (Elute 5) 
Fractions of 5 ml were collected throughout and 
assayed for radioactivity. The figure shows 
the radioactive counts of each fraction. 
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FIGURE 3.12 - WHEAT GERM LECTIN AFFINITY 
CHROMATOGRAPHY OF HSV-1 
GLYCOPROTEIN B (gB) 
The HSV-1 glycoprotein, gB (Figure 3.4 Peak 
III) was applied to a column containing 8 ml of 
wheat germ lectin sepharose 6 MB. After wash-
ing, attempts were made to elute the bound 
glycoprotein with 20 ml of the following buf-
fers : 
1. Equilibration buffer containing 0,4 M 
NaCl, 1% Triton X-100 and 0,2 GlcNAc. 
(Elute 1). 
2. Equilibration buffer containing 0,4 M 
NaCl, 1% Triton X-100 and 0,5 M GlcNAc. 
(Elute 2). 
C 
0 
-
141 
0 
I 
I 
" 
0 
\ 
0 
" 
0 
\ 
./0 
0/ 
0/ 
/0/. 
0/ 
C 
00 
0 
I 
0 
\ 
0 
0/ 
" 
0 
I 
·"' 0 
C 
N 
Lt') 
-
C 
-
It) 
C 
i... 
a, 
.c 
E 
:::s 
z 
C: 
0 
..... 
(.) 
ro 
'-
u. 
FIGURE 3.13 - HELIX POMATIA LECTIN AFFINITY 
CHROMATOGRAPHY OF HSV-1 
GLYCOPROTEIN B (gB) 
The HSV-1 glycoprotein, gB (Figure 3.4 Peak 
III) was applied to a column containing 2 ml of 
Helix pomatia lectin sepharose 6MB. After 
washing, attempts were made to elute the adsor-
bed protein with 20 ml of the following buf-
fers:-
1. Equilibration buffer containing 1% Triton 
X-100 and 0,05 M GalNAc. (Elute 1) 
2. Equilibration buffer containing 0,4 M 
NaCl, 1% Triton X-100 and 0,1 M GalNAc. 
(Elute 2) 
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DISCUSSION 
Gel-bound lectin affinity chromatography is a technique 
which is commonly used for purifying glycoproteins, and 
has been used successfully for purifying some glycopro-
teins of HSV-1 (Chapter 3.1.4). 
Glycoproteins gC and gB of HSV-1, which had been separa-
ted and partially purified by Prep-PAGE, were individu-
ally applied to a column containing wheat germ lectin 
sepharose 6MB. Glycoprotein gC bound to the wheat germ 
lectin column but could only be eluted using very strong 
conditions (Figure 3.11), and this was unsatisfactory 
because analytical SOS-PAGE of the eluant revealed that 
the glycoprotein had been broken up by the treatment 
(Results not shown). Glycoprotein gB was also bound by 
the wheat germ lectin and, although some (3H)-labelled 
glycoprotein eluted with the elution buffer (Figure 
3.12), this was only a small fraction of the total (3H)-
labelled glycoprotein that had been applied to the col-
umn. An attempt to elute more of the glycoprotein with a 
higher concentration of GlcNAc was not successful. 
Glycoprotein gB was also applied to a column containing 
Helix Pomatia lectin sepharose 6MB. Almost all of the 
radiolabelled glycoprotein eluted without binding to the 
lectin, and there was no further glycoprotein released by 
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the elution buffer (Figure 3. 13). This is in agreement 
with previous reports which state that only gC binds to 
Helix Pomatia lectin (See Chapter 3.1.4). 
Glycoprotein gC should also have been applied to the 
Helix Pomatia lectin column. However, when this work was 
done, it was believed that gB was, in fact, gC. Subse-
quently, the phenomenon discussed in Chapter 3. 1. 1, in 
which the comparative positions of gB and gC on SDS-PAGE 
reverse according to the cross-linker used, was realized. 
Hence, gB was applied to the Helix Pomatia lectin column 
instead of gC. 
The difficulty encountered with eluting the bound glyco-
proteins from the wheat germ lectin column may have been 
caused by the use of an anionic detergent - sodium dode-
cyl sulphate (SDS) - to solubilize the infected cell pro-
teins. The SDS may have formed strong ionic bonds be-
tween the glycoproteins and the lectin. To investigate 
this possibility, the gel-bound lectin affinity chroma-
tography was repeated using HSV-1 membrane proteins solu-
bilized in a non-ionic detergent - Triton X-100 (Chapter 
3.2.5). 
3.2.4 
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Experiment to test the activity of the wheat germ lectin 
Sepharose 6 MB 
As a result of the difficulty encountered in eluting the 
HSV-1 glycoproteins from the column of wheat germ lectin 
Sepharose 6MB (Chapter 3.2.3(A)), the column was tested 
to see whether it responded normally to a glycoprotein 
which is known to have an affinity for wheat germ lectin 
and to elute in the presence of N-acetyl-D-glucosamine 
(GlcNAc). The glycoprotein chosen for this test was 
ovalbumin, which has previously been used to test the 
activity of wheat germ lectin (Gombos et al, 1974). The 
experiment was performed as follows:-
A solution of ovalbumin was prepared in physiological 
saline with a concentration of 1 mg/ml. A volume of 5 ml 
was applied to the WGL column at a flow rate of 20 ml/hr. 
The column was then washed through with 50 ml of equili-
bration buffer (Appendix 1.3.5). After washing, the 
ovalbumin was eluted from the column using 25 ml of 0,2 M 
GlcNAc in equilibration buffer. Fractions of 5 ml were 
collected throughout the experiment and the absorbance at 
280 nm (A2ao) of each fraction was measured. The elution 
profile of A2ao against fraction number was then drawn 
( Figure 3 .14). 
RESULTS 
Ovalbumin was adsorbed to the wheat germ lectin column 
and readily eluted in buffer containing 0,2 M GlcNAc. 
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TABLE 3.2 - THE ABSORBANCE AT 280 nm (A230) OF FRACTIONS ELUTED 
FROM A WHEAT GERM LECTIN COLUMN WHICH HAD BEEN LOADED 
WITH OVALBUMIN 
Fraction A230 
Ovalbumin solution containing 
1 mg/ml in physiological saline 0.68 
Elution buffer containing equil-
ibration buffer+ 0,2 M GlcNAc 0 
Eluant fraction 1 0.25 
fraction 2 0.33 
fraction 3 0.46 
fraction 4 0.22 
fraction 5 0 
DISCUSSION 
Ovalbumin bound to the wheat germ lectin column and was 
eluted in the presence of 0,2 M GlcNAc demonstrating that 
the wheat germ lectin Sepharose 6MB was still active. 
Therefore, the problems encountered in eluting HSV-1 
glycoproteins could not be ascribed to the lectin 
column. 
FIGURE 3.14 - WHEAT GERM LECTIN AFFINITY 
CHROMATOGRAPHY OF OVALBUMIN 
A solution of ovalbumin containing 1 mg/ml in 
physiological saline was applied to a wheat 
germ lectin Sepharose 6 MB column. The column 
was washed with equilibration buffer and the 
ovalbumin was eluted using 0,2 M GlcNAc in 
equilibration buffer. Fractions of 5 ml were 
collected and the Azso was measured. The elu-
tion profile of Azso against fraction number is 
shown. 
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Gel-bound lectin affinity chromatography of HSV-1 mem-
brane proteins solubilized in the non-ionic detergent, 
Triton X-100 
Solutions containing the HSV-1 glycoproteins, gC and gB, 
respectively, were prepared by solubilizing (3H)-gln 
labelled HSV-1 infected BHK-21 cells in a buffer contain-
ing 2,5% SDS and 5% 2-mercaptoethanol (Appendix 1.2.l(d)) 
and isolating the glycoproteins by Prep-PAGE (Chapter 
3.2.1). These glycoprotein solutions contained a signi-
ficant amount of non-glycosylated proteins, and attempts 
to purify the glycoproteins using gel-bound lectin affin-
ity chromatography were unsuccessful (Chapter 3.2.3). 
Both wheat germ lectin Sepharose 6MB and Helix pomatia 
lectin Sepharose 6MB (Appendix 1.3.2) have previously 
been used successfully for the purification of HSV-1 
glycoproteins (Jeansson, Elwing & Nilsson, 1979; 
Olofsson, Jeansson & Lycke, 1981; Svennerholm et al, 
1984). However, in all cases the HSV-1 proteins were 
solubilized in the non-ionic detergent, Triton X-100. 
This would indicate that the failure encountered with 
gel-bound lectin affinity chromatography thus far, may be 
due to the use of sodium dodecyl sulphate (SDS) to solu-
bilize the HSV-1 proteins. For this reason, it was deci-
ded to repeat the gel-bound lectin affinity chromatogra-
phy with proteins dissolved in Triton X-100 according to 
the method of Olofsson, Jeansson & Lycke, 1981. 
A. 
B. 
c. 
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Preparation of HSV-1 membrane proteins for gel-bound 
lectin affinity chromatography 
HSV-1 membrane proteins were prepared according to 
the method described in Appendix 2.3.4. The product 
was stored in aliquots of 0,5 ml at -70°C until 
needed. 
Helix pomatia lectin affinity chromatography 
A volume of 4 ml of a solution of (3H)-gln labelled 
HSV-1 membrane proteins (Appendix 2.3.4) was applied 
to a column containing 2 ml of Helix pomatia lectin 
Sephaose 6MB (Appendix 2.3.3(B)) at a flow rate of 
2 ml/hr. The column was washed with 30 ml of equi-
libration buffer (Appendix 1.3.S) containing 1% 
Triton X-100 at a flow rate of SO ml/hr. Bound 
protein was eluted with 20 ml of O, 1 M GalNAc in 
equilibration buffer containing 1% Triton X-100 at a 
flow rate of 5 ml/hr. Fractions of 3 ml were col-
lected throughout and assayed for radioactivity 
(Appendix 2.3.S) and an elution profile of counts 
per minute against fraction number was drawn (Figure 
3.15). Fractions 3, 4 and 5 were analyzed by SDS-
PAGE and autoradiography (Figure 3.16). 
Wheat germ lectin affinity chromatography 
A volume of 1,75 ml of a solution of (3H)-gln label-
led HSV-1 membrane proteins (Appendix 2. 3. 4) was 
applied to a column containing 8 ml of wheat germ 
lectin Sepharose 6MB (Appendix 2.3.3(A)). The col-
149 
umn was washed with 30 ml of equilibration buffer 
containing 1% Triton X-100 and then the bound pro-
teins were eluted with 20 ml of 0,2 M GlcNAc in the 
same buffer. A flow rate of 8 ml/hr was used 
throughout and 3 ml fractions were collected. Frac-
tions were assayed for radioactivity and an elution 
profile of counts per_ minute against fraction number 
was drawn (Figure 3.17). 
Eluted fractions were analyzed by SDS-PAGE and auto-
radiography (Figure 3.18). 
RESULTS 
A. Preparation of HSV-1 membrane proteins for gel-bound 
lectin affinity chromatography 
The procedure used for preparing HSV-1 membrane 
proteins (Appendix 2.3.4) yielded 10 ml of solution 
containing approximately 3000 counts per minute 
( cpm) per O, 1 ml. A comparison of the yield of 
( 3H )-gln labelled proteins obtained by this method 
with that from whole cells solubilized in SDS (Chap-
ter 2.2.2) showed that a significant amount of the 
radiolabelled protein was lost during this proce-
dure. 
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B. Helix pomatia lectin affinity chromatography 
c. 
The elution profile of (3H)-gln labelled HSV-1 mem-
brane proteins from a column of Helix pomatia lectin 
Sepharose 6MB is shown in Figure 3 .15. A large 
proportion of the radioactivity which was applied to 
the column, eluted without adsorbtion. When the 
elution buffer, containing 0,01 M GalNAc, was passed 
through the column, there was no elution of radio-
labelled proteins. 
The fractions comprising the peak of radioactivity 
(Fractions 3,4 and 5; Figure 3.15) were analyzed by 
SOS-PAGE and autoradiography. This revealed that 
all of the glycoproteins which were applied to the 
column (Tracks 1 and 5; Figure 3.16) were eluted 
immediately without adsorbing to the Helix pomatia 
lectin (Tracks 2, 3 and 4 ; Figure 3 .16). 
Wheat germ lectin affinity chromatography 
The elution profile of (3H)-labelled HSV-1 membrane 
proteins from a column of wheat germ lectin Sepha-
rose 6MB is shown in Figure 3. 17. A small propor-
tion of the radioactively labelled protein was elu-
ted during sample application and subsequent washing 
of the column with the equilibration buffer, while 
most of the radioactively labelled protein was elu-
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ted using the elution buffer containing 0,2 M 
GlcNAc. 
Representative fractions from the small peak of 
radioactivity (Fractions 2 and 6, Figure 3.17), and 
from the large peak of radioactivity (Fractions 18, 
19 and 23, Figure 3.17) were analyzed by SDS-PAGE 
and autoradiography (Figure 3.18). The results show 
that almost all of the protein content of the sample 
applied to the column was eluted from the column 
immediately (Figure 3.18(a), Tracks 2 and 3), while 
very little protein was eluted in the second peak of 
radioactivity (Figure 3.18(a), Tracks 4, 5 and 6). 
Conversely, very little radioactive material eluted 
in the first peak, and this appears to represent one 
glycoprotein species (Figure 3.18(b), Tracks 2 and 
3), while most of the radioactive material eluted in 
the second peak and represented approximately six 
different glycoprotein species (Figure 3.18(b), 
Tracks 4, 5 and 6). 
FIGURE 3.15 - HELIX POMATIA LECTIN AFFINITY 
CHROMATOGRAPHY OF Hsv·-1 MEMBRANE 
PROTEINS SOLUBILIZED IN TRITON X-
100 
(3H)-gln labelled HSV-1 membrane proteins, 
solubilized in Triton X-100, were applied to a 
column containing 2 ml of Helix pomatia lectin 
Sepharose 6MB. The column was washed with 
equilibration buffer before eluting bound pro-
teins with 0,1 M GalNAc in equilibration buf-
fer. Fractions of 2 ml were collected and 
assayed for radioactivity. The elution profile 
of counts per minute against fraction number is 
shown. 
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1 2 3 4 5 
FIGURE 3.16 - AUTORADIOGRAPH OF FRACTIONS ELUTED FROM 
HELIX POMATIA LECTIN AND ANALYZED BY SDS-
PAGE 
Fractions 3,4 and 5 (Figure 3.15) were analyzed by analy-
tical SDS-PAGE and autoradiography. 
Track 1 - (3H)-gln labelled membrane proteins. 
Track 2 - Fraction 5 
Track 3 - Fraction 4 
Track 4 - Fraction 3 
Track 5 - (3H)-gln labelled membrane proteins. 
FIGURE 3.17 - WHEAT GERM LECTIN AFFINITY 
CHROMATOGRAPHY OF HSV-1 MEMBRANE 
PROTEINS SOLUBILIZED IN TRITON X-
100 
(3H)-gln labelled HSV-1 membrane proteins, 
solubilized in Triton X-100, were applied to a 
column containing 8 ml of wheat germ lectin 
Sepharose 6MB. The column was washed with 
equilibration buffer before eluting bound pro-
teins with 0,2 M GlcNAc in equilibration buf-
fer. Fractions of 1 ml were collected and 
assayed for radioactivity. The elution profile 
of counts per minute against fraction number is 
shown. 
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FIGURE 3.18 - ANALYSIS BY SDS-PAGE AND 
AUTORADIOGRAPHY OF FRACTIONS 
ELUTED FROM WHEAT GERM LECTIN 
Fractions 2, 6, 18, 19 and 23 (Figure 3.17) 
were analyzed by analytical SDS-PAGE (a) and 
autoradiography (b). 
Figure 3.18(a) - Silver Stain 
Track 1 - (3H)-gln labelled membrane 
Track 2 - Fraction 2 
Track 3 - Fraction 6 
Track 4 - Fraction 18 
Track 5 - Fraction 19 
Track 6 - Fraction 23 
Figure 3.18(b) - Autoradiograph 
Tracks as in Figure 3.18(a). 
proteins 
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DISCUSSION 
Although the HSV-1 membrane p_roteins were carefully pre-
pared according to the method of Olofsson, Jeansson & 
Lycke, 1981, the results of Helix pomatia lectin affinity 
chromatography show conclusively that none of the HSV-1 
glycoproteins bound to the lectin column. 
for this conclusion are:-
The reasons 
(a) A large proportion of the radioactivity which was 
applied to the column eluted without binding (Figure 
3.15). 
(b) Analytical SDS-PAGE of the fractions constituting 
the peak of radioactivity reveals that all of the 
(3H)-gln labelled proteins which were applied to the 
column were present in the initial peak of radio-
activity (Figure 3.16). 
(c) No (3H)-gln labelled proteins were eluted in the 
presence of 0,1 M GalNAc (Figure 3.15). 
(d) When a sample of the Helix pomatia lectin Sepharose 
6 MB was assayed for radioactivity, no significant 
radioacivity was present on the gel. 
Subsequent to the observation that only glycoprotein C 
(gC) of HSV-1 has affinity for Helix pomatia lectin (HPL) 
(Olofsson, Jeansson & Lycke, 1981), it has been reported 
that approximately 25% of the total gC population has 
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this affinity. The remainder of the gC population, like 
the other HSV-1 glycoproteins, is without affinity for 
HPL (Olofsson et al, 1983). The gC population which 
bound to the HPL was found to consist of two electrophor-
etic bands with lower molecular weights than the non-
binding gC. For this reason, it was suggested that pre-
cursors of gC were reponsible for the HPL binding frac-
tion, while the fully glycosylated product lacked this 
affinity. 
However, Olofsson et al concluded that · the existence of 
two populations of gC with different affinities for HPL 
was the result of two different glycosylation pathways 
(Olofsson et al, 1983). 
In the present work, the HSV-1 infected cells labelled 
with (3H)-gln were grown in the presence of non-radio-
active medium for the last 4 hours before harvesting. 
This was done to ensure that the radiolabelled proteins 
would be fully glycosylated and so eliminate the possibi-
lity of radiolabelled precursors. Therefore, since no 
radiolabelled precursors were present during the Helix 
pomatia lectin ,affinity chromatography, this may explain 
why glycoprotein C failed to bind to the HPL. These 
results may, therefore, be in agreement with the findings 
of Olofsson et al, and would support the hypothesis that 
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the two different populations of gC are a result of dif-
ferent levels of glycosylation and not two different 
glycosylation pathways (Olofsson et al, 1983). 
Wheat germ lectin affinity chromatography of the same 
preparation of HSV-1 membrane proteins revealed that most 
of the HSV-1 glycoproteins bound to the wheat germ lectin 
and were eluted by 0,2 M GlcNAc (Figure 3.17). Analyti-
cal SDS-PAGE of some of the eluted fractions revealed 
that all of the non-glycosylated proteins and one glyco-
protein were not bound to the lectin and eluted immedi-
ately (Figure 3.18, Tracks 2 and 3). Approximately six 
glycoproteins eluted when O, 2 M GlcNAc was added to the 
column (Figure 3.18, Tracks 4, 5 and 6). 
The observation that one glycoprotein species of HSV-1 
was selectively separated from the other glycoproteins on 
a wheat germ lectin Separose 6MB column, indicates that 
this technique may be useful in selectively purifying the 
glycoprotein. 
This glycoprotein, which lacks affinity for wheat germ 
lectin (Figure 3.18, Tracks 2 and 3), appears to co-mi-
grate with a glycoprotein which bound to the column and 
was eluted in the presence of 0,2 M GlNAc (Figure 
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3.18(b), Tracks 4, 5 and 6). There are two possible 
explanations for this observation: 
1. They represent the same protein which only binds 
loosely to wheat germ lectin so that some was bound 
to the column while the remainder eluted. 
2. These are two separate glycoprotein species which 
have similar electrophoretic mobilities. 
If these proteins are in fact different, then the tech-
nique of wheat germ lectin affinity chromatography may be 
a useful means of separating them. 
requires further investigation. 
This possibility 
CONCLUSION 
1. 
2. 
Helix pomatia lectin Sepharose 6MB was not suitable 
for purifying HSV-1 glycoproteins from non-glycosy-
lated proteins. 
Helix pomatia lectin Sepharose 6MB did not selec-
tively bind glycoprotein gC of HSV-1, as has been 
previously reported (Olofsson, Jeansson & Lycke, 
1981; Svennerholm et al, 1984). 
3. Wheat germ lectin Sepharose 6MB is suitable for 
purifying HSV-1 glycoproteins from non-glycosylated 
proteins when the membrane proteins are solubilized 
in Triton X-100. 
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4. The use of SDS to solubilize the proteins of HSV-1 
infected cells appears to have been responsible for 
the problems encountered during earlier attempts to 
purify the glycoproteins of HSV-1 by wheat germ 
lectin affinity chromatography (Chapter 3.2.3). 
3.3 SUMMARY 
Preparative-PAGE (Prep-PAGE) was used to provide an initial 
separation of the HSV-1 glycoproteins. Two cycles of Prep-
PAGE were sufficient to purify glycoproteins gC and gB with 
respect to other HSV-1 glycoproteins, but the solutions still 
contained non-glycosylated proteins. Two different techniques 
were used to further purify the glycoprotein solutions: 
1. Hydroxylapatite chromatography in the presence of SDS 
(SDS-HTP) did not separate different HSV-1 glycoproteins 
and was not suitable for removing the non-glycosylated 
proteins from the glycoprotein solutions. 
2. Gel-bound lectin affinity chromatography using wheat germ 
lectin and Helix pomatia lectin did not provide a means 
of purifying the glycoproteins because: 
( a) The glycoproteins which bound to wheat germ lectin 
could not be eluted except by using strong buffers 
containing chaotropic ions, and 
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(b) The glycoprotein which was applied to the Helix 
pomatia lectin did not bind and was eluted with the 
non-glycosylated proteins. 
The difficulties encountered in eluting the glycoproteins 
from wheat germ lectin may have been due to the SDS in 
which the proteins had been solubilized. Therefore, the 
gel-bound lectin affinity chromatography was repeated 
using HSV-1 membrane proteins solubilized in Triton X-
100. Using this material, it was observed that : 
( a) None of the HSV-1 glycoproteins had affinity for 
Helix pomatia lectin, and 
(b) Several HSV-1 glycoproteins bound to wheat germ 
lectin and were purified with respect to non-glyco-
sylated proteins. 
It still remains to separate glycoprotein C (gC) from the 
other HSV-1 glycoproteins and Prep-PAGE would be a means 
of accomplishing this. 
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APPENDIX I - MATERIALS 
1.1. PRODUCTION OF HERPES SIMPLEX VIRUS 
1.1.1. CELLS 
1.1. 2. 
1.1. 3. 
Baby Hamster Kidney (BHK-21) cells were provided by the 
State Vaccine Institute (South Africa) at Passage 73 and 
were initially obtained by the State Vaccine Institute 
from Flow Laboratories at Passage 62. The BHK-21 cells 
were used at Passage levels of between 84 and 95. 
VIRUSES 
(a) Herpes Simplex virus Type I (HSV-1), strain E47. 
This virus was isolated from the liver of a patient 
with a fatal disseminated herpes infection by the 
University of Cape Town Diagnostic Virology labora-
tory in February 1967. 
(b) Herpes Simplex Virus Type 2 (HSV-2), strain MS. 
This virus was obtained by courtesy of Dr John 
Stewart, of the Centres for Disease Control, 
Atlanta, Georgia, USA. 
CELL CULTURE MEDIUM 
(a) Growth Medium (10% MEM) 
The growth medium used was Eagle's minimum essential 
medium (MEM) (Gibco Europe) with Earle's salts, L-
Glutamine and non-essential amino acids. This med-
ium was supplemented with 10% (v/v) foetal calf 
1.1.4. 
163 
serum (Appendix l.l.3(c)), 1% (v/v) sodium bicarbo-
nate solution (Appendix l.l.5(b)) and 0,5% (v/v) PSN 
solution (Appendix l.l.5(a)). The pH was maintained 
at approximately 7.0. 
(b) Maintenance Medium (4% MEM) 
The maintenance medium used was Eagle's MEM with 
Earle's Sal ts, L-glutamane and non essential amino 
acids. The medium was supplemented with 4% (v/v) 
foetal calf serum, 2% (v/v) sodium bicarbonate solu-
tion and 0,5% (v/v) PSN solution. 
(c) Serum 
Foetal calf serum (FCS) was obtained from the State 
Vaccine Institute (South Africa) and had been ster-
ilized by filtration and ultraviolet irradiation. 
BUFFERS 
(a) Phosphate Buffered Saline (After Dulbecco) 
To make 1 litre (ca++ and Mg+tfree). 
Use ANALAR grade or equivalent purity reagents. 
NaCl 
KCl 
NazHP04 (Anhydrous) 
KHzP04 
8g 
0.2g 
0.91g 
0.12g 
Dissolve in about 900 ml of distilled H2o. 
Bring the pH to 7.2 with HCl or NaOH. 
(b) 
( c) 
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Then, bring the volume accurately to 1 litre. 
Autoclave at 115°C for 20 minutes in order to steri-
lize. 
Freezing Buffer 
10% MEM 91.0 ml 
PSN solution 0.5 ml 
7,5% Dimethylsulphoxide (DMSO) 7.5 ml 
1,5ml HEPES buffer 1.5 ml 
Hepes Buffer 
To make 100 ml of 1 M stock solution: 
Dissolve 23,8 grams Hepes in 80ml of 1/3 N NaOH. 
Adjust the pH to 7,2 using 1 N NaOH or 1 N HCl. 
Make the volume up to 100 ml with distilled H2o. 
Filter to sterilize. 
(d) Trypsin Base (10 x stock) 
(ca++ and Mg++ free Dulbecco PBS with EDTA and Glu-
cose) 
NaCl 
KCl 
KH2P04 
Na2HP04 (anhydrous) 
Phenol Red (Appendix l.l.5(c)) 
Glucose 
80.0g 
2.0g 
1.2g 
9.lg 
25.0ml 
5.0g 
Dissolve the above in about 700 ml distilled H20 
using a magnetic stirrer and adjust the pH to about 
7,8. 
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Dissolve 2,0 gms EDTA in about 100 ml distilled H20 
and add it to the salt solution with stirring. 
Adjust the pH to 7,8 with 1 N NaOH and stir until 
all solids have dissolved completely to give a clear 
red solution. 
Bring the volume to 1000 ml with distilled H20. 
Membrane filter and dispense in 20 ml amounts. 
Store at -20°C. 
(e) Trypsin 
5% Trypsin Stock (For Activated Trypsin Versene): 
Weigh out 5 gm trypsin powder. 
Prepare 100 ml of trypsin base (10 ml of lOx concen-
trated trypsin base diluted with 90 ml of distilled 
H20) and acidify to bright yellow with lN HCl. 
Pour the trypsin base into a glass beaker; sprinkle 
the trypsin powder onto the surface of the trypsin 
base. 
Allow the trypsin to dissolve slowly, without agita-
tion, at room temperature. Do not stir or shake. 
Once dissolved, stir briefly and leave at 4°C over-
night. 
Next day, stir for 30 minutes on a magnetic stirrer 
at room temperature. 
Centrifuge at 9000 rpm for 45 minutes at 4°C in the 
Sorvall RC-5 centrifuge. 
1.1. 5. 
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Taking care not to disturb the deposit, pipette off 
the clear supernatant fluid into a beaker or bot-
tle. 
Sterilize by passing through an O, 2 µ membrane fil-
ter. 
Dispense in 1 ml amounts 
Store at -20 °C. 
(f) Activated Trypsin Versene (ATV) 
Prepare lx concentration trypsin base by diluting 10 
ml of lOx concentrated trypsin base in 90 ml distil-
led HzO). 
Add 1 ml stock 5% trypsin and 0,5 ml PSN (Appendix 
1.l.5(a)). 
Adjust pH to 7 ,8 (purple) with 1 N NaOH. 
MISCELLANEOUS SOLUTIONS 
(a) PSN Solution 
2 bottles penicillin 2 X 106 units 
2 bottles streptomycin 2 X 1 gram 
4 bottles neomycin 4 X 0,5 gram 
100 ml physiological saline 
Reconstitute the antibiotic powder in each bottle 
with approximately 4 ml physiological saline. Use a 
needle and syringe. 
Mix well and withdraw the antibiotic with the syrin-
ge and add to the remainder of the physiological 
saline. 
Filter to sterilise and dispense in usable amounts. 
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(b) 5% Sodium Bicarbonate Solution 
Weigh out 100 grams NaHC03 
Dissolve in distilled HzO in a 2 litre volumetric 
flask. 
When dissolved, add 2 ml of 0,4% (w/v) phenol red. 
Make the volume up to 2 litres. 
Using dry ice, bubble COz through the solution until 
it is a brownish pink colour. 
Filter to sterilise and dispense in bijou bottles. 
The bottles are filled to leave no air space. 
Store at 4°C. 
(c) Phenol Red 
Weigh out 0,4 gm phenol red. 
Dissolve in 60 ml N/ 2o NaOH with the aid of heat. 
Do not allow to boil. 
Allow to return to room temperature and then make up 
to 100 ml with distilled HzO in a volumetric flask. 
Filter and dispense in 20 ml amounts. 
(d) Trypan Blue 
Weigh out 0,5 gms Trypan Blue 
Dissolve in 100 ml of normal saline (i e O, 85 gm 
NaCl in 100 ml HzO) 
Filter through paper. 
(e) Physiological Saline 
Dissolve 0,85 gm NaCl in 100 ml distilled HzO. 
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(f) Fixing Solution 
The solution used to fix cells in testing for myco-
plasma consists of 25% acetic acid and 75% Methanol 
( Chen , 1 9 77 ) • 
(g) Bisbenzamide Fluorochrome Stain 
(i) Stock concentrate (100 ml) 
Bisbenzamide fluorochrome stain (Hoechst No 
33258) 5 mg. 
Hank's balanced salt solution (BSS) without 
sodium bicarbonate and phenol red 100 mg. 
Thiomersal (Merthiolate) 0,01 gm. 
Mix these components thoroughly at room temper-
ature with a magnetic stirrer for 30 minutes. 
Wrap the bottle in aluminium foil and store in 
the dark at 2-8°C. The stain is light and heat 
sensitive. 
(ii) Working stain (100 ml) 
Add 1 ml of stock concentrate to 100 ml of 
Hank's BSS for a final concentration of O, 5 
g/ml. 
Store in a dark bottle wrapped in aluminium 
foil at 2-8°C. Before use, mix thoroughly with. 
a magnetic stirrer at room temperature for 30 
minutes. 
Examine periodically for microbial contami-
nation. 
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Discard when contamination or deterioration 
occurs. 
Membrane filtration diminishes fluorescence. 
(h) Citric acid - disodium phosphate buffer for mounting 
fluid. (100 ml) 
0,1 M Citric acid 
0,2 M Disodium phosphate 
Glycerol 
22,2 ml 
27,8 ml 
50,0 ml 
Final pH 5,5 (Check periodically as pH is critical 
for optimal flourescence.) 
Store at 2-8°C. 
(i) Maxidens - an inert, water immiscible density gradi-
ent displacing liquid (Density= 1.9 g/ml at 25°C) 
was obtained from Nyegaard and Co, Oslo, Norway. 
(j) D.P.X. mountant - a synthetic mounting fluid. (BDH 
Chemicals Ltd, Poole, England.) 
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1.2. RADIOLABELLING AND ANALYSIS OF RSV PROTEINS 
1.2.1 BUFFERS 
1. 2. 2. 
(a) Running gel buffer: 
1. 5M Tris (hydroxymethyl)methylamine (Tris) /HCl, 
pH 8,8 + 0,4% sodium dodecyl sulphate (SDS) 
(b) Stacking gel buffer: 
0,5 M Tris/HCl, pH 6,8 + 0.4% SDS 
(c) Reservoir buffer: 
0,025 M Tris+ 0,192 M Glycine, pH 8,5 + 0,1% SDS 
(d) Sample Buffers: 
HMW sample buffer - lOmM Tris/HCl, 1 mM EDTA, pH 8,0 
+ 1% SDS + 1% 2-mercaptoethanol 
LMW sample buffer - lOmM Tris/HCl, lnM EDTA, pH 8,0 
+ 2,5% SDS + 5,0% 2-mercaptoenthanol 
MISCELLANEOUS SOLUTIONS 
(a) Acrylamide stock solution: 
30 grams acrylamide + 0,8 g N, N'-methylenebis-
acrylamide (bis-acrylamide) made up to 100 ml with 
distilled H20 and stored at 4°C in the dark. 
(b) Ammonium Persulphate solution: 
The ammonium persulphate solution should be made up 
fresh each week. 
1.2.3. 
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0, 1 g Ammonium Persulphate in 1 ml distilled H20. 
Store at 4 °C. 
(c) TEMED - NNN'N' - Tetramethylethylenediamine 
This is used directly. The solution is stable when 
kept at 4°C in the dark. 
CALIBRATION MARKER PROTEIN SETS FOR MOLECULAR WEIGHT 
DETERMINATION USING ELECTROPHORESIS. 
High molecular weight (HMW) and low molecular weight 
(I.MW) calibration marker protein sets were obtained from 
Pharmacia Fine Chemicals (Uppsala, Sweden). The contents 
of these sets are as follows : 
(a) HMW Calibration Set 
Protein Mol.Wt. Subunit Mol. Wt. 
Thyroglobulin 669000 330000 
Ferritin 440000 18500 (220000) 
Catalase 232000 60000 
Lactate 
Dehydrogenase 140000 36000 
Albumin 67000 67000 
Treatment - To each ampoule add 100 µl HMW sample 
buffer (Appendix 1.2.l(d)) and heat at 60°C for 15 
minutes. 
1.2.4. 
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(b) LMW Calibration Set 
Protein Subunit Mal. Wt. 
Phosphorylase b 94000 
Albumin 67000 
Ovalbumin 43000 
Carbonic Anhydrase 30000 
Trypsin Inhibitor 20100 
a -Lactalbumin 14400 
Treatment - To each ampoule add 100 µ 1 of I.MW sample 
buffer (Appendix 1.2.l(d)) and heat at 100°C for 5 
minutes. 
RADIOISOTOPES 
D (6 3H) Glucosamine (Specific Activity, 34,6 
Ci/mmol), and L - (U - 14c) Amino acid mixture (Specific 
Activity, 10 mCi/mmol) were obtained from Amersham Corp., 
Buckinghamshire, England. 
Composition of L-(u-14c) Amino acid mixture 
1. 2.5 
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The following amino acids are present in equimolar pro-
portions: 
L-(u-1 4c) Alanine 
L-(u-14c) Arginine hydrochloride 
L-(u-1 4c) Aspartic acid 
L-(u-14c) Glutamic acid 
(u-14c) Glycine 
L-(u-14c) Leucine 
L-(u-14c) isoleucine 
L-(U)-14c) Lysine hydrochloride 
L-(u-14c) Phenylalanine 
L-(u-14c) Proline 
L-(u-14c) Serine 
L-(u-14c) Threonine 
L-(u-14c) Tyrosine hydrochloride 
L-(u-14c) Valine 
EN3HANCE 
The fluorographic solution EN3HANCE was obtained from New 
England Nuclear (Boston, Massachusetts). 
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1.3 PURIFICATION OF HERPES SIMPLEX VIRUS TYPE 1 (HSV-1) 
GLYCOPROTEINS 
1. 3.1 · 
1. 3. 2 
1. 3.3 
1. 3.4 
1. 3. 5 
1. 3. 6 
HA Ultrogel (LKB Quality Chemicals, Bromma, Sweden). 
Wheat germ lectin Sepharose 6MB and Helix pomatia lectin 
Sepharose 6MB were obtained from Pharmacia Fine Chemi-
cals, Uppsala, Sweden. 
Scintillation fluid 
Beckman Ready-Solv HP was obtained from Beckman Instru-
ments. 
Saccharides 
n-acetyl-D-glucosamine (GlcNAc) and n-acetyl-D-galacto-
samine (GalNAc) were obtained from Sigma Chemical Com-
pany, St. Louis, U.S.A. 
Equilibration buffer used for gel-bound lectin affinity 
chromatography. 
0,01 M tris (hydroxymethyl) aminomethane (Tris) - hydro-
chloride+ 0,15 M NaCl+ 0,02% (w/v) NaN3 pH 8.0. 
Phenylmethylsulphonyl fluoride (PMSF) was obtained from 
Sigma Chemical company, St. Louis, U.S.A. 
175 
PMSF is a proteinase inhibitor. Prepare a solution of 
0, 1 M R1SF in n-propanol. Dilute to O, 001 M R1SF in the 
solution of protein. 
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APPENDIX 2 - METHODS 
2.1. PRODUCTION OF HERPES SIMPLEX VIRUS 
2.1.1. GROWTH OF BABY HAMSTER KIDNEY (BHK-21) CELLS FROM 
AMPOULES STORED IN LIQUID NITROGEN AT -180°C 
(a) An ampoule containing .BHK-21 cells was removed from 
storage in liquid nitrogen (Appendix 2.1.3) and 
immediately placed in a beaker of warm water. This 
was done to thaw the cell suspension rapidly and so 
reduce cell damage. 
(b) The contents of the ampoule were removed and diluted 
approximately five-fold with 10% MEM. This cell 
suspension was centrifuged at 800 rpm for 5 minutes 
to pellet the cells. The supernatant fluid was 
discarded and the cells resuspended in another 5 ml 
of 10% MEM in order to wash away any remaining Di-
methylsulphoxide (DMSO) from the cells (See Appendix 
2.1.3) 
( c) The cell suspension was centrifuged for another 5 
minutes at 800 rpm and then the supernatant discar-
ded. The cells were resuspended in exactly 5, 0 ml 
of 10% MEM and then counted (Appendix 2.1.4). 
( d) Using the cell count, the cell suspension was dilu-
ted with 10% MEM to give a cell concentration of 2 x 
105 cells/ml. 20 ml of this cell suspension was 
placed in a medical flat bottle and the bottle then 
incubated at 37°C. 
2.1.2. 
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PASSAGE OF BHK-21 CELLS 
(a) BHK-21 cells were passaged when the cell cultures 
were confluent. The growth medium was discarded and 
the cell monolayer was washed with sterile physiolo-
gical saline to rinse off the remaining growth 
medium. 
(b) 5 ml of activated trypsin versene (ATV) (Appendix 
l.l.4(f)) which had been pre-heated to 37°C, was 
added to the cell monolayer and distributed evenly 
over the surface of the cells. The cells were incu-
bated with ATV at 37°C for 20 minutes. 
(c) After the 20 minute incubation the bottle was shaken 
to dislodge any cells still attached to the growth 
surface. The cell suspension was collected and 
centrifuged at 800 rpm for 5 minutes, after which 
the supernatant fluid was discarded and the cells 
resuspended in 10 ml of 10% MEM to wash off any 
remaining ATV and to inactivate the trypsin. 
(d) The cell suspension was again centrifuged at 800 rpm 
for 5 minutes and the supernatant fluid was discar-
ded. The pellet of cells was resuspended in exactly 
10, 0 ml of 10% MEM and the cells were counted (Ap-
pendix 2.1.4). 
(e) The cell suspension was diluted to a concentration 
of 2 x 105 cells/ml and 20 ml of this cell suspen-
sion was used to seed each new medical flat bottle. 
The culture bottles were then incubated at 37°C. 
2.1.3. 
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STORAGE OF BHK-21 CELLS IN LIQUID NITROGEN at -180°C 
(a) The growth medium was removed from a confluent BHK-
21 cell monolayer and the cells were washed with 
sterile physiological saline to rinse off the re-
maining growth medium. 
(b) The cells were harvested using ATV. (Appendix 
2.l.2(b)) and then washed in 10% MEM. 
( c) After washing, the cell suspension was centrifuged 
at 800 rpm for 5 minutes and the supernatant fluid 
was discarded. 
(d) The pellet of cells was resuspended in a total vol-
ume of 2 ml of "Freezing Buffer" (Appendix 1.l.4(b)) 
and the cells were counted (Appendix 2.1.4). 
(e) The suspension of cells in freezing buffer was then 
diluted to a final concentration of 1 x 106 cells/ml 
with freezing buffer. This cell suspension was 
stored in ampoules containing 1 ml each. 
(f) The ampoules were frozen in a controlled rate free-
zing machine in order to reduce the amount of cell 
damage, and then stored in liquid nitrogen at 
-180°C. 
2.1.4. 
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CELL COUNTING 
(a) The suspension of cells to be counted is made up to 
a known volume with growth medium. If the cell 
concentration is high, then a 1/10 dilution is made 
by adding O, 1 ml of suspension to O. 9 ml of 10% 
MEM. 
(b) Dilute the cell suspension 1:1 in Trypan Blue solu-
tion (Appendix 1.1.S(d)). Normally, 0.1 ml of each 
is sufficient. 
( c) Place a clean coverslip over the graduated section 
of a haemocytometer and apply the trypan blue stain-
ed cell suspension to the graduated section so that 
the surface is just covered. 
(d) Place the haemocytometer under a microscope and 
count the number of cells in four large squares. 
(Each large square is subdivided into sixteen 
squares.) 
(e) From the number of cells in each large square, cal-
culate the average number of cells per large 
square. 
(f) Assuming that the volume of cell suspension covering 
a large square is 10-4 ml, the cell concentration is 
calculated as follows:-
Cell concentration = Average cell count x 2 (dilu-
tion with trypan blue) x 104 cells/ml. 
2 .1. 5. 
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If the original cell suspension was diluted 1/ 10, 
then the result must be multiplied by a factor of 
10. 
(g) Multiply this value by the total volume of cell 
suspension in order to get a total cell count. 
TEST FOR MYCOPLASMA CONTAMINATION IN BHK-21 CELL 
CULTURES 
(a) Grow BHK-21 or HeLa cells on coverslips in tubes. 
When the cells are confluent, remove the covers lips 
from the tubes and place them in small bijou bot-
tles. The coverslips must not be allowed to dry as 
this will cause artifacts. 
(b) Add 5 ml of fixing solution (Appendix l.1.5(f)) to 
each bijou bottle. After 5 minutes, remove the 
fixing solution and replace with a further 5 ml for 
another 10 minutes. 
(c) Discard the fixing solution and allow the coverslips 
to air dry. 
(d) Remove the "working stain" (Appendix l.1.5(g)) from 
refrigeration at 4°C and mix thoroughly for 30 min-
utes at room temperature, using a magnetic stirrer. 
( e) Attach each covers lip to a microscope slide using 
D.P.X Mountant (Appendix l.1.5(j)). The coverslips 
should be attached with the cells uppermost. 
2.1.6. 
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(f) Place the slides flat in a container which can be 
darkened (i.e. a tin) and cover the cells with "wor-
king stain". Close the tin and allow the cells to 
stain for 30 minutes at room temperature. 
(g) After staining, rinse each coverslip three times 
with distilled water. 
(h) Detach the coverslips from the microscope slides and 
while still wet, mount them on clean microscope 
slides using mounting fluid (Appendix 1.1.S(h)). 
The stained cell monolayer must be positioned bet-
ween the coverslip and the microscope slide. 
(i) Examine the slides under a fluorescence microscope 
using incident light at 360 nm. 
GROWTH OF HERPES SIMPLEX VIRUS IN BHK-21 CELLS 
(a) Grow BHK-21 cells in cell culture flasks (Appendix 
2.1.2). When the cells are confluent, pour off the 
growth medium and inoculate the cells with 2 ml of 
the stock virus suspension containing 1, 0 TCID50/ 
cell (Appendix 2.1.7). The inoculum should be 
spread over the entire surface of the cell culture. 
(b) Incubate the culture flask in a horizontal position 
for 1 hour at 37 °C to allow the virus to adsorb to 
the cells. After the 1 hour incubation period, add 
another 20 ml of maintenance medium (Appendix 
l.l.3(d)) and continue to incubate the cells at 
37 °c. 
2.1.7. 
2.1.8. 
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(c) Harvest the cells at 24 hours post-infection. 
STORAGE OF STOCK HERPES SIMPLEX VIRUS 
HSV-1 and HSV-2 were grown in BHK-21 cells. When the 
cells showed 100% cytopathic effect (CPE) the culture 
bottles were frozen and thawed to remove cells from sur-
face of the bottle. The suspension of RSV infected BHK-
21 cells in culture medium was mixed with 10% skimmed 
milk solution at a ratio of 1 part skimmed milk to 5 
parts culture medium. This suspension was stored at 
-70°C in ampoules containing 2 ml. 
TITRATION OF HERPES SIMPLEX VIRUS IN BHK-21 CELLS 
a) Make up a BHK-21 cell suspension in 10% MEM contain-
ing 2 x 105 cells/ml. Place 4 drops of this cell 
suspension in each well of a flat bottomed micro-
titre plate. 
b) Seal the top of the microtitre plate with plate 
sealing tape and incubate the plate at 3 7 °C until 
the cell cultures are confluent. 
c) When the cell cultures are confluent, remove the 
growth medium from each well using a pasteur pi-
pette. 
d) Make a 10-fold dilution series in maintenance medium 
(Appendix l.l.3(b)) of the RSV-infected material 
which is to be titrated. Place one drop of each 
dilution to each of six wells on the microtitre 
plate as shown in the diagram (Figure 2.1.1). 
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Flask 1 Flask 2 
0.1 ml 0.1 ml 
0.9 ml-
.-----·-----·-- -·-··- ·-··--,-·· 
\ 
Flask 1 Flask 2 
Figure 2.1.1 Diagram illustrating the titration of HSY on BHK-21 cells. 
h X % 
% 
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(e) Seal the plate with plate sealing tape and incu-
bate at 37°C for 1 hour to allow the virus to adsorb 
to the cells. After 1 hour, add a further three 
drops of maintenance medium to each well, seal the 
plate and continue incubation at 37°C. 
(f) Study the microtitre plate under an inverted light 
microscope every day for 7 days. Note on a record 
sheet which cell cultures show positive signs of HSV 
induced cytopathic effect (CPE). 
(g) After 7 days no further infection is likely and the 
study is terminated. Using the recorded results, 
calculate the 50% tissue culture infective dose 
(TClD50) which is the dose at which 50% of the cell 
cultures are infected. 
The TClD50 is calculated by the method of Reed and 
Muench (Reed & Muench, 1938) as follows:-
Using the example in Table 2.1.1, none of the dilu-
tions gives a 50% infectivity endpoint: this lies 
between the second and third dilutions. The TClD50 
is calculated from the cumulated values, assuming 
that the proportion of the cultures infected varies 
linearly with loglO dilution. The interpolated 
value is given by:-
cultures infected at dilution next above 50% - 50% 
cultures infected ,at dilution next above 50% - % cultures 
infected at dilution next below 50% 
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In this formula h is the log of a dilution step. The 
interpolated value is then added arithmetically (i e with 
the proper sign) to the log of the total dilution at the 
step just above 50% of infected cultures ( in this case 
the second dilution). In the example: 
Interpolated value= h 100 - 50 = h 50 = 0,5h and h = 1/10 
100 - 0 100 
log h = -1; the total dilution at the second step is 
(1/10) 2 = 10-2 and log · dilution = -2. The interpolated 
value then is (-1) x 0,5 = -0,5. The log TClD50 = -2 + 
(-0, 5) = 
10-2, 5; 
doses. 
-2,5. The TClD50 titre is expressed as = 
i.e. the virus sample contains 10 2 ,5 TClD50 
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TABLE 2.1.1 - EXAMPLE OF ENDPOINT TITRATION 
CUMULATED VALUES 
DILUTION INFECT I VI TY TOTAL TOTAL INFECT I VI TY 
STEP RATIO INF UNINF INF UNINF RATIO % 
1 6/6 6 0 12 0 12/12 100 
2 6/6 6 0 6 0 6/6 100 
3 0/6 0 6 0 6 0/6 0 
4 0/6 0 6 0 12 0/12 0 
5 0/6 0 6 0 18 0/18 0 
6 0/6 0 6 0 24 0/24 0 
INF= Infected 
UNINF = Uninfected 
2.1.9. DISRUPTION OF RSV INFECTED CELLS BY ULTRASONICATION. 
RSV infected cells were disrupted by ultrasonication 
using the Virsonic Cell Disrupter, Model 16-850 (The 
Virtis Company, Gardiner, New York.) In all cases, the 
"intermediate tip" was used at 50% power. 
2.1.10. 
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DENSITY DETERMINATION OF CAESIUM CHLORIDE SOLUTIONS 
(a) Samples of caesium chloride (CsCl) containing 0,5g; 
l,Og; 2,0g; 3,0g; 4,0g; and 5,0g were weighed out 
accurately. 
(b) The CsCl samples were made up to 5 ml with buffer 
(0, 01 M Tris, pH 7, 4 + 1% foetal calf serum (FCS)) 
giving solutions of 0,1; 
1,0 g/cm3 respectively. 
0,2; 0, 4; 0, 6; 0, 8 and 
(c) A clean, dry pycnometer was weighed. 
(d) The pycnometer was filled with distilled water and 
weighed. (Ensure that the outside of the pycnometer 
was dry and clean.) 
(e) The room temperature was recorded. 
(f) From the difference in mass between the empty and 
full pycnometer, the volume of the pycnometer at 
room temperature was calculated. The density of 
water at room temperature was obtained from tables. 
(Documenta Geigy) 
(g) The pycnometer was emptied and dried before filling 
with the Cs Cl solutions, beginning with the most 
dilute. The pycnometer was reweighed with each of 
,the CsCl solutions. 
(h) The mass of each CsCl solution in the pycnometer was 
calculated and hence the density determined. 
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(i) The refractive indices of the CsCl solutions were 
read using an Abbe Refractometer. 
(j) The graph of Refractive Index against Density was 
drawn (Figure 2.1.2). 
Temperature (Room Temp) •••••••••••••••••••••• 19°C 
Mass of clean and dry Pycnometer ••••••••••••• 10,6357 
Mass of Pycnometer & Distilled Water ••••••••• 12,6643 
Mass of Distilled Water •••••••••••••••••••••• 2,0286 
Density of water at 19°C ••••••••••••••••••••• 0,998407 
Volume of Pycnometer •••••••••••••••••••••••••• 2,0318 
Mass of Pycnometer + CsCl solution 
0,1 g/ml. •••••••••••• 12,8248 
0,2 ............. 12,9787 
0,4 ............. 13, 2353 
0,6 ............. 13 ,5848 
0,8 ............. 13,8738 
1,0 ............. 14,1408 
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Concentration . Mass of Mass of CsCl Density Refrac-
of Pycnometer Solution (g) (g/ cm3) tive 
CsCl (g/ml) + CsCl (g) Index 
0 12.6643 2.0286 0.998425 2.3340 
0.1 12.8248 2.1891 1.0774 1. 3424 
0.2 12.9787 2.3430 1.1532 1.3500 
0.4 13. 2853 2. 6496 1.3941 1. 3644 
0.6 13. 5848 2.9491 1. 4515 1.3781 
0.8 13. 8738 3.2381 1.5937 1.3913 
1.0 14.1408 3.5051 1. 7251 1.4035 
See Figure 2.1.2 
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• 
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• 
• 
/ 
• 
1.33 ._ _____________ ..... _____________ _ 
1.1 1.2 1.3 1.4 1.5 1.6 1.7 
Density (g/cm3) 
Figure 2.1.2 Graph of refractive index (RI) against density for solutions of 
caesium chloride (CsCl) in 0.01 M Tris, pH 7.4 +l % foetal calf 
serum. 
Coefficient of correlation = 0.9998. 
2.1.11. 
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HERPES SIMPLEX VIRUS PURIFICATION BY CAESIUM CHLORIDE 
DENSITY GRADIENT CENTRIFUGATION. 
(a) Herpes simplex virus, type 1 (HSV-1) infected BHK-21 
cells were harvested in 20 ml of 10% MEM by freezing 
and thawing. . The infected cell suspension was cen-
trifuged at 10 K rpm for 10 minutes and the super-
natant fluid stored at 4 °c. The pellet of infected 
cell debris was resuspended in approximately 3 ml of 
10% MEM and then ul trasonicated for 10 seconds (Ap-
pendix 2.1.9). The suspension was again centrifuged 
at 10 K rpm for 10 minutes, after which the super-
natant fluid was collected and stored at 4°C and the 
pellet of cellular material was discarded. 
(b) The RSV was collected from the infected medium by 
centrifuging the medium at 25 K rpm for 120 minutes 
at 4 °C in a Beckman SW 25.1 rotor. In order to 
prevent the herpes virions being damaged by pellet-
ing, 4 ml of caesium chloride solution was placed at 
the bottom of the tube to cushion the sedimenting 
virus. This cushion had a density of 1,30 g/cm3 
in O, 01 M Tris/HCl pH 7, 4 buffer + 1% foetal calf 
serum. 
(c) After centrifugation, the CsCl cushion was carefully 
removed from the bottom of the tube and inserted 
into two CsCl density gradients (Figure 2.1.3). The 
CsCl density gradients were then centrifuged at 40 K 
rpm for 20 hours at 4°C in a Beckman SW 50.1 rotor • 
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1 ml 
2 ml 
1 ml 
1 ml 
1.2 g/cm3 
Approx. 1.25 g/cm3 (HSV) 
1.4 g/cm3 
1.5 g/cm3 
Figure 2.1.3 - Diagram illustrating the formation of CsCl density 
gradients and showing the position of the HSY 
containing material before centrifugation. 
(d) When the centrifuge tubes were viewed under a fluo-
rescent light after centrifugation, two light scat-
tering bands were visible (Figure 1.8). The two 
light scattering bands from one of the gradients 
were carefully removed by hand and diluted to appro-
ximately 5 ml in O, 01 M Tris/HCl pH 7, 4. These 
solutions were then centrifuged at 20 K rpm for 60 
minutes in a Beckman SW 50.1 rotor. The resultant 
pellets were studied by electron microscopy. (Ap-
pendix 2.1.12) (Figure 1.9) 
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(e) The second CsCl density gradient was collected in 15 
drop fractions using the apparatus shown in Figure 
2.1.4. Each fraction was titrated on BHK-21 cells 
(Appendix 2.1.8) and the refractive index read on an 
Abbe Refractometer. The density of CsCl in each 
fraction was determined from the graph of refractive 
index against density (Figure 2.1.2). 
FIGURE 2.1.4 - UPWARD DISPLACEMENT FRACTIONATOR USED IN 
FRACTIONATING CsCl DENSITY GRADIENTS. 
Operation 
Insert the centrifuge tube (A), containing the material 
for fractionation, into the cup (B) which is attached to 
the fixed arm (C) of the stand (D). When using smaller 
diameter centrifuge tubes, an insert (E) is placed in the 
cup to accommodate the smaller tube. Place the sealing 
cone (F) on top of the centrifuge tube and lower the 
moveable arm (G) onto the sealing cone so as to hold the 
centrifuge tube firmly between the two arms. Wind in the 
upper screw (H) so as to apply extra pressure and improve 
the seal between the sealing cone and the centrifuge 
tube. Using a peristaltic pump, displace all air from 
the lower section of tubing by filling the tubing with 
Maxidens (Appendix 1.1.S(i)) until the Maxidens begins to 
emerge from the tip of the syringe needle (I). Wind in 
the lower screw (J) so that the tip of the syringe needle 
penetrates the centrifuge tube by approximately 2 mm. 
Slowly pump Maxidens into the centrifuge tube and collect 
the displaced contents of the centrifuge tube through the 
upper section of tubing. 
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ELECTRON MICROSCOPY 
In order to study RSV by electron microscopy, the virus 
is pelleted by centrifuging at 20 K rpm for 60 minutes in 
a Beckman SW 50.1 rotor. After centrifugation, the 
supernatant fluid is discarded and the pellet is nega-
tively stained with 2% phosphotungstic acid (PTA), pH 
6,0, before examination in a Hitachi 600 electron micro-
scope. 
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2.2 RADIOLABELLING AND ANALYSIS OF RSV GLYCOPROTEINS 
2.2.1 SDS - POLYACRYLAMIDE GEL ELECTROPHORESIS (SDS-PAGE) 
A. Preparation of SDS-Polyacrylamide slab gels. 
(a) Wash the glass plates with water. 
(b) Dry and then wipe with methanol. 
( c) Clean the side pieces (spacers) and place on the 
larger glass plate. 
(d) Place the smaller plate on top of the spacers, with 
the clean side inward. 
(e) Fit in a clean comb and ensure that the pieces fit 
tightly together. Clamp the glass plates together 
with "bulldog-clips". 
(f) Seal the bottom of the cassette with parafilm 
(g) Place the rubber gasket in position on the stand. 
(h) Prepare the wick gel, running gel and stacking gel 
ingredients according to Table 2. 2. 1. Do not add 
ammonium persulphate (APS) or TEMED (Appendix 1.2.2) 
at this stage. 
(i) Add TEMED and APS to the wick gel mixture. Remove 
the comb from the cassette and immediately pour the 
wick gel mixture into the cassette. 
(j) Remove the parafilm from the cassette and attach the 
cassette to the stand with the small glass plate 
facing the buffer reservoir. 
(k) Add TEMED and APS to the running gel mixture. Shake 
to mix and then pour quickly into the cassette to 
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approximately 1 cm from the top of the small glass 
plate. 
(1) Carefully layer distilled water onto the surface of 
the running gel to seal it from the air which pre-
vents polymerization. 
(m) .When running gel has set, remove the water and add 
TEMED and APS to the stacking gel mixture and pour 
to the top of the cassette. 
TABLE 2.2.1 - COMPOSITION OF PAA GELS OF DIFFERENT 
ACRYLAMIDE CONCENTRATION 
Ingredients Wick Gel Running Gel Stacking Gel 
15% 7.5% 10% 3,0% 
ml ml ml ml 
Acrylamide (30%) 1.0 2.0 2.67 0.5 
Running Gel Buffer 0.5 2.0 2.0 -
Stacking Gel Buffer - - - 1.25 
Distilled Water 0.5 4.0 3.33 3.25 
10% APS 0.025 0.025 0.025 0.025 
TEMED 0.025 0.025 0.025 0.025 
(n) Place the comb in position and allow the gel to 
set. 
(o) To prevent reservoir buffer leaking between the gel 
cassette and the electrophoresis apparatus, the 
B. 
c. 
D. 
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surface between the glass plate and the top reser-
voir should be sealed with 1% agarose gel. 
(p) Store the apparatus in a moist container at 4 °C 
until required. 
Sample Preparation 
Samples for analytical SDS-PAGE were added to a mixture 
of 100% glycerol and phenol red dye so as to give a final 
glycerol concentration of approximately 25% (v/v). The 
volume of sample applied to each well was varied accor-
ding to the protein concentration of the sample. 
Electrophoresis 
Electrophoresis was performed at a constant current of 
8 mA per gel. 
Fixing 
After electrophoresis in PAA gel, the proteins must be 
"fixed" in order to prevent them from being washed out of 
the gel during the staining procedure. The proteins were 
fixed by immersing the PAA gel in a solution of 20,% (w/v) 
Trichloroacetic acid (TCA) for a minimum of 30 minutes. 
2.2.2. 
A. 
B. 
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STAINING PROCEDURES FOR PROTEINS IN POLYACRYLAMIDE GELS 
Coomassie Brilliant Blue Stain (CBB) 
Stain - 0.05% CBB (w/v) dissolved in a solution contain-
ing 30% methanol, 10% acetic acid and 60% distilled 
water. 
Destaining Solution - 30% methanol, 10% acetic acid and 
60% distilled water. 
Method - After fixing the proteins in 20% TCA, immerse 
the PAA gel in stain overnight. Then discard the stain 
and wash the gel with several changes of destaining solu-
tion until all of the background stain has been removed 
from the gel and the background is completely trans-
parent. 
Silver Stain - Method 1 (Taken from Merril, Goldman and 
Van Keuren, 1982) 
(a) After fixing the proteins in 20% TCA, wash the gel 
for 30 minutes with a solution containing 10% etha-
nol and 5% acetic acid (v/v). 
(b) Soak the gel for 5 minutes in a solution containing 
0, 0034 M potassium dichromate and O. 0032 N Nitric 
acid. 
(c) Transfer the gel to a solution containing 0,012 M 
silver nitrate and soak for at least 2 hours. 
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(d) Rinse the gel by agitation in a solution containing 
0,28 M sodium carbonate and 0,5 ml formaldehyde (37% 
commercial formaldehyde) per litre. This step re-
quires at least two changes of solution to prevent 
precipitated silver salts from adsorbing to the 
surface of the gel. 
(e) Development is usually stopped when a slightly yel-
lowish background appears. This is done by immers-
ing the gel in a solution of 1% (v/v) acetic acid. 
C. Silver stain - Method 2 (Taken from Sammons, Adams 
and Nishizawa, 1981) 
(a) After fixing the proteins, wash the gel extensively 
(i.e. overnight) in a solution of 10% ethanol and 
0,5% acetic acid to completely remove SDS. 
( b) Immerse the gel in AgN03 solution containing 1, 9 
g/litre for at least 2 hours. 
( c) Rinse the gel twice in distilled water to remove 
excess surface silver. 
(d) Immerse the gel in a reducing solution of 0,75 M 
NaOH, 7,5 ml/litre formaldehyde (37% commercial 
formaldehyde) and 87,5 mg/litre NaBH4. 
(e) For the best results, the gel should be removed from 
the reducing solution within 10 minutes and placed 
2.2.3. 
2.2.4. 
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into a colour enhancing solution of 0,75% NazC03 for 
30 minutes. 
(f) Stop development by immersing the gel in a solution 
of 1% (v/v) acetic acid. 
DRYING OF POLYACRYLAMIDE GELS 
The PAA gels should first be soaked for at least 10 
minutes in 3% glycerol. The glycerol prevents cracking 
of the gel during drying. The PAA gel is then wrapped in 
wet, porous cellophane (Hoefer Scientific Instruments) 
and dried under vacuum at 80 °C, using a slab gel dryer 
(Hoefer Scientific Instruments). 
AUTORADIOGRAPHY 
(a) Impregnation with EN3HANCE 
After proteins have been fixed in the PAA gel, (Ap-
pendix 1.2.3.), the gel is impregnated with EN3HANCE 
(Appendix 1.2.5) by adding enough EN3HANCE so that 
the gel is free floating. The gel should remain in 
EN3HANCE for at least one hour with gentle agita-
tion. 
(b) Precipitation 
Once the gel has been impregnated with EN3HANCE, 
discard the used enhancer solution into an appropri-
ate radioactive waste container. An excess of cold 
water is then added to the gel to precipitate the 
fluorescent material inside the gel. The gel should 
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be kept in water for one hour only with gentle agi-
tation, after which the gel should appear uniformly 
opaque. (Longer times are unnecessary and may be 
detrimental.) 
(c) Drying and Exposure 
After the EN3HANCE has been precipitated into the 
gel, the gel is dried (Appendix 2. 2. 4). The dried 
gel is then exposed to X-ray film (either Kodak X-
Omat MA or Kodak X-Omat ARS) for an appropriate 
length of time. 
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2.3 Purification of Herpes Simplex virus type 1 (HSV-1) 
glycoproteins 
2.3.1 Preparative Polyacrylamide Gel Electrophoresis (Prep-
PAGE 
Preparative polyacrylamine gel electrophoresis (Prep-
PAGE) is based on the same technique as analytical SDS-
PAGE ( Chapter 2 .1. 2) except that Prep-PAGE is performed 
in an apparatus which allows for the use of preparative 
amounts of material and the collection of samples during 
electrophoresis (Figure 2. 3.1). The preparation of the 
PAA gel for Prep-PAGE is the same as that for analytical 
SDS-PAGE (Appendix 2. 2.1) except that a "wick" gel cannot 
be used. The method is as follows:-
(a) Remove the gel tube from the Prep-PAGE apparatus 
(Figure 2.3.1) and seal the bottom of the gel tube 
with parafilm. 
(b) Cast a 7,5% PAA running gel (Appendix 2.2.1) in the 
gel tube (Diameter, 1.3 cm) to a length of 6 cm. 
( c) When the running gel has set, cast a stacking gel 
(Appendix 2.2.1) above it. The gel tube containing 
the PAA gel can be stored for up to one week at 4 °C 
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by sealing both ends of the tube with parafilm to 
prevent the gel dehydrating. 
(d) When the PAA gel is required, remove the parafilm 
from the gel tube and insert the gel tube into the 
Prep-PAGE apparatus (Figure 2.3.1). Attach the 
other instruments to the Prep-PAGE apparatus in 
order to give the complete set up required for Prep-
PAGE as shown in the diagram. 
(e) Fill the buffer reservoirs with the reservoir buffer 
(Appendix 1.2.l(c)) as shown in the diagram and seal 
the lower section of the gel tube with dialysis 
membrane. 
(f) Solubilize the sample for electrophoresis in 1,0 ml 
of I.MW sample buffer (Appendix 1.2.l(d)) and heat at 
100°C for 5 minutes. Then add 0,3 ml of 100% gly-
cerol containing phenol red dye. 
(g) Apply the prepared sample to the top of the PAA gel 
and electrophorese at 8 mA until the required mater-
ial has been eluted from the bottom of the PAA gel. 
Fractions of 5 ml. were collected at a flow rate of 
approximately 8 ml/hour. 
(h) Assay 0, 1 ml aliquots of each fraction for radio-
activity (Appendix 2.3.5). 
(i) Draw an elution profile of counts per minute (CPM) 
against fraction number. 
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Hydroxylapatite chromatography in the presence of 
sodium dodecyl sylphate (SDS-HTP). 
Hydroxylapatite chromatography in the presence of sodium 
dodecyl sulphate (SDS-HTP) was performed according to ,the 
method of Eberle & Courtney (Eberle & Courtney, 1980 (a). 
The only change to the method was the use of HA Ultrogel 
(Appendix 1.3.1) instead of ordinary hydroxylapatite. 
(a) Pour 10 ml of HA Ultrogel into a column (Diameter 16 
mm) and wash the column with 20 ml of O, 01 M phos-
phate buffer, pH 6,4, containing 0,1% SDS and 1 mM 
dithiothreitol at a flow rate of 8 ml/hr. 
(b) Samples for SDS-HTP chromatography were dialyzed 
overnight against 0,01 M phosphate buffer, pH 6,4, 
containing 0,1% SDS and heated at 100°C for 5 minut-
es before applying to the SDS-HTP column. 
(c) The material was eluted from the column using a 
linear gradient of increasing phosphate molarity 
from 0,1 M to 0,5 M phosphate buffer, pH 6,4, con-
taining O, 1% SDS and 1 mM dithiothreitol over a 6 
hour period. The phosphate gradient was produced in 
a Gilson MixoGrad automatic gradient former (Gilson 
Medical Electronics, Inc.) 
(d) 5 ml fractions were collected at a flow rate of 16 
ml/hr. 
(e) 0, 1 ml aliquots of each fraction were assayed for 
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radioactivity (Appendix 2.3.5) and the elution pro-
file of counts per minute against fraction number 
was drawn. 
Gel-bound lectin affinity chromatography 
Gel bound lectin affinity chromatography was used as a 
means to further purify glycoproteins, which had been 
separated by Prep-PAGE, from non-glycosylated proteins. 
The techniques used were as follows:-
A. Wheat germ lectin affinity chromatography. 
Column preparation: 8 ml of wheat germ lectin Seph-
arose 6 MB (Appendix 1.3.2) was poured into a column 
( diameter 9 mm). The gel was then washed with 50 
column volumes of equilibration buffer (0,01 M tris 
(hydroxymethyl) aminomethane (Tris)-hydrochloride -
0,15 M NaCl - 0,02% (wt/vol) NaN3 (pH 8.0)) in order 
to remove preservatives. 
Sample preparation: Material that had been prepared 
by Prep-PAGE and stored at -20°C (Chapter 3.2.l(B)) 
was thawed and dialysed overnight against O, 1 M 
glycine-sodium hydroxide buffer (pH 8,8) containing 
1% Triton X-100. After dialysis, this material was 
applied to the wheat germ lectin column at a rate of 
20 ml/hr. 
Elution: After applying the sample to the wheat 
germ lectin column, · the column was washed with a 
further 50 ml of equilibration buffer, at a flow 
B. 
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rate of 20 ml/hr to wash away any proteins which had 
not adsorbed to the column. The adsorbed proteins 
were eluted using 20 ml of 0,2 M N-acetyl-D-gluco-
samine (GlcNAc) in equilibration buffer with 1% 
Triton X-100 at a flow rate of 20 ml/hr. 
Helix pomatia lectin affinity chromatography. 
Column preparation: 2 ml of Helix pomatia lectin 
Sepharose 6 MB (Appendix 1. 3. 2) was poured into a 
column and washed with 50 column volumes of equili-
bration buffer (O, 01 M tris (hydroxymethyl) amino-
methane (Tris) - hydrochloride - 0,15 M NaCl - 0,02% 
(wt/vol) NaN3 (pH 8,0) to remove preservatives. 
Sample preparation: As for wheat germ lectin chro-
matography (Appendix 2.3.3(A)). 
Elution: After applying the sample to the Helix 
pomatia lectin column, the column was washed with a 
further 20 ml of equilibration buffer at a flow rate 
of 20 ml/hr to wash away any unadsorbed proteins. 
Adsorbed proteins were eluted using 20 ml of 0,05 M 
N-acetyl-D-galactosamine (GalNAc) in equilibration 
buffer + 1% Triton X-100 at a flow rate of 20 
ml/hr. 
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Preparation of HSV-1 membrane proteins in Triton X-100 
for lectin affinity chromatography. 
HSV-1 membrane proteins were prepared for lectin affinity 
chromatography using the method of Olofsson et al, 1981. 
The method was as follows:-
(a) HSV-1 infected BHK-21 cells were grown in the pres-
ence of ( 3H)- glucosamine (( 3H)-gln), as described 
previously (Chapter 2.2.2). 
(b) At 28 hrs post-infection, the infected cells were 
shaken from the surface of the cell culture flask 
and the infected cell suspension was centrifuged at 
1500 x g for 5 minutes in order to pellet the cells. 
The supernatant was discarded and the cell pellet 
stored at -70°C until required. 
(c) The packed cells were thawed and adjusted to 4 times 
their volume using ice-cold 0,025 M Tris-hydrochlo-
ride, pH 8,0. The cell extracts were kept on ice 
throughout the remainder of the procedure. 
(d) The infected cell suspension was ul trasonicated for 
three cycles of 5 seconds (Appendix 2. 1. 9) and the 
homogenate was centrifuged at 1500 x g for 5 
minutes. 
(e) The supernatant was decanted and stored at 4 °C and 
the cell pellet was resuspended in 2 ml of O, 025 M 
Tris-hydrochloride, pH 8,0 ultrasonicated and cent-
rifuged at 800 rpm for 5 minutes. This procedure 
was repeated twice and the supernatants were pooled 
at 4°C. 
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(f) The pooled supernatants were centrifuged at 27 000 x 
g for 1 hr. After centrifugation the supernatant 
was collected and the pellet discarded. 
(g) The membranes remaining in the supernatant were 
pelleted by centrifuging at 160 000 x g for 1 hr. 
(h) The pelleted membranes were resuspended in 5 ml of 
cold 0,1 M glycine - NaOH buffer, pH 8,8 and centri-
fuged at 160 000 x g for 1 hr. 
(i) The washed membranes were resuspended in 5 ml of 
cold 0,1 M glycine-NaOH buffer, ~H 8,8 containing 1% 
Triton X-100 (wt/vol). 
(j) The membrane suspension was ultrasonicated for three 
cycles of 10 seconds and incubated on ice for 10 
min. The membrane suspension was then centrifuged 
at 100 000 x g for 1 hr. 
(k) The supernatant was stored at -70 °C until required 
for affinity chromatography. 
Assay for Radioactivity 
0, 1 ml aliquots of aqueous solutions containing either 
(3H)-glucosamine or (14c)-amino acid labelled proteins 
were placed in scintillation vials. 3,0 ml of scintilla-
tion fluid (Appendix 1.3.3) was then added to each vial 
and mixed thoroughly. The radioactive content of each 
vial was read in a Beckman LS 8000 Liquid Scintillation 
System (Beckman Instruments). 
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Lyophilization (Freeze-drying) 
Solutions of proteins can be concentrated by freeze-dry-
ing and then resuspending in the required volume of buf-
fer. The method used for freeze-drying was as follows:-
(a) If the volume of solution was excessive, it could be 
reduced by pervaporation (Appendix 2.3.7). 
(b) Dialyze the solution against the buffer in which the 
protein is dissolved in order to remove excess buf-
fer salts. 
(c) Place the protein solution in a suitable container 
i e a glass-ampoule or test-tube. 
(d) Freeze the sample rapidly in 2-Methoxyethanol which 
has been pre-cooled with dry-ice to approximately 
-80 °C. While freezing the sample, the container 
must be rotated constantly so that the sample freez-
es over as large an area as possible. 
(e) Expose the sample(s) to a vacuum of 0,1 Torr. until 
they are totally dehydrated. 
Pervaporation 
Another technique that can be used for concentrating 
protein solutions is pervaporation. 
(a) Place the protein solution in a dialysis tube and 
suspend the tube in a fridge or cold room at 4 °C. 
The solution becomes concentrated as water is eva-
porated. 
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b) When the solution is sufficiently concentrated, 
dialyze the tube against the original buffer in 
which the protein is dissolved, in order to remove 
excess buffer salts. 
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